Graduate Theses, Dissertations, and Problem Reports
2003

Molecular mechanisms of G protein-receptor coupling
Hongzheng Ma
West Virginia University

Follow this and additional works at: https://researchrepository.wvu.edu/etd

Recommended Citation
Ma, Hongzheng, "Molecular mechanisms of G protein-receptor coupling" (2003). Graduate Theses,
Dissertations, and Problem Reports. 1878.
https://researchrepository.wvu.edu/etd/1878

This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses,
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU.
For more information, please contact researchrepository@mail.wvu.edu.

Molecular Mechanisms of G Protein-Receptor Coupling

Hongzheng Ma
Dissertation submitted to the School of Medicine at West Virginia University
in partial fulfillment of the requirements for the degree of

Doctor of Philosophy
in
Pharmacology & Toxicology

Approved by
Stephen G. Graber, Ph.D. (Chair)
Daniel C. Flynn, Ph.D.
James E. Mahaney, Ph.D.
Jeannine S. Strobl, Ph.D.
William F. Wonderlin, Ph.D.

Department of Biochemistry & Molecular Pharmacology
School of Medicine
West Virginia University
Morgantown, West Virginia
2003

Keywords: G-protein, GPCR, Receptor coupling, Muscarinic, AGS3, Sf9 cells.

UMI Number: 3132956

________________________________________________________
UMI Microform 3132956

Copyright 2003 by ProQuest Information and Learning Company.
All rights reserved. This microform edition is protected against
unauthorized copying under Title 17, United States Code.
____________________________________________________________
ProQuest Information and Learning Company
300 North Zeeb Road
PO Box 1346
Ann Arbor, MI 48106-1346

ABSTRACT
Molecular Mechanisms of G Protein-Receptor Coupling
Hongzheng Ma
A variety of extracellular signals are transmitted into the cell interior by
interactions with a superfamily of heptahelical cell surface receptors.
Heterotrimeric G proteins mediate the signal transduction by coupling these
receptors to intracellular effector proteins. The molecular mechanisms in G
protein-receptor coupling processes are still not completely understood. In this
project, two aspects of G protein-receptor coupling were examined: 1) the G
protein-coupling properties of the five human muscarinic acetylcholine receptors
(mAChRs); 2) a novel regulatory mechanism by a newly identified G protein
signal regulator, Activator of G-protein Signaling 3 (AGS3). To study the
regulation of G protein-receptor coupling, an Sf9 cell membrane-based in vitro
reconstitution system was used, in which purified G protein heterotrimers were
reconstituted with individually expressed membrane receptors and their coupling
was assessed with radioligand binding assays.
Functional G protein coupling was successfully established for M1, M2,
M4 and M5 mAChRs in urea-extracted Sf9 cell membranes. Under the same
conditions, M3 mAChRs failed to couple with purified G proteins, indicating they
may have a unique G protein signaling mechanism. Within the odd- or evennumbered mAChR groups similar apparent affinities for G protein interactions
were observed, however, the odd-numbered mAChRs exhibited higher affinity for
G protein heterotrimers than did the even-numbered mAChRs. Differences were
also observed among the individual receptor subtypes in their affinity states for
the agonist, Oxotremorine-M.
Studies on AGS3 revealed that cytosolic AGS3, but not membraneassociated AGS3, can interfere with receptor-Gi protein coupling. Cytosolic
AGS3 can remove Giα subunits from the plasma membrane and sequester them
in the cytosol. Each of the four AGS3 GPR (G protein regulatory) domains was
able to interfere with receptor-Gi protein coupling; however, individual domains
were less effective than the full-length GPR domain. None of the GPR domains
distinguish among the three Giα subunits but they all interact more weakly with
Goα subunits.
These studies demonstrate that five mAChRs have distinct G proteincoupling behaviors in an identical membrane environment and that AGS3 may
down-regulate G protein signaling by interfering with receptor coupling. These
findings contribute to the understanding of the mechanism and regulation of G
protein-receptor coupling.
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CHAPTER 1: INTRODUCTION
In all eukaryotic organisms, heterotrimeric guanine nucleotide binding protein (G
protein) mediated signal transduction is used by cells to respond to a diverse array of
extracellular stimuli such as hormones, neurotransmitters, dietary chemicals and sensory
stimuli. G proteins mediate the transduction of extracellular signals across the plasma
membrane by coupling cell surface receptors to effector proteins. These signal inputs
propagate to the intracellular signaling network to control a broad range of cellular
responses such as metabolism, contractility, secretion, motility, transcription and growth.
Integration of these cellular responses at systemic levels leads to the regulation of many
physiological functions such as organismal homeostasis, embryonic development,
gonadal development, learning and memory (Neves et al., 2002). Dysfunction of this
signaling transduction system has been shown to relate to a variety of human diseases
(Spiegel, 1996; Spiegel, 1997; Farfel et al., 1999; Edwards et al., 2000)
The essential roles of the G protein signal transduction system in both normal and
pathological states have made its components attractive targets for pharmacological
interventions. In fact, more than 40% of all currently prescribed drugs target G protein
coupled receptors (GPCRs) (Drews, 2000). Most of these drugs exert their effects on
GPCRs either as agonists or as antagonists, but researchers have also been trying to
develop new approaches to manipulate this signal transduction process (Akhter et al.,
1998; Feldman et al., 2002). Recently, a membrane permeable peptide, designed on the
structural basis of receptor-G protein coupling, successfully blocked the thrombin
receptor-mediated human platelet aggregation (Covic et al., 2002). Thus, elucidation of
1

the detailed molecular mechanisms of G protein signaling pathway will not only help us
better understand human physiology, but may also provide novel therapeutic strategies to
treat human diseases.
Heterotrimeric G protein:
Historical perspectives. The study of heterotrimeric G proteins began over three
decades ago in 1971, when Rodbell et al noticed that GTP was involved in the activation
of adenylyl cyclase by glucagon (Rodbell et al., 1971). Later on, observations from
several groups suggested the existence of a GTP-associated protein distinct from the
receptor and adenylyl cyclase (Londos et al., 1974; Salomon et al., 1975; Cassel and
Selinger, 1976; Maguire et al., 1976). In 1977, Ross and Gilman provided the first direct
evidence showing that the GTP-dependent transmembrane signaling pathway was
composed of at least three distinct proteins: receptor, G protein and effector (Ross and
Gilman, 1977a; Ross and Gilman, 1977b).

In 1980, a G protein involved in the

stimulation of adenylyl cyclase was first purified by Northup et al and shown to have a
heterotrimeric structure, which was designated as α, β and γ subunits (Northup et al.,
1980). A few years later, the same group purified another G protein, which has an
inhibitory effect on adenylyl cyclase (Bokoch et al., 1984). With the use of molecular
cloning techniques, numerous G protein subunits have been cloned since 1985 (Simon et
al., 1991).
Diversity of G protein subunits. To date over 20 α subunits, 6 β subunits and 12
γ subunits have been identified (Simon et al., 1991; Ray et al., 1995; Watson et al.,
1996). Based on amino acid sequence similarity, G protein α subunits are classified into
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four major families, αs, αi, αq and α12 and the heterotrimeric G proteins are
conventionally named after their α subunits. Overall α subunits share at least 40%
identity at the amino acid level, with 60-90% identity within individual families (Simon
et al., 1991). The αs family, in which “s” refers to the stimulatory effect on adenylyl
cyclases, was discovered first and includes αs and αolf members. The αi family including
αi1, αi2, αi3, αoA, αoB, αt1, αt2 and αz was initially named for the ability of αi to inhibit
adenylyl cyclases. The αq family consists of αq, α11, α14, α15 and α16 members that can
stimulate phospholipase C. The α12 and α13 were classified into the last family because
of their sequence similarity; however, their exact functions have not been well
established. In contrast with the α subunits, the amino acid sequences of β subunits are
highly conserved. Above 80% of their amino acid sequence are identical with β5 as an
exception, which only has 53% sequence identity to other β subunits (Watson et al.,
1996; Clapham and Neer, 1997). The G protein γ subunits are the most divergent ones
(Cali et al., 1992).

Although they share considerable sequence similarity at their

carboxyl termini, their amino terminal sequences are much more different from each
other.
G protein α subunits. The α subunits of heterotrimeric G proteins consist of a
single polypeptide chain with molecular weight from 39 to 52 kDa. All α subunits can
bind and hydrolyze GTP, although their intrinsic rates of GTP hydrolysis vary
dramatically (Carty et al., 1990; Linder et al., 1990; Chidiac et al., 1999).
Crystallographic studies (Lambright et al., 1994; Sondek et al., 1994; Coleman et al.,
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1994a; Coleman et al., 1994b; Mixon et al., 1995; Wall et al., 1995; Lambright et al.,
1996) reveal that α subunits share common structural features and have significant
conformational changes when either the bound guanine nucleotide or the interaction with
βγ subunits is changed (Noel et al., 1993). Briefly, α subunits contain two principal
domains.

A GTPase domain, which is involved in nucleotide binding and GTP

hydrolysis, shares considerable sequence similarity with a superfamily of GTPase
proteins including elongation factor EFTu and small G proteins such as Ras, Rab, Rac,
Ral, etc (Bourne et al., 1990). The GTPase domain consists of six stranded β-sheets
surrounded by six helices (α1- α5 and αG) (Figure 1). The other is a unique α-helical
domain consisting of a long central helix (αΑ) surrounded by five shorter helices
(αΒ−αF). The guanine nucleotide binds tightly in the cleft between the GTPase and αhelical domains. When bound to GTP, α subunits dissociate from receptors and βγ
subunits to interact with their downstream effector proteins such as adenylyl cyclase,
phosphodiesterase, phospholipase C, and ion channels (Gilman, 1987).
G protein βγ subunits. The Gβ subunits with molecular weight of about 37 kDa
consist of two distinct domains, an amino terminal domain, which has a 20-amino acid αhelical structure, and the remainder of the molecule, which has seven repeated sequences
(Wall et al., 1995; Lambright et al., 1996; Sondek et al., 1996). The amino terminal αhelical domain associates with Gγ subunit through a coiled-coil interaction, while the
seven repeated sequences, termed as WD-repeats, are made up of small antiparallel β
strands that are arranged in a ring to form a propeller-like structure (Lupas et al., 1991;
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Figure 1.

β1
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α

β4

β2 β3
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β5

C
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Figure 1. Schematic representation of Gα
α secondary structural domains. The secondary structural domains, which are
common to Gα subunits were determined from the crystallographic studies (Lambright et al., 1994; Sondek et al., 1994;
Coleman et al., 1994a; Coleman et al., 1994b; Mixon et al., 1995; Wall et al., 1995; Lambright et al., 1996). The shaded
regions represent the sequences that form the corresponding secondary structures and are labeled as α for α-helices or β for
β-sheets. The underlined are the components of the unique helical domain. N, the amino terminus; C, the carboxyl terminus.
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Sondek et al., 1996). These WD-repeats, composed of approximately 43 amino acids are
not unique to Gβ subunits and are found in a superfamily of proteins with diverse
functions (Neer et al., 1994). The Gγ subunits are about 75 amino acids long with a
molecular weight of about 8 kDa. They are not only divergent in their sequence but also
different in their lipid modifications by prenyl groups (Spiegel et al., 1991; Clapham and
Neer, 1993; Casey, 1994). The amino terminus of Gγ subunits forms a coiled-coil
contact with the amino terminal α-helix of Gβ, and the rest of the molecule extends to the
contacting faces of the blades 5, 6 and 7 of the Gβ propeller structure (Sondek et al.,
1996). The multiple contact sites contribute to the tight association of βγ subunits such
that they can only be separated under denaturing conditions.

In fact, βγ subunits act

functionally as a monomer, though they are two distinct polypeptides. When freed from
Gα subunit they can independently or synergistically modulate a variety of effectors such
as K+ channel, Ca2+ channel, phospholipase A2, phospholipase C-β, adenylyl cyclase,
PI3K, GPCR kinase, MAP kinase cascade and yeast pheromone response (Clapham and
Neer, 1997).
GTPase cycle. In the conventional model (Gilman, 1987; Neer, 1995; Hamm,
1998), G proteins cycle between a GDP-bound inactive state and a GTP-bound active
state to transmit signals from cell surface receptors to effectors. As illustrated in Figure
2, when bound to GDP, Gα subunits associate with Gβγ subunits to form the inactive
heterotrimer.

When

extracellular

stimuli

activate

GPCRs,

GPCRs

undergo

conformational changes, which enable them to interact with G protein heterotrimers. The
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Figure 2.
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αGDP βγ

GDP

Pi

R*α
αe βγ

βγ
R*

Turn off

Turn on

αGTP

GTP

βγ
Ε2

Ε1

Figure 2. The GTPase cycle of heterotrimeric G proteins (Adapted from Iiri et al.,
1998). The “turn on” step begins when the activated receptor (R*) interacts with the
GDP-liganded heterotrimer (α
αGDP βγ),
βγ catalyzing the GDP dissociation and resulting in a
“empty-pocket” state of R*α
αeβγ complex (“e” indicates the empty state of α subunit).
The GTP binding to α causes its dissociation from R* and βγ subunit. Both αGTP and
free βγ are able to activate their effectors (E1, E2) and initiate signaling cascades. The
“turn off” step depicts the GTP hydrolysis (to GDP and inorganic phosphate, Pi) and
consequent α GDP and βγ subunit reassociation.
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activated GPCRs then catalyze the dissociation of GDP from Gα subunits resulting in a
so-called “empty-pocket” complex of liganded receptor and αβγ heterotrimer and the
intracellular GTP consequently binds to the empty Gα subunit. Once GTP is bound, Gα
subunit switches to its active state and dissociates from both receptor and Gβγ subunits.
Both Gα•GTP and free Gβγ are able to activate a number of effectors, however, the
bound GTP will eventually be cleaved back to GDP due to the intrinsic GTPase activity
of Gα subunits. Gα•GDP and free Gβγ then reassociate with each other and the signal is
turned off.

Thus, the rate of GDP release from Gα subunit and the rate of GTP

hydrolysis are two key components determining the timing of signal activation and
deactivation.
Cellular localization.

Unlike transmembrane GPCRs, newly synthesized G

protein subunits do not insert into the ER membrane to be translocated to the plasma
membrane. In contrast, after synthesis in the cytosol (Rehm and Ploegh, 1997) they have
to be modified and assembled before trafficking to the plasma membrane to transmit
signals from GPCRs. For example, mutations disrupting the myristoylation of Gαi shift
Gαi from the membrane to the cytosol fraction (Jones et al., 1990) and mutations
preventing Gβγ interaction with Gαs and Gαq disrupt the membrane targeting of these α
subunits (Evanko et al., 2000). Currently there are several possible mechanisms that
explain how G protein subunits are assembled and targeted to the plasma membrane.
First of all, lipid modifications of G protein α and γ subunits in general facilitate the
membrane localization and subunit assembly of heterotrimeric G proteins (Marshall,
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1993; Casey, 1994; Wedegaertner et al., 1995; Chen and Manning, 2001).
Myristoylation and/or palmitoylation of Gα subunits and the prenylation of Gγ subunits
occur post- or co-translationally in a presumably cytosolic compartment and are believed
to provide membrane anchors for the heterotrimeric G proteins. As for N-myristoylation
modification, a myristoyl group is co-translationally attached at the amino terminal
glycine residue of α subunits and this occurs only for Gi family members, while for
palmitoylation a palmitoyl group is post-translationally attached to a cysteine residue
near the amino terminus of almost all Gα subunits except Gαt. For Gi family members,
palmitoylation appears to be sufficient to target their α subunits to the plasma membrane
(Shahinian and Silvius, 1995), while N-myristoylation, though not sufficient by itself to
target Gαi to the plasma membrane, plays an important role in facilitating the membrane
anchorage and the palmitoylation of Giα (Jones et al., 1990; Mumby et al., 1990; Hallak
et al., 1994; Mumby et al., 1994; Mumby and Linder, 1994). N-myristoylation also play
a critical role in assembling Gαi with Gβγ subunits (Jones et al., 1990; Linder et al.,
1991). Other than Gαi subunits, the majority of Gα subunits are not N-myristoylated but
they are all palmitoylated at either one site (Gαs and Gα11) or two sites (Gαq and Gα13)
near their amino termini (Chen and Manning, 2001). There was an initial dispute about
whether or not palmitoylation is sufficient to ensure a stable membrane anchorage for
these α subunits, but Evanko et al have demonstrated that Gβγ subunits are required for
both membrane anchorage and palmitoylation (Evanko et al., 2000). Although lipid
modification of Gγ subunits is not necessary for their assembly with Gβ subunits, it is

9

required for the productive interaction of Gβγ with Gα subunits, receptors and other
proteins, and for the correct membrane targeting as well (Casey, 1994; Wedegaertner et
al., 1995).

All Gγ subunits undergo prenylation, in which a 20-carbon isoprenoid

geranylgeranyl or a 15-carbon isoprenoid farnesyl group is covalently added to the
cysteine residue in the carboxyl terminal “CAAX” box of the Gγ subunits.
As partly discussed above, Gβγ subunits are required for Gα subunit membrane
targeting and stable membrane association (Sternweis, 1986; Wedegaertner et al., 1995;
Chen and Manning, 2001). Rehm and Ploegh reported that Gβ and Gγ subunits dimerize
immediately upon their synthesis in the cytosol (Rehm and Ploegh, 1997), while
Michaelson et al demonstrated that Gα subunit has to associate with Gβγ on the Golgi
before the heterotrimer is translocated to the plasma membrane (Michaelson et al., 2002).
Gβγ subunits not only direct the plasma membrane targeting of Gα subunits, but also
facilitate their palmitoylation (Wang et al., 1999; Evanko et al., 2000; Evanko et al.,
2001). There are several lines of evidence showing that the amino terminal region of Gα
subunit may provide additional membrane anchoring via protein-lipid or protein-protein
interaction (Busconi et al., 1997; Busconi and Denker, 1997; Gillen et al., 1998). Taken
together, the membrane targeting and anchoring of heterotrimeric G proteins may depend
on multiple factors including lipid modification, subunit assembly and even direct
interaction of G proteins with the plasma membrane.
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G protein coupled receptors:
Historical perspectives.

After the cloning of human rhodopsin in 1984 and

hamster β2-adrenergic receptor in 1986, it was found that the G protein-coupled “lightreceptor” rhodopsin and the “classical” ligand-binding receptor, β2-adrenergic receptor,
share considerable sequence identity (Nathans and Hogness, 1984; Dixon et al., 1986).
Based on the physical structure from studies of bacteriorhodopsin (Henderson and
Unwin, 1975) and human rhodopsin itself, it was proposed that GPCRs share a common
structure consisting of a single-chain peptide with seven stretches of 18-30 hydrophobic
amino acid residues that may form membrane-spanning α-helical segments.

This

concept was rapidly confirmed by the cloning of other GPCRs (Dohlman et al., 1991).
Diversity and classification. In humans, approximate 750 GPCRs have been
reported (Watson and Arkinstall, 1994; Vassilatis et al., 2003). These receptors belong to
a superfamily of cell surface receptors with seven transmembrane segments and mediate
signal transduction via heterotrimeric G proteins. Their ligands range from Ca2+ ions to
small biogenic amines, nucleotides, eicosanoids, peptides and glycoproteins (Ji et al.,
1998; Wess, 1998). Based on the sequence similarity, GPCRs can be classified into four
major families and they can be further grouped according to their ligand structure and G
protein coupling properties (Wess, 1998).
Structure. Although only the crystal structure of rhodopsin has been resolved so
far (Palczewski et al., 2000), the seven transmembrane α-helical structure of the other
family members has been inferred from cloning, physical, biochemical and theoretical
studies (Nathans, 1987; Dohlman et al., 1991; Baldwin, 1993; Pogozheva et al., 1997;

11

Herzyk and Hubbard, 1998). As shown in Figure 3, the seven α-helical segments are
linked by three alternative intracellular (i1-i3) and extracellular loops (o2-o4) with the
amino terminus (o1) and the carboxyl terminus (i4) at the extracellular and intracellular
side, respectively. If a cysteine residue within the carboxyl terminus is palmitoylated, a
fourth intracellular loop may be formed. The seven transmembrane segments are the
highly conserved regions among different families and within an individual family while
the other regions vary both in their sequences and sizes, which may correlate to their
diverse structures and functions. In general, the extracellular segments and the exofacial
portions of the transmembrane segments are involved in ligand binding while the
intracellular segments participate in the G protein activation and the interaction with
other proteins (Dohlman et al., 1991; Schwartz, 1994; Wess, 1997; Ji et al., 1998; Wess,
1998).
Ligand binding and receptor activation. The domains and modes of GPCRs for
ligand binding vary greatly as reviewed by Ji et al (Ji et al., 1998). Ligand binding is
believed to cause GPCR conformational changes that may be a distinct step from receptor
activation depending on the nature of the ligands (i.e. full agonist, partial agonist,
competitive antagonist or inverse antagonist). It was proposed that ligand binding may
cause relative movements of transmembrane helices, which either stabilize GPCR in
inactive conformations (as for antagonists) or shift to active conformations (as for
agonists) (Wess, 1997). This idea was supported by direct structural analyses with the
fluorescence spectroscopic technique from Kobilka’s group (Gether et al., 1995; Gether
et al., 1997a; Gether et al., 1997b).
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Figure 3.
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Figure 3: Schematic presentation of the general structure of GPCRs and
terminology.

N’ and C’ represent the amino and carboxyl termini. The seven

transmembrane helices are numbered I-VII from left to right; four extracellular segments
o1-o4; and four intracellular segments i1-i4.
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The models explaining GPCR activation upon ligand binding are still evolving.
Currently the majority of the experimental data can be explained by the widely accepted
“extended ternary complex model”, which was deduced from the studies of mutations of
β2-adrenergic receptor (Samama et al., 1993). In this model, GPCRs equilibrate between
an inactive (R) and an active (R*) conformation.

When shifted to the active

conformation, GPCRs are capable of coupling to the heterotrimeric G proteins. The
conformational change associated with activation may occur spontaneously, or be
induced by agonists or certain mutations. The active receptor conformation, R*, couples
to the heterotrimeric G proteins and catalyzes the GDP dissociation from the Gα
subunits, resulting in guanine nucleotide-free G proteins, which in turn stabilize R* in the
highest affinity state for agonist binding. This association of agonist/receptor/G-protein
is referred to as the ternary complex.

This model successfully explained agonist-

independent basal G protein activation and mutation-induced “constitutive” G protein
activation. However, there are several lines of evidence indicating that the extended
ternary model may oversimplify the GPCR behaviors (Krumins and Barber, 1997; Leff
and Scaramellini, 1998; Wenzel-Seifert and Seifert, 2000; Lopez-Gimenez et al., 2001).
Current results support the existence of multiple activated states of GPCRs that may be
induced by agonists with different affinity orders or efficacy orders, or stabilized by
heterotrimeric G proteins with different conformations (Chidiac, 1998; Scaramellini and
Leff, 1998; Surya et al., 1998). Further evidence also comes from our laboratory with the
identification of a G protein chimera, which is inactive in stabilizing receptor in high
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affinity agonist binding state but still active in agonist-catalyzed guanine nucleotide
exchange (Slessareva et al., 2002).

GPCR-G protein coupling:
Diversity in R-G coupling.

A striking characteristic of G protein mediated

signaling is the redundancy of receptor subtypes. One extracellular stimulus may exert
diverse physiological effects by acting on a variety of receptor subtypes that may have
different tissue expression patterns and/or signaling pathways. For biogenic amines as
examples, 9 epinephrine receptors, 5 dopamine receptors, 2 histamine receptors, 5
muscarinic acetylcholine receptors and 13 serotonin receptors have been identified by
molecular cloning studies and all of them can elicit their responses by coupling to
heterotrimeric G proteins (Wess, 1998).

By coupling to different heterotrimeric G

proteins, these receptors elicit a broad range of actions in response to their endogenous
ligands (Hulme et al., 1990; Lucas and Hen, 1995). It is still not well understood if there
is any subtle difference in their abilities to recognize endogenous ligands or what may
account for the differences in their G protein coupling properties. More puzzlingly,
within these receptors and other receptor families multiple subtypes have been shown to
couple to the same set of G protein heterotrimers (Gudermann et al., 1996). For example,
three muscarinic acetylcholine receptor subtypes (M1, M3 and M5) all couple to Gq
proteins upon activation by acetylcholine but elicit different physiological responses
(Caulfield and Birdsall, 1998). Therefore, the molecular details of their G protein
coupling properties need closer examination to better understand the physiological
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actions of a given receptor subtype. Such information will also improve pharmacological
intervention of these receptors. Furthermore, as summarized by Gudermann et al and
exampled in Figure 4 many receptor subtypes are known to often couple to multiple G
protein heterotrimers, which adds more complexity to this signaling system (Gudermann
et al., 1997). Extensive efforts have been made to understand how an extracellular
stimulus leads to an appropriate response after activating GPCRs and what are the
additional components that direct and fine-tune the signal propagation within the
intracellular signaling network (see discussion below).
Despite of the fact that many GPCRs can elicit their effects by coupling to
multiple G proteins, the majority of GPCRs only interact with a distinct subset or even a
specific G protein heterotrimer (Hedin et al., 1993; Raymond, 1995; Gudermann et al.,
1996; Wess, 1997; Gudermann et al., 1997). The 20 Gα subunits, 6 Gβ subunits and 12
Gγ subunits may theoretically make 1,440 combinations of Gαβγ heterotrimers, however,
evidence has indicated that not all the possible combinations can occur (Schmidt et al.,
1992; Pronin and Gautam, 1992; Iniguez-Lluhi et al., 1992; Yan et al., 1996).
Considering the high homology in the G protein sequences (Simon et al., 1991), it is very
interesting to understand how a specific receptor can distinguish among these highly
homologous G proteins and especially what is the structural basis determining such a
selective interaction. In fact, the knowledge obtained from the studies on the structural
basis of selective R-G coupling has been successfully applied to intervene the
physiological events in vivo. For example, Covic et al designed membrane permeable
peptides based on the sequences of the third intracellular loop of protease-activated
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Figure 4.

LH-R
β2-AR

Gs

PTH-R
CT-R
H2R
α1B-AR

Gi

M1-R
M3-R
M5-R
A3-R

TXA2-R

Gq
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Thrombin-R

Figure 4.

Examples of multiple GPCR/G-protein coupling (Adapted from

Gudermann et al., 1997). A single receptor subtype may couple to multiple G protein
families and individual G proteins may also receive signals from multiple receptors.
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receptor 1 or 4, which were determined to be their selective G protein coupling domain.
They applied these peptides to target the intracellular interface of the receptors and
effectively blocked the thrombine-mediated human platelet aggregation (Covic et al.,
2002). Another group used the transgenic approach to target the carboxyl terminal region
of Gqα and successfully prevented cardiomyocyte hypertrophy in the experimental
animals (Akhter et al., 1998).
Molecular determinants for selective R-G coupling.

A huge body of

investigation has been performed to study how a selective R-G interaction is achieved at
the molecular level. On the GPCR side, numerous studies suggest that the intracellular
segments of GPCRs are involved in G protein recognition. Generally speaking, although
all GPCRs share a common structural topology, their intracellular segments vary greatly
both in size and amino acid sequence. It has been shown that some GPCRs, which share
little or no sequence homology in these regions, couple to the same set of G proteins
(Hedin et al., 1993). Thus, the G protein coupling profile of a given GPCR can not be
deduced solely from its amino acid sequence. However, the general positions of its
selective coupling domains could be predicted based on the conserved structural features
among GPCRs.

As comprehensively reviewed by Wess (Wess, 1998), all four

intracellular domains have been indicated to be involved in G protein coupling with the
most critical regions being the second intracellular loop, and the amino and carboxyl
portions of the third intracellular loop (Wess, 1997). The two most important concepts
developed to date are that the selective G protein coupling results from the cooperative
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contribution of multiple intracellular regions and that the relative contributions of
different intracellular domains vary among individual receptors (Wess, 1998).
On the G protein side, both Gβ and Gγ subunits have been shown to specify
receptor-G protein coupling, but most Gβγ complexes appear to function similarly
(Phillips and Cerione, 1992). Thus, extensive efforts have been focused on Gα subunits.
Similar to GPCRs, the selective receptor coupling of Gα subunits is also determined by
multiple domains. As implicated and supported by the overall crystal structures of G
protein (Wall et al., 1995; Lambright et al., 1996), the extreme amino and carboxyl
terminal domains of Gα subunits are the critical selective coupling determinants from a
variety of studies (For reviews, see Conklin and Bourne, 1993; Neer, 1995; Bourne,
1997; Wess, 1998). Evidence also shows that additional domains participate in receptor
recognition, such as the α2 helix-α2/β4 loop (Lee et al., 1995), α3/β5 loop (Grishina and
Berlot, 2000) and α4 helix-α4/β6 loop (Hamm et al., 1988; Onrust et al., 1997; Bae et
al., 1997; Natochin et al., 1999; Bae et al., 1999) regions.
Our laboratory has applied a chimeric protein approach to study the molecular
basis of R-G protein coupling and our results show that even closely related GPCRs
couple to their G proteins differently (Ma et al., 2000). Some closely related GPCRs,
although coupled to the same set of G proteins, display different apparent affinities for
their coupling to G proteins. Individual receptors use different combinations of multiple
Gα domains to achieve their selective coupling (Ma et al., 2000; Slessareva and Graber,
2003). Taken together, our studies and those of others suggest that a particular R-G
coupling interface is formed by the molecular determinants from both the receptor and G
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protein. The R-G coupling interface of each closely related GPCRs or G proteins may
vary from each other.

R-G coupling studies using mAChRs as a model:
Muscarinic acetylcholine receptors (mAChRs). Acetylcholine, a classic
neurotransmitter, exerts its ionotropic and metabotropic effects via two classes of
cholinergic receptors. The metabotropic effects are mediated by the family of muscarinic
cholinergic receptors, which belongs to the GPCR superfamily (Wess, 1996; Wess, 1998;
Schoneberg et al., 1999). Activation on mAChRs modulates a broad range of
physiological functions in human body (Hardman et al., 2001). It was first revealed by
ligand binding studies that at least two tissue-specific populations of muscarinic receptors
exist (Hammer et al., 1980; Hammer and Giachetti, 1982). To date five members or
subtypes of this family (M1-M5) have been identified from pharmacological and
molecular cloning studies (reviewed by Caulfield and Birdsall, 1998). Though some
subtypes are predominant in certain peripheral tissues, it has been shown that mAChRs
display an overlapping expression pattern in tissues based on studies with
pharmacological labeling, mRNA detection and immunological approaches, (for reviews,
see Hulme et al., 1990; Caulfield, 1993; Eglen et al., 1996).
mAChR pharmacology. The endogenous neurotransmitter, acetylcholine, acts on
both nicotinic and muscarinic receptors and is rapidly hydrolyzed by acetylcholinesterase
and plasma butyrylcholinesterase. Thus, it has little clinical application. In contrast,
enormous efforts have been made to obtain its derivatives from both natural and
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chemically synthetical resources, but unfortunately no highly subtype-selective reagent
has been found (Eglen and Watson, 1996). Several agonists have relative selectivity
based

on

their

functional

potencies.

For

example,

(4-Hydroxy-2-butynyl)-1-

trimethylammonium-m-chlorocarbanilate chloride (McN-A-343) is relatively selective
for M1 receptors, but its functional selectivity was probably due to the receptor reserve in
the tissue tested (Caulfield, 1993; Eglen and Watson, 1996). Some non-selective agonists
such as acetylcholine, carbachol, oxotremorine, oxotremorine M acetate (Oxo-M) are
extensively used to characterize the ligand binding properties and functional responses of
mAChRs. Compared with mAChR agonists, mAChR antagonists draw much attention
because of their usefulness in both receptor pharmacological studies and clinical
therapeutics. For examples, non-selective antagonist [3H]N-methylscopolamine (NMS)
and [3H]quinuclidinyl benzilate (QNB) are generally used to label mAChR sites either in
tissues or in expressed cell lines; atropine (non-selective), pirenzepine (M1 selective),
AF-DX 116 (M2 selective), methoctramine (M2 and M4 selective), 4-diphenylacetoxyN-methylpiperidine

methiodide

(4-DAMP,

M1

and

M3

selective),

para-

fluorohexahydrosiladifenidol (p-F-HHSiD, M3 selective, himbacine (M2 and M4
selective) and tripitramine (M2 selective) are for characterizing pharmacological and
functional properties of mAChR subtypes (Hulme et al., 1990; Eglen et al., 1996).
As extensively reviewed in Goodman&Gilman’s “The Pharmacological Basis of
Therapeutics” (Hardman et al., 2001), mAChR agonists are typically classified into
acetylcholine congeners and natural alkaloids. Due to their non-selective effects on
mAChR subtypes, they may cause wide side effects when administrated systemically.
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Some agonists are clinically applied to treat smooth muscle disorders in gastrointestinal
and lower urinary tract (bethanechol), xerostomia (pilocarpine) and ophthalmological
disease such as glaucoma (pilocarpine). mAChR antagonists include the natural alkaloids
(atropine, scopolamine) and their derivatives and synthetic congeners. In addition to
applications in ophthalmological, gastrointestinal and urinary tract disorders, they may
also be used in respiratory disorder (atropine), anesthesia (atropine), cardiovascular and
central nervous system, and anticholinesterase and mushroom poisoning.
mAChR-G protein coupling. The mAChR system is a good model for studying
the molecular basis of R-G coupling. All five mAChR subtypes mediate their effects via
coupling to heterotrimeric G proteins (Hulme et al., 1990). Like other GPCR members,
mAChRs

share

a

common

three-dimensional

topology

consisting

of

seven

transmembrane (TM) helices linked by three alternative intracellular (i1-i3) and
extracellular (o2-o4) loops (Figure 3) (Wess, 1996). Five mAChRs share high sequence
homology (50%) and the sequence homology is even higher (60%) within the oddnumbered mAChRs (M1, M3 and M5) and the even-numbered mAChRs (M2 and M4)
subgroups (Hulme et al., 1990; Wess, 1996). Interestingly, not only do the mAChRs in
the same subgroup share higher sequence homology but also prefer to couple to the same
G protein family members. M1, M3 and M5 mAChRs preferentially couple to the Gq/11
family and primarily modulate PLC-β activity, whereas M2 and M4 mAChRs couple to
the Gi/o family members and primarily inhibit adenylyl cyclase activity and activate the
inward rectifier K+ channel (Wess, 1996; Caulfield and Birdsall, 1998). Therefore, the
molecular basis determining the selective G protein coupling between two subgroups and
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the possible subtle difference among the same subgroup members have made mAChRs a
focus in R-G protein coupling studies. Despite of intensive investigation, the molecular
mechanism of their selective G protein coupling is still not completely explained to date.
Structural basis for the selective mAChR-G protein coupling. The G proteincoupling selectivity of mAChRs has been studied using a variety of mutagenesis methods
including chimeric receptors, deletions, insertions and site-directed mutations. Previous
results suggest that the second and third intracellular segments (i2 and i3) define the G
protein-coupling selectivity for mAChRs, especially the amino and carboxyl portions of
i3 (hereafter referred to as Ni3 and Ci3, respectively) (Kubo et al., 1988; Shapiro and
Nathanson, 1989; Wong et al., 1990; Arden et al., 1992; Kunkel and Peralta, 1993; Blin
et al., 1995). By mapping these regions, several amino acid residues conserved in either
the M1- or M2-like subgroups are predicted to determine their G protein coupling
preferences. For example, within the M1-like subgroup a conserved tyrosine residue in
the Ni3 (corresponding to Tyr254 in M3 sequence), a conserved “AALS motif” in the Ci3
(corresponding to Ala488, Ala489, Leu492, and Ser493 in M3 sequence) and four conserved
amino acid residues in the i2 loop (corresponding to Ser168, Arg171, Arg176, and Arg183 in
M3 sequence) are critical for their Gq coupling. Similarly, a conserved “VTIL motif” in
the Ci3 of the M2-like subgroup (corresponding to Val385, Thr386, Ile389, and Leu390 in M2
sequence) is critical for their Gi/o coupling (Bluml et al., 1994a; Bluml et al., 1994b;
Blin et al., 1995; Liu et al., 1995; Burstein et al., 1995). Based on these studies Wess
proposed a model that the key residues in the i2, Ni3 and Ci3 regions of mAChRs are
predicated to cluster together to form a well-defined G protein binding site, thus
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determining their G protein coupling selectivity (Wess, 1998; Kostenis et al., 1999).
Based on studies with M2/M5 mutants, Burstein et al. proposed a similar model in which
the several key residues located in the Ni3 and Ci3 form a G protein coupling pocket
composed of a positively charged “lip” and a hydrophobic core (Burstein et al., 1998).
Taken together, these data strongly support the idea that multiple intracellular domains of
GPCRs act in a cooperative way to contribute to their selective G protein coupling (Wess,
1998).
Problems and remaining questions. A major drawback in previous studies
is that effector (E) activity (i.e. the generation of second messengers or
electrophyisiological changes) or even further downstream cellular responses were used
as a reporting system to interpret functional R-G interactions. As our knowledge of G
protein-mediated signaling pathways has grown, it becomes clear that this linear pattern
of signal transduction along a specific “R-G-E” axis is no longer tenable. In contrast, our
current view of G protein-mediated signaling pathways suggests a complicated network
(Neves et al., 2002). Signals initiated upon ligand binding to GPCRs may converge and
diverge at multiple interfaces and effector activities and cellular responses are regulated
by many factors at multiple stages (see discussion below). Therefore, effector activity or
cellular response may not be the best tool for direct evaluation of the interactions at the
R-G interface, especially not for identifying the R-G contact sites.
Reconstitution approaches provide marked advantages in analyzing direct R-G
protein coupling. In reconstitution systems, purified or membrane-bound GPCRs are
reconstituted with purified G protein subunits with well-controlled concentrations and
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stoichiometries (Butkerait et al., 1995; Clawges et al., 1997; McIntire et al., 2002; Windh
and Manning, 2002).

Thus the R-G coupling step can be separated from other

components of the whole signaling pathway in reconstitution. Typically, their functional
coupling is analyzed by measuring the enhanced radiolabeled-agonist binding upon the
formation of the agonist-R-G ternary complex or the radiolabeled-GTPγS binding on the
α subunits driven by the agonist-occupied receptor (Clawges et al., 1997; Barr et al.,
1997; Windh and Manning, 2002). The major advantage of such a reconstitution system
is that it provides a direct assay for the functional R-G interaction and the stoichiometry
of R-G interaction in a precisely controlled manner. Of note is that other factors that may
contribute to selective R-G interaction are eliminated in this artificial assay system
(Neubig, 1994; Bohm et al., 1997).
At the molecular level it is still not clear how individual mAChR subtypes with
the same G protein coupling preference couple to G proteins and if there is any subtle
difference in their G protein coupling properties. For quite a long time mAChRs have
been known to mediate the metabotropic effects of the first identified neurotransmitter,
acetylcholine. However, the lack of highly subtype-selective agents makes it difficult to
define the exact physiological function of individual mAChR subtypes, especially
subtypes within the same subgroup and with similar signaling transduction mechanisms.
A major problem in developing such selective agents may be the fact that residues
predicted to form the ligand-binding cavity are identical among the five subtypes (Wess,
1996). Recent efforts with gene “knock-out” techniques have been made to delineate the
physiological roles of individual mAChRs (Hamilton et al., 1997; Gomeza et al., 1999a;
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Gomeza et al., 1999b; Matsui et al., 2000; Yamada et al., 2001a; Yamada et al., 2001b).
These studies provide a wealth of useful information in understanding the physiological
roles of a specific mAChR subtype. For example, M1 receptor gene disruption reveals
that the non-selective agonist, pilocarpine-induced chronic seizure is specifically
mediated by the M1 subtype (Hamilton et al., 1997). In addition to its regulatory roles in
cardiac functions that has been well characterized by pharmacological studies, the
“knock-out” studies reveal that M2 receptors may also be involved in some muscarinicdependent central nervous effects such as movement, temperature control and
antinociceptive responses (Gomeza et al., 1999a). However, some conflicting results
were also reported from these gene “knock-out” studies. For example, using the same
strain of the M3 mAChR knock-out mice, Matsui et al reported that salivation was
impaired in these mice while Yamada et al observed unchanged salivation (Matsui et al.,
2000; Yamada et al., 2001a). In addition to the species variance of a given receptor, the
overlapping expression of mAChRs in many tissues and the possible compensatory
effects of other receptors (Hulme et al., 1990) should be carefully considered to interpret
the results observed in transgenic animals (Caulfield, 1993). Previous studies (Surya et
al., 1998; Strange, 1999; Slessareva et al., 2002) indicate that even structurally similar
GPCRs may differ in their ability to recognize the same ligand and may display
differential agonist binding states stabilized by different G proteins. Thus, in the present
study the G protein coupling properties of five closely related mAChRs were analyzed
and compared in a reconstitution system with radioligand binding assays.
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Regulation of G protein signaling:
Complexity in the regulation of G protein signaling. As discussed above there is
a great deal of complexity existing in the GPCR-G protein coupling process. Meanwhile,
recent reports on both G protein-independent GPCR signaling pathways (reviewed by
Brzostowski and Kimmel, 2001) and GPCR-independent G protein activation
(Cismowski et al., 1999; Takesono et al., 1999) make this signal transduction system
even more complicated. Thus, the important question prompted is how extracellular
stimuli are transduced and integrated via the G protein signaling network to initiate
appropriate responses. To date many additional regulatory mechanisms and accessory
cellular components have been appreciated, which can augment or attenuate signaling
strength, optimize signal specificity and integrate cellular responses. The cell-specific
distribution and the segregation of specific signaling molecules in intact cells clearly
contributes to the specificity observed in vivo (Raymond et al., 1993; Neubig, 1994; Li et
al., 1995).

With regards to GPCRs, continuous stimulation by agonists leads to

phosphorylation of most GPCRs by either GPCR kinases (GRKs), which mediate
agonist-dependent desensitization, or by second messenger-dependent kinases (PKC and
PKA), which mediate agonist-independent desensitization (Bohm et al., 1997; Pitcher et
al., 1998; Krupnick and Benovic, 1998). Another class of proteins known as arrestins,
are required for GRK-mediated GPCR desensitization and subsequent GPCR
internalization (Krupnick and Benovic, 1998). Internalization and downregulation of cell
surface GPCR numbers (Bohm et al., 1997) both contribute to the attenuation of GPCR-
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initiated signaling. At the level of heterotrimeric G proteins, signal termination was
thought to depend solely on the intrinsic GTPase activity of Gα subunits. This picture
was changed by the identification of a novel class of proteins known as regulators of G
protein signaling (RGS), most of which act as GAPs (GTPase activating proteins) to
accelerate the GTP hydrolysis (Berman and Gilman, 1998; Hepler, 1999; De Vries et al.,
2000a). In contrast with GAPs, other proteins function as GEFs (guanine nucleotide
exchanging factors) to stimulate the guanine nucleotide exchange on Gα subunits (Luo
and Denker, 1999; Cismowski et al., 2000). Accessory regulation also exists for Gβγ
subunits, which are regulated by proteins called phosducins (Bauer and Lohse, 1998;
Bauer et al., 1998). Recently, a new family of proteins, activators of G protein signaling
(AGS) was discovered, which activate Gβγ-mediated signaling in yeast independently of
GPCRs (Cismowski et al., 1999; Takesono et al., 1999).

Taken together, current

information indicates that the signals transmitted via GPCR-G protein pathway are
regulated at multiple levels by multiple accessory proteins.
Activators of G protein signaling (AGS). Using a functional screen system based
on the Gβγ-mediated pheromone response pathway in yeast, Cismowski, Takesono and
their colleagues identified a series of proteins, which can activate this pathway in a
receptor-deficient genetic background (Cismowski et al., 1999; Takesono et al., 1999).
Collectively, these proteins are termed activators of G protein signaling (AGS) for their G
protein activation properties, but sequence analysis indicated that these proteins did not
share any sequence homology, suggesting that they might have different mechanisms for
G protein activation. The first member of this family, AGS1 is found to be a Ras-related
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protein, which acts as a GEF for Gi proteins and may antagonize GPCR-initiated
signaling (Cismowski et al., 1999; Graham et al., 2002; Takesono et al., 2002). AGS2
selectively interacts with Gβγ but it is not clear whether it actively promotes the subunit
dissociation or just simply competes with Gα for Gβγ interaction (Takesono et al., 1999).
The third member, AGS3 is found in various tissues and has tissue-specific splicing
variants (De Vries et al., 2000b; Bernard et al., 2001; Pizzinat et al., 2001). Sequence
analysis of AGS3 reveals that it has two distinct domains connected by a linker region
(Takesono et al., 1999). Its amino terminal half consists of seven tetratricopeptide repeat
(TPR) sequences while the carboxyl half contains four repeated sequences termed as G
protein regulatory (GPR) motifs or GoLoco motifs (Siderovski et al., 1999). The TPR
sequences have been implicated in its subcellular localization while the GPR sequences
are responsible for competing with Gβγ subunit to selectively interact with Gi/o α
subunits (Siderovski et al., 1999; Takesono et al., 1999; Bernard et al., 2001; Pizzinat et
al., 2001). As reviewed by Kimple et al., the GPR sequence is conserved in a variety of
proteins from different species with diverse functions but all of them share the ability to
selectively interact with the GDP-bound conformation of the α subunits from the Gi
family via their GPR sequence(s) (Kimple et al., 2002). Biochemical studies from several
groups have demonstrated that the GPR sequence functions as a guanine nucleotide
dissociation inhibitor (GDI) to stabilize Giα subunits in their GDP-bound form (Natochin
et al., 2000; Peterson et al., 2000; De Vries et al., 2000b; Bernard et al., 2001; Kimple et
al., 2001; Natochin et al., 2001; Pizzinat et al., 2001; Peterson et al., 2002). Recent
studies indicate that AGS3-related GPR-containing proteins are involved in cell polarity

29

and asymmetric cell divisions (Schaefer et al., 2000; Bellaiche et al., 2001; Schaefer et
al., 2001; Blumer et al., 2002). However, little is known about the molecular mechanisms
of AGS3 in cellular signaling.
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Dissertation objectives:
Clearly, many aspects of G protein mediated signal transduction pathways need
closer examination.

My thesis work addressed two questions in GPCR-G protein

coupling mechanisms: 1) Do highly homologous GPCRs couple to their G proteins
differently? and 2) how may GPCR-G protein coupling be impacted by a newly identified
G protein signaling regulator, AGS3. The hypotheses tested were: 1) at molecular level,
the closely related mAChRs (Gq/11-coupled mAChRs or Gi/o-coupled mAChRs) couple
to their G proteins differently, 2) AGS3 can selectively interfere with Gi/o protein
coupling to receptors.

These hypotheses were tested by achieving the following specific aims:
Specific aim 1: To assess and compare the apparent affinities of Gq and Gi proteins for
five mAChRs in Sf9 cell membrane-based reconstitution system.
Specific aim 2: To assess and compare the G protein-stabilized high-affinity agonist
binding states of five mAChRs.
Specific aim 3: To study the effects of AGS3 on receptor-Gi protein coupling and its
potential mechanisms in cellular signaling.
Specific aim 4: To study the selectivity of AGS3-GPR domains for Gi/o proteins.
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CHAPTER 2: METHODS

Materials:
[3H]-Hydroxytryptamine (3H-5-HT, 25.5 Ci/mmol) Binoxalate or Creatinine
Sulfate, [3H]-Oxotremorine-M Acetate (3H-Oxo-M, 85.8 Ci/mmol) and [3H]-N-Methyl
Scopolamine Chloride (3H-NMS, 70.0 Ci/mmol) were purchased from NEN Life
Science Products, Inc. (Boston, MA). 3-[(3-cholamidopropyl)dimethylammonil]-1propanesulfonic acid (CHAPS) was from Calbiochem (San Diego, CA). Atropine
Sulfate, N-Methyl Scopolamine Chloride, Oxotremorine-M Acetate (Oxo-M), 5Hydroxytryptamine (5-HT) and other chemicals were from Sigma-Aldrich Corp. (St.
Louis, MO). Grace’s insect cell culture media were purchased as powder from
GibcoBRL Life Technologies (Rockville, MD). Restriction endonucleases, T4
polynucleotide kinase, T4 DNA ligase, Taq DNA polymerase, Pfu DNA polymerase and
M-MLV reverse transcriptase were from New England Biolabs (Beverly, MA),
Epicentre Technologies (Madison, WI), USB Corp. (Cleveland, OH), PGC Scientifics
Corp. (Gaithersburg, MD), Stratagene (La Jolla, CA) and GibcoBRL Life Technologies,
respectively. Human Gαq cDNA was obtained from Guthrie cDNA resource center
(Sayre, PA). DNA primers were ordered from IDT, Inc (Coralville, IA) and DNA/RNA
hybrid primers were from Oligos Etc, Inc (Wilsonville, OR). QIAprep Spin Miniprep
and

QIAprep

Midiprep

kits,

Bac-N-Blue

Transfection

Kit,

ProtoBlot

AP

immunoblotting reagents and BCA Protein Assay Kit were from QIAGEN Inc.
(Valencia, CA), Invitrogen (Carlsbad, CA), Promega (Madison, WI) and Pierce
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(Rockford, IL), respectively. Ni-NTA superflow resin was from QIAGEN Inc. AntiGαi1/2 C-terminal antibody, anti-Gαq C-terminal antibody and anti-Gβ antibody were
from Calbiochem-Novabiochem Corp. (San Diego, CA), Santa Cruz Biotechnology
(Santa Cruz, CA) and NEN Life Science Products (Boston, MA), respectively. Whatman
GF/C filters were from Brandel Inc. (Gaithersburg, MD) and PVDF membranes were
from Millipore Corp. (Bedford, MA).

Sf9 cell cultures:
Spodoptera frugiperda (Sf9) insect cells are grown either as monolayer cultures in
T25 flasks or plates, or as suspension cultures in spinner flasks. Stock cells are kept as
suspension cultures at 1.25 X 106 cells/ml, agitated at 55-60 rpm for small scale cultures
(< 500 ml) or 50 rpm for large cultures (> 500 ml) and subcultured every third day. Only
cells with at least 95% viability are used for transfection or baculovirus infection. 2 X
106 cells are seeded per T25 culture flask as monolayer cultures for transfection; 1 X 106
cells per 60 mm plate as monolayer cultures for plaque assay; and 3 X 106 cells/ml as
suspension cultures for infection. Sf9 cells are grown in FMNH media (Grace’s insect
cell culture media supplemented with 0.35 g/L NaHCO3, 3.33 g/L lactalbumin and 3.33
g/L TC-yeastolate, pH6.05) with 10% fetal bovine serum and incubated at 27°C in the
incubator with a gas mixture (50% O2:50% air).
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Human mAChRs subcloning and recombinant baculovirus production:
Human M1 and M2 mAChR recombinant baculoviruses were kind gifts from Dr.
Elliot Ross (University of Texas Southwestern Medical Center). Human M3 mAChR
recombinant baculovirus was kindly provided by Dr. Karl Akerman (Åbo Akademi
University, Finland). The production of these viruses was described previously (Parker et
al., 1991; Kukkonen et al., 1996).
To produce human M4 mAChR recombinant baculoviruses, the pCD plasmid
containing its coding cDNA (Bonner et al., 1987) was first linearized at an upstream Tfi I
site and then followed by Mung Bean Nuclease incubation to create blunt ends. The
cDNA containing the coding region was excised as a 1.7-kb fragment from the linearized
plasmid with Bgl II at its 3’-end and ligated into pVL1393 transfer vector at Sma I and
Bgl II sites. To produce human M5 mAChR recombinant baculoviruses, M5 receptor
cDNA was excised from its pCD plasmid (Bonner et al., 1988) as a 1.8-kb fragment with
Pst I alone and ligated into the Pst I site at the multiple cloning site region of pVL1392
transfer vector. Both constructs were confirmed by restriction analysis and DNA
sequencing (All the sequencing confirmations were performed by the Molecular Genetics
Instrumentation Facility at University of Georgia). Using Bac-N-Blue Transfection Kit
(Invitrogen, CA) each transfer vector was used to co-transfect Sf9 cells with the
linearized wild-type AcMNPV DNA to produce recombinant baculoviruses and
recombinant viruses were purified following manufacturer’s manual.
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Preparation of Sf9 cell membranes containing expressed receptors.
As previously described (Clawges et al., 1997), Sf9 cells are infected with
recombinant baculoviruses expressing the desired receptor usually at an MOI of 2 for 1
hour. Infected cells are seeded in spinner flasks at 3 X 106 cells/ml, cultured for 40-70
hours with the cell density and viability monitored by microscopy and trypan blue dye
and harvested depending on their appearance and density. For harvest, cells are pelleted
at 50xg for 5 minutes and washed three times by resuspending and pelleting in ice-cold
PBS buffer (47 mM NaCl, 7.3 mM NaH2PO4, 2.0 mM CaCl2, 60 mM KCl, pH 6.2). The
final cell pellets are resuspended at 0 - 2.5 g wet weight per 5 ml homogenization buffer
(10 mM Tris-Cl, 25 mM NaCl, 10 mM MgCl2, 1 mM EGTA, pH 8.0 at 4 °C)
supplemented at use with 0.1 mM PMSF, 20 µg/ml of benzamidine and 2 µg/ml of each
of aprotinin, leupeptin and pepstatin A, snap-frozen in liquid N2 and stored at –70 °C.
To prepare membranes, harvested cells are thawed in 15x their wet weight of ice
cold homogenization buffer with the same protease inhibitors as described above and
burst by N2 cavitation at 600 p.s.i. for 20 minutes. Cavitated cells are centrifuged at
500xg, 4 °C for 10 minutes to remove the unbroken nuclei and cell debris.

The

supernatant from the low speed spin is centrifuged at 28,000 g, 4 °C for 30 minutes. The
second supernatant is discarded and the pellets are resuspended and pooled in 35 ml of
HE buffer (5 mM NaHEPES, l mM EDTA, pH 7.5) containing the same protease
inhibitors as used in the homogenization buffer. The membranes are washed twice,
resuspended in the HE buffer without the protease inhibitors at a concentration of 1-3 mg
protein/ml, aliquoted, snap-frozen in liquid N2 and stored at -70 °C.
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Expression and purification of G proteins:
All recombinant G protein subunits are purified using Waters 650E Advanced
Protein Purification System (Millipore Corp, Milford, MA) at 4°C after expression in Sf9
cells with recombinant baculoviruses. For soluble G protein subunits expression and
purification such as Gi1α or Gβ1γ2, Sf9 cells are infected with recombinant
baculoviruses at an MOI of 2 for Gα or an MOI of 1β:1γ for Gβ1γ2 and purified as
described previously (Graber et al., 1992a; Graber et al., 1992b; Graber et al., 1994). For
insoluble Gα subunits such as Gqα, Sf9 cells are co-infected with the recombinant
baculoviruses to express Gα, Gβ and His-tagged Gγ subunits at an infection MOI of
1α:1β:1γ and purified as heterotrimers (Kozasa and Gilman, 1995). Briefly, infected cells
are cultured and harvested as described above for receptor expression except that 10 µM
GDP was added to the final homogenization buffer. For purification, harvested cell
pellets are thawed in 15x their wet weight of ice-cold homogenization buffer, burst by
nitrogen cavitation at 600 p.s.i. for 20 minutes and centrifuged at 100,000xg, 4°C for 60
minutes. The 100,000xg-pellets are first extracted for 1 hour in an extract buffer (50 mM
Tris/HCl, pH 8.0 with 10 µM GDP, 2 mg/ml aprotinin, 20 mg/ml benzamidine, 2 mg/ml
leupeptin, 2 mg/ml pepstatin, 0.1 mM PMSF, 5 mM BME and 1% CHAPS) and then
centrifuged at 100,000xg, 4°C for 45 minutes. The supernatant containing the solubilized
G protein heterotrimers is filtered and loaded into a 30 ml AP-2 DEAE anion exchange
column, which is pre-washed with a DEAE column buffer (50 mM Tris, pH 8.0 with
0.7% CHAPS, 5 mM BME and 10 µM GDP). Proteins are eluted with 4 column volumes
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of 0 – 400 mM NaCl linear gradient. Fractions containing G proteins (as indicated by
anti-Gα immunoblotting in pilot experiments) are pooled, mixed with 2 ml Ni-NTA
Superflow resin (used as 4 ml of 50% slurry) and incubated for at least 1 hour before
loaded into a 15 ml column. The resin then is washed first with a buffer A (20 mM
HEPES, 1 mM MgCl2, 100 mM NaCl, pH 8.0 with 5 mM Imidazole, 5mM BME, 10 µM
GDP and 0.7% CHAPS), then with a buffer B (buffer A plus 300 mM NaCl), and again
with the buffer A. Each washing step is completed when baseline is flat for at least 10 ml.
The proteins are eluted with a buffer C (20 mM Hepes, pH 8.0 with 150 mM Imidazole,
1mM MgCl2, 25 mM NaCl, 5 mM BME and 0.7 % CHAPS). The elute is diluted 3
times with a Q buffer (20 mM HEPES, 2 mM MgCl2, pH 8.0 with 1mM DTT and 0.7%
CHAPS) and loaded into an 8 ml AP-1 QHR15 anion exchange column. Fractions are
eluted with 0 – 400 mM linear NaCl gradient. Free Gβ1γ2HIS subunits and Gαqβ1γ2HIS
heterotrimers are eluted within 100 – 125 mM NaCl and 200 - 220 mM NaCl gradients,
respectively. The corresponding fractions are pooled, concentrated using Centricon-30
concentrators (Amicon), snap-frozen in liquid N2 and stored at -70°C. To verify the
protein purity, samples from the fractions are resolved by SDS-PAGE, transferred to
PDVF membranes and immunoblotted using their corresponding antibodies.

Characterization of expressed receptors with radioligand saturation binding assay:
The mAChR receptor expression levels are characterized by 3H-NMS saturation
binding assays. About 5 to 20 µg membrane protein aliquots are incubated at 25 °C with
3

H-NMS in a concentration range of 0.02 to 10 nM in a binding buffer (50mM Tris-HCl,
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5mM MgCl2, 0.5mM EDTA, pH 7.5) for 1.5 hours to achieve equilibrium in a
temperature-controlled shaker.

The incubations are terminated by filtration over

Whatman GF/C filters using a Brandel Cell Harvester. The filters are rinsed thrice with 4
ml ice cold washing buffer (50 mM Tris-Cl, 5 mM MgCl2, 0.5 mM EDTA, 0.01%
NaAzide, pH 7.5 at 4 °C), placed in 4.5 ml CytoScint (ICN Pharmaceuticals, Costa Mesa,
CA) and counted to constant error in a scintillation counter. The binding data are fit to a
one-site binding model and compared with a two-site binding model using GraphPad
Prism software (GraphPad software, CA). Without reconstitution with G proteins, onesite binding is the best-fit model in every assay performed for mAChRs as analyzed by Ftest. The receptor expression level (Bmax) and the affinity for the radioligand (Kd) are
computed with the software and expressed as pmol/mg membrane protein and nM,
respectively (Figure 5A). Since there is no radiolabeled antagonist available for the 5-HT
receptors, their expression levels are characterized with radiolabeled agonist saturation
binding assays. The assays are performed in a similar way as above except that the
receptor membranes are first reconstituted with a saturating amount of Gi1 protein in a
reconstitution buffer (5 mM NaHEPES, 100 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 500
nM GDP, 0.04% CHAPS, pH 7.5) prior to the binding (Figure 5B).

Urea-extraction of Sf9 cell membranes expressing mAChRs:
When mAChRs are expressed in Sf9 cell membranes, endogenous G proteins
(probably also other peripheral proteins) may hinder the mAChR coupling to the
exogenous G proteins added in reconstitution. As shown in Figure 6, on untreated M5
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Figure 5. Representative experiment of characterization of receptor expression
level with radioligand saturation binding assay. A. Sf9 cell membranes (~ 22 µg)
expressing M1 receptors were incubated with 3H-NMS in a range of 0.02 – 10 nM at 25
C for 1.5hr. B. Sf9 cell membranes (~10 µg) expressing 5-HT1A receptors were first

o

reconstituted with ~ 20 pmol Gi1 heterotrimer and incubated at 25 oC for 15 minutes.
Binding on reconstituted membranes were determined after incubating the membranes
with 3H-5-HT in a range of 0.01 – 25 nM at 25 oC for 1.5hr. Data points represent the
mean ± SD of triplicate determinations from a representative experiment and the Bmax
and Kd values were generated from the best-fitted one- or two-site model determined by
F-test using GraphPad Prism software.
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Figure 6. Effects of urea-extraction treatment on M5 mAChR coupling. Sf9 cell
membranes (~ 20 µg) before or after treated with 200 nM unlabeled Oxo-M, 25 µM
GTPγS and 6 M urea were reconstituted with (solid bars) or without (open and stripped
bars) 300 nM Gq proteins at 25oC for 15 minutes. About 6 nM 3H-Oxo-M was incubated
with reconstituted membranes in the presence (stripped bars) or absence (open and solid
bars) of 50 µM GTPγS. Binding data were normalized as percent of binding on the
control membranes (open bars).

Each bar represents mean ± SEM from 3 to 6

experiments. *, p<0.01, Tuky’s test.
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receptor membrane, addition of GTPγS (striped bar in “Before treatment” group in Fig
6) significantly reduced 3H-Oxo-M binding as compared to the control (open bar in
“Before treatment” group in Fig 6), reflecting the coupling of expressed M5 receptors to
the endogenous G proteins in Sf9 cell membranes. Reconstitution with G proteins (solid
bar in “Before treatment” group in Fig 6) did not enhance agonist binding, indicating that
the exogenous G proteins were unable to stabilize high-affinity agonist binding on M5
receptors in untreated membranes.
To establish the functional coupling between the purified, exogenous G proteins
and the mAChRs expressed in Sf9 cell membranes, we adapted a urea-extraction protocol
based on the previously published urea-extraction protocols from other groups (Hartman,
IV and Northup, 1996; Hellmich et al., 1997; Lindorfer et al., 1998). Briefly, before
extraction with a high concentration of urea (6 M) Sf9 cell membranes are pre-treated
with a high concentration of agonist (200 nM Oxo-M) and GTPγS (25 µM), which are
expected to uncouple the endogenous G proteins from the expressed mAChRs. Frozen
membranes are thawed on ice, pelleted at 18,000xg at 4 °C for 10 minutes.

The

membrane pellets are resuspended at a concentration of about 0.5 mg/ml in the binding
buffer (50 mM Tris-Cl, 5 mM MgCl2, 0.5 mM EDTA, pH 7.5) and incubated with 200
nM Oxo-M and 25 µM GTPγS in a shaking incubator at 25 °C for 1 hour. After
incubation, membranes are pelleted again at 288,000xg, 4 °C for 30 minutes. The
resulting pellets are resuspended in a urea-extraction buffer (25 mM HEPES, 1 mM
EDTA, pH 7.5 with 6M urea prepared fresh before use) and incubated on ice for 30
minutes. The extracted membranes are washed twice by resuspending in the HE buffer
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and centrifuging 30 minutes at 288,000xg, 4 °C. The final pellets are resuspended in the
HE at a concentration of 1-3 mg protein/ml, aliquoted, snap-frozen in liquid N2 and
stored at -70 °C. Urea-extracted membranes are also characterized by 3H-NMS saturation
binding assay as described above.
Hartman et al reported that GTPγS binding was reduced 4 fold on the 5-HT2C
receptor membranes after urea-extraction, reflecting the decrease or inactivation of the
endogenous G proteins (Hartman, IV and Northup, 1996). Consistent with their GTPγS
binding results, our results show that the uncoupling effect of GTγS on the treated
membrane was significantly reduced, indicating the decreased coupling between the
endogenous G proteins and the M5 receptors in the membrane (compare open and striped
bars in “After treatment” group in Fig 6). After treatment, the expressed M5 receptors can
be stabilized in the high-affinity agonist binding state by reconstitution with exogenous
Gq proteins as reflected by the enhanced agonist binding (solid bar in “After treatment”
group in Fig 6).

Thus, treating mAChR membranes with high concentrations of

unlabeled agonist, GTPγS and urea can clearly reduce endogenous G protein coupling
and improve exogenous G protein-stabilized high-affinity agonist binding, which will be
a useful tool in establishing the functional GPCR-G protein coupling in vitro.

Reconstitution of receptors with exogenous G-proteins or AGS3 protein:
Reconstitution is performed as previously described (Clawges et al., 1997).
Briefly, frozen membranes are thawed, pelleted in a refrigerated microcentrifuge (10
minutes, 12,000 rpm) and resuspended at about 5-10 mg/ml in the reconstitution buffer
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plus 0.04% or 0.08% CHAPS for 5-HT receptor or mAChR membranes, respectively. G
protein subunits are diluted in the same buffer such that the desired amount of subunit is
contained in 1-5 µl. Aliquots of membrane and G proteins are mixed in the presence or
absence of indicated additional components. The mixtures are incubated at 25 °C for 15
minutes and then held on ice until the start of the binding assay or pelleted in a
refrigerated microcentrifuge at 12,000 rpm, 4 °C for 10 minutes for immunoblotting
assay.
To allow soluble, cytosolic AGS3 or exogenous G protein heterotrimers to
associate with membranes, membranes containing 5-HT1A receptors are first incubated
(25 °C, 15 minutes) with the Sf9 cytosol fractions containing AGS3 or purified G protein
heterotrimers, respectively.

The membranes are then pelleted in a refrigerated

microcentrifuge at 12,000 rpm, 4 °C for 10 minutes and washed thrice with 100 µl
reconstitution buffer. The resulting membranes are then used in a second reconstitution
with the indicated additional components as described above.

Radiolabeled agonist binding assay:
To assess functional receptor-G protein coupling, the high-affinity agonist binding
on membrane receptors, which is stabilized by the coupling G proteins, is measured with
radiolabeled agonist. Based on the extended ternary complex model of GPCR-G protein
coupling (Samama et al., 1993), G proteins stabilize GPCRs in the high affinity agonist
binding state upon the formation of agonist/receptor/G-protein ternary complex. Thus,
using a single, low concentration of radiolabeled agonist near the high-affinity Kd for that
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agonist, the G protein-stabilized high affinity agonist binding on membrane receptors
when reconstituted with coupling G proteins can be readily detected as enhanced agonist
binding compared with the agonist binding on receptors without G protein reconstitution
(Clawges et al., 1997; McIntire et al., 2002; Windh and Manning, 2002).
Radiolabeled agonist binding is performed as described (Clawges et al., 1997).
Briefly, reconstitution mixtures are diluted 10-fold with the binding buffer prior to the
start of the binding assay such that the desired amount of membranes (5 - 25 µg/assay
tube) are contained in 50 - 100 µl. Aliquots of diluted membranes are incubated in the
presence of a single concentration of radiolabeled agonist near the high affinity Kd of the
receptor of interest as indicated in the text. Non-specific binding is determined by
addition of 103-fold or greater excess of unlabeled ligand. Incubation and measurement
of radioligand binding are performed as described for 3H-NMS saturation binding assays
above.

Analysis of G protein apparent affinities for membrane receptors with radiolabeled
agonist binding assay:
Previous results from our laboratory show that four Gi coupled receptors have
different apparent affinities for the same Gi protein (Ma et al., 2000). It has not been
shown if five mAChRs have different apparent affinities for their coupling G proteins. To
assess the apparent affinity of a G protein for a specific receptor, increasing amounts of G
protein heterotrimers (typically 10 to 500 nM) are reconstituted with receptor
membranes.

After reconstitution, high-affinity agonist binding on the reconstituted

60

membranes is determined with a single, low concentration of radiolabeled agonist as
described above. Binding data are fit to a one-site interaction model between receptor and
G protein and analyzed with GraphPad Prism software. EC50 values of G protein
concentration in stabilizing receptors in high-affinity agonist binding are computed from
nonlinear regression analysis and represent the apparent affinity of G proteins for
receptors (See Figure 7).

Competition binding assay:
Previous studies indicate that GPCRs may have multiple conformations
depending on agonists and G protein coupling (see discussion in Chapter 1). To compare
the possible differences in the proportions and the agonist affinities (low and high) of five
mAChRs that can be stabilized by their coupling G proteins, competition binding assays
are performed for each mAChR-G protein pair and compared with mAChR membranes
without G protein reconstitution. Briefly, urea-extracted Sf9 membranes expressing
mAChRs are first reconstituted with or without a saturating amount of G proteins.
Reconstitution is performed as described above and is diluted 10-fold with the binding
buffer prior to the start of binding assay. Aliquots of the diluted reconstitution mixture
(100 µl) are incubated with a single concentration (~ 4nM) of radiolabeled non-selective
antagonist (3H-NMS) and increasing concentrations of unlabeled agonist (Oxo-M) as a
competitor with a range from 10-1 M to 10-12 M in a final volume of 300 µl. The Oxo-M
concentrations with duplicate determinations at each point are equally spaced on a log
scale. Incubation and measurement of 3H-NMS binding are performed as described
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Representative experiment of G protein concentration titration with

radiolabeled agonist binding assay. Aliquots of about 40 µg urea-extracted Sf9 cell
membranes containing M4 mAChRs (0.4 pmol) were reconstituted with increasing
amounts (5 – 250 pmol) of Gi1 protein in 25 µl at 25 °C for 15 minutes. The reconstitution
mixtures were diluted with binding buffer and then incubated with 6 nM 3H-Oxo-M in a
final volume of 150 µl. The final concentration of M4 mAChR was 0.8 nM (12 µg
membrane protein) and the Gi1 concentrations were 10-500 nM. Data points were mean ±
SD of triplicate determinations from a representative experiment repeated three times.
Agonist binding were fit to a one-site interaction model between receptor and G protein
and analyzed with GraphPad Prism software to calculate EC50 values, which represent the
apparent affinity between G protein and receptor.
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above.

Binding data are first fitted into one- and two-site competition models to

determine the best-fit model with F-test. The dissociation constants (Ki) for Oxo-M and
the fractions of receptors in the high-affinity state are then computed from the best-fit
curve with the Cheng-Prusoff correction (Ki = IC50/(1+[radioligand]/Kd)).

Immunoblot analysis:
To verify and quantitate expressed protein, protein is resolved by 12%
SDS/PAGE and transferred to a PVDF membrane (Millipore). The membrane is first
probed with appropriate primary antibody for the protein of interest and then visualized
with ProtoBlot AP immunoblotting system (Promega). The amount of proteins is
analyzed by comparing the band intensities within the linear range of a standard curve
prepared from known amounts of purified protein as standards using a FluorChemTM
8000 system (Alpha Innotech Corp.) (see Figure 8 for example). To determine the
amounts of protein that associated with membranes during reconstitution, the
reconstitution mixtures are pelleted and washed three times as described above. The
washed pellets or one-tenth volume of the first supernatant (for proteins in the membrane
and cytosol fractions, respectively) are electrophoresed, transferred to PVDF membranes
and probed with appropriate primary antibodies (see Figure 9 for example). The antibody
detection, visualization and quantitation are performed with a ProtoBlot AP kit as
described above.
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Figure 8. Quantitation of AGS3 expressed in Sf9 cell membranes. Purified GST-GPR proteins and the Sf9 cell membranes
prepared from recombinant AGS3 baculovirus-infected cells were mixed with Laemmlli buffer and boiled for 5 minutes prior
to loading to 12% SDS-PAGE gels. After electrophoresis, proteins were transferred to PDVF membranes, probed and
visualized as described in the text. Band densities were analyzed using a FluorChemTM 8000 system and the amounts of AGS3
proteins were determined from the linear range of a standard curve from the known amounts of purified GST-GPR. The
amounts of GST-GPR in lane 1-6 were 5, 10, 2, 1, 0.5 and 0.1 pmol, respectively while the amounts of total Sf9 cell membrane
proteins were 2.30, 1.15, 1.15 and 0.575 µg in lane 6-10, respectively.
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Figure 9.
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Figure 9. Concentration- and Gβγ
βγ-dependent
membrane association of Giα
α subunit. Aliquots of Sf9 cell membranes
βγ
(~30 µg) were reconstituted with increasing amounts (0-250 pmol, lane 2-8) of Gi1α subunits in the presence (+Gβγ, upper
panel) or absence (-Gβγ, lower panel) of equal molar Gβγ subunits at 25 oC for 15 minutes. After reconstitution, membranes
were pelleted, washed and resuspended in Laemmlli buffer. The Gi1α subunits associated with the membranes were resolved
by 12% SDS-PAGE gels, transferred, probed and visualized as described in the text. Lane 1 was loaded with 1.0 pmol Gi1α as
standard. Data show that Giα subunits associate with the membrane in a concentration-dependent pattern in reconstitution and
that this association is greatly impaired in the absence of Gβγ subunits.
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Protein assay:
Protein concentrations are assayed routinely by the BCA method with the BCA
Protein Assay Kit from Pierce (Rockford, IL) using bovine serum albumin as standard.
Protein samples are solubilized in 0.5 N NaOH:5% SDS and samples containing reducing
reagents such as β-mercaptoethanol or Dithiothreitol in the buffer are first incubated with
0.2 M iodoacetamide at 60 oC for 15 minutes with vented plastic caps to eliminate their
reducing effects that will interfere with the assay. Absorbance of samples at 562 nm is
performed in a Spectronic Genesys 5 spectrophotometer (Milton Roy Com.) and protein
concentration is determined by the linear regression analysis with GraphPad Prism
software (GraphPad Software, CA).

Data analysis:
All data computation and statistical analyses are performed using GraphPad Prism
software (GraphPad Software, CA). All experiments were repeated the indicated number
of times and each data point within experiments are obtained from duplicate or triplicate
samples. Data are represented as mean ± SD determined from single experiment or mean
± SEM from multiple experiments. Binding and dose-response curve are fitted using
non-linear regression analysis and F-test. Student t-test, one-sample t-test, one-way or
two-way ANOVA and appropriate post tests are used to compare differences as indicated
in the text.
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5-hydroxytryptamine;

CHAPS,
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guanine nucleotide binding protein; GPCRs, G protein coupled receptors; GTPγγS,
guanosine 5’-3-O-(thiotriphosphate); mAChR, muscarinic acetylcholine receptor; MOI,
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Abstract
The G protein coupling of five human muscarinic acetylcholine receptors
(mAChRs) was studied in an Sf9 cell based reconstitution system, in which Sf9 cell
membranes expressing individual mAChR subtypes were reconstituted with purified Gq
and Gi1 proteins. Functional coupling was assessed by the enhancement of high-affinity
agonist binding using radioligand binding assays. Urea-extraction of the Sf9 cell
membranes containing the expressed mAChRs greatly improved their coupling with
purified G proteins. Functional G protein coupling was established for M1, M2, M4 and
M5 receptors in reconstitution. However, functional G protein coupling could not be
established for M3 receptors. Similar apparent affinities were observed for Gq and Gi
interactions with M1 and M5 receptors, which were significantly stronger than the
interactions of Gi1 with M2 and M4 receptors. M2 and M4 receptors did not interact with
Gq. The affinity for the muscarinic agonist Oxotremorine-M also varied among the
receptors in both the coupled and uncoupled states.

Thus, the five closely related

mAChRs displayed different agonist binding and G protein coupling behaviors in an
identical membrane environment.
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Introduction
The metabotropic responses of acetylcholine are mediated by a family of
muscarinic acetylcholine receptors (mAChRs). With molecular cloning studies, five
mAChR subtypes have been identified (Kubo et al., 1986; Bonner et al., 1987; Peralta et
al., 1987; Bonner et al., 1988). Though some subtypes are predominant in certain
peripheral tissues, accumulating evidence suggests an overlapping distribution pattern of
mAChRs in many tissues. For example, all five subtypes are detected in central nervous
tissues (See Caulfield and Birdsall, 1998 for a recent review). Five mAChRs all belong to
the G protein coupled receptor (GPCR) superfamily and elicit their cellular responses via
coupling to heterotrimeric G proteins upon activation. Based on their G protein coupling
profiles and signal transduction mechanisms, five mAChRs can be further classified into
two subgroups. The odd-numbered subtypes (M1, M3 and M5) preferentially couple to
phosphoinositide hydrolysis and calcium mobilization via Gq/11 proteins while the evennumbered subtypes (M2 and M4) typically couple to the inhibition of adenylyl cyclase
and activation of potassium channel via Gi/o proteins (Caulfield and Birdsall, 1998).
Given that multiple mAChRs share the same G protein coupling preference and
similar signal transduction mechanisms, it is of interest to understand the functional
significance of these closely related subtypes. Intensive study in a variety of systems
indicates that mAChRs may differentially couple to G proteins (Peralta et al., 1988; Buck
and Fraser, 1990; Wang and el Fakahany, 1993; Burford et al., 1995a). A great number of
studies attempting to define the specific roles of individual subtypes are compromised by
the heterogeneity of mAChRs in tissues, variations in expression systems and the lack of
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highly subtype-selective reagents (Caulfield, 1993; Eglen and Watson, 1996; Wess,
1998). At the biochemical level, elucidation of the detailed G protein coupling
mechanisms of each mAChR by reconstitution of the individual components will help
distinguish the functional significance of the individual subtypes.
The aim of the present work was to compare the G protein coupling properties of
five closely related mAChRs using a membrane-based reconstitution approach. In vivo
evidence indicates that GPCRs are outnumbered by G proteins (Neubig, 1994; Post et al.,
1995). Jakubik and colleagues studied the effects of different GPCR-G protein ratios on
their coupling properties and suggested that a constant ratio between GPCRs and G
proteins might retain in native cells (Jakubik et al., 1998). Earlier work from our
laboratory indicates that four closely related 5-HT1 receptors can distinguish themselves
by the affinities for their coupling G proteins (Clawges et al., 1997). Clearly, GPCR-G
protein stoichiometry may be a characteristic aspect of G protein mediated signal
transduction. For mAChRs, it is not known if these aspects of G protein coupling vary
among the individual subtypes.
The extended ternary complex model has been widely used to explain GPCR-G
protein coupling (Samama et al., 1993). In this model, GPCRs shift between two
conformational states: an inactive, uncoupled state with low agonist binding affinity and
an active, G-protein-coupling state with high agonist binding affinity. However, an
increasing number of observations indicate that this model needs revision and that
GPCRs may exhibit multiple conformation states depending on the identities of agonists
and the coupling of G proteins (Strange, 1999). Akam et al have shown that the G
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proteins activation by mAChRs not only depends on receptor subtype but also depends
on the nature of agonists (Akam et al., 2001). In this work, we investigated if a specific
mAChR subtype could have different affinity states for the same agonist when interacting
with different G proteins and if this feature is different among five mAChRs.
Our results show that five mAChRs displayed different G protein coupling
behaviors when examined by the formation of the high affinity agonist binding state in
radioligand binding assays. The Gi-coupled M2 and M4 mAChRs displayed similar
apparent affinities for Gi1 heterotrimers and did not interact with Gq heterotrimers. The
Gq-coupled M1 and M5 receptors had similar apparent affinities for both Gi1 and Gq
heterotrimers. However, although the M3 receptor is coupled to Gq-mediated responses
in tissues, it did not exhibit a high affinity agonist binding state with either Gi1 or Gq
heterotrimers in the Sf9 cell membranes. Differences were also observed among the
individual mAChR subtypes in their high and low affinity states for the agonist
Oxotremorine-M. Thus, when placed in an identical membrane environment the
individual mAChR subtypes exhibit distinct G protein coupling behaviors.
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Materials and Methods

Materials.

[3H]-Oxotremorine-M Acetate (3H-Oxo-M, 85.8 Ci/mmol) and [3H]-N-

Methyl Scopolamine Chloride (3H-NMS, 70.0 Ci/mmol) were purchased from NEN Life
Science Products, Inc. (Boston, MA). 3-[(3-cholamidopropyl)dimethylammonil]-1propanesulfonic acid (CHAPS) was from Calbiochem (San Diego, CA).

Atropine

Sulfate, Oxotremorine-M Acetate (Oxo-M) and other chemicals were from SigmaAldrich Corp. (St. Louis, MO). Restriction endonucleases and Mung Bean Nuclease were
from New England Biolabs (Beverly, MA). T4 DNA ligase was from USB Corp.
(Cleveland, OH). Bac-N-Blue Transfection Kit and BCA Protein Assay Kit were from
Invitrogen (Carlsbad, CA) and Pierce (Rockford, IL), respectively.

Production of recombinant baculoviruses expressing human mAChRs. Recombinant
baculoviruses expressing human M1 and M2 mAChR were kind gifts from Dr. Elliot
Ross (University of Texas Southwestern Medical Center). Human M3 mAChR
recombinant baculovirus was kindly provided by Dr. Karl Akerman (Åbo Akademi
University, Finland). The production of these viruses was described previously (Parker et
al., 1991; Kukkonen et al., 1996).
To produce human M4 mAChR recombinant baculoviruses, the pCD plasmid
containing its coding cDNA (Bonner et al., 1987) was first linearized at a Tfi I site (103
nucleotides upstream of the initiation codon) and then followed by Mung Bean Nuclease
incubation to create blunt ends. The cDNA containing the coding region was excised as a
1.7-kb fragment from the linearized plasmid with Bgl II at its 3’-end and ligated into
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pVL1393 transfer vector at its Sma I and Bgl II sites. To produce human M5 mAChR
recombinant baculoviruses, its cDNA was excised from its pCD plasmid (Bonner et al.,
1988) as a 1.8-kb fragment with Pst I and ligated into pVL1392 transfer vector at its Pst I
site. Both constructs were confirmed by restriction analysis and DNA sequencing. Using
Bac-N-Blue Transfection Kit (Invitrogen, CA) each transfer vector was co-transfected
into Sf9 cells with the linearized wild-type AcMNPV DNA to produce recombinant
baculoviruses and recombinant viruses were purified following manufacturer’s manual.

Expression and preparation of human mAChRs in Sf9 cell membranes. Each
mAChR was expressed in Sf9 cells using recombinant baculoviruses expressing the
desired receptor subtype. Sf9 cells were infected, cultured, harvested and the membranes
were prepared as described (Clawges et al., 1997). Protein concentrations were analyzed
with the BCA Protein Assay Kit from Pierce (Rockford, IL) using bovine serum albumin
as standard.

Urea-extraction of Sf9 cell membranes containing the expressed mAChRs. To
establish functional coupling between the purified G proteins and the mAChRs expressed
in Sf9 cell membranes, we adapted a urea-extraction protocol based on previous reports
from others (Hartman, IV and Northup, 1996). Briefly, 28,000 x g postnuclear
membranes prepared as described (Clawges et al., 1997) were resuspended at a
concentration of about 0.5 mg/ml in a binding buffer (50 mM Tris-Cl, 5 mM MgCl2, 0.5
mM EDTA, pH 7.5) and incubated with 200 nM Oxo-M and 25 µM GTPγS in a shaking
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incubator at 25 °C for 1 hour. After incubation, membranes were pelleted at 288,000 x g,
4 °C for 30 minutes and then resuspended in a urea-extraction buffer (25 mM HEPES, 1
mM EDTA, pH 7.5 and 6M urea added freshly at use) at about 0.6-0.75 mg/ml and
incubated on ice for 30 minutes. The extracted membranes were washed twice by
resuspending in a HE buffer (5 mM NaHEPES, l mM EDTA, pH 7.5) and centrifuging at
288,000 x g, 4 °C for 30 minutes. The final pellets were resuspended in the HE at a
concentration of 1-3 mg protein/ml.

Expression and purification of G proteins. Recombinant G protein subunits were also
expressed in Sf9 cells using recombinant baculoviruses. Gi1α subunits were purified as
described (Bae et al., 1999). Gq proteins were purified as detergent-extracted Gαqβ1γ2
heterotrimers from Sf9 cells co-infected with the recombinant baculoviruses to express
Gqα, Gβ1 and His-tagged Gγ2 subunits at an infection MOI of 1α:1β:1γ (Kozasa and
Gilman, 1995). Briefly, a 100,000 x g-pellet from cell homogenates was first extracted
for 1 hour in an extract buffer (50 mM Tris/HCl, pH 8.0 with 10 µM GDP, 2 mg/ml
aprotinin, 20 mg/ml benzamidine, 2 mg/ml leupeptin, 2 mg/ml pepstatin, 0.1 mM PMSF,
5 mM BME and 1% CHAPS) and then centrifuged again at 100,000xg, 4°C for 45
minutes. The resulting supernatant was subject to sequential chromatography on AP-2
DEAE anion exchange, Ni-NTA Superflow resin and AP-1 QHR15 anion exchange
columns. Free Gβ1γ2HIS subunits and Gαqβ1γ2HIS heterotrimers were eluted at 100 - 125
mM and 200 - 220 mM NaCl gradients, respectively.
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Reconstitution of G proteins with mAChR-containing Sf9 cell membranes.
Reconstitution was performed as previously described (Clawges et al., 1997) except that
0.08% CHAPS was included in the reconstitution buffer (5 mM NaHEPES, 100 mM
NaCl, 5 mM MgCl2, 1 mM EDTA, 500 nM GDP, 0.08% CHAPS, pH 7.5). G protein
subunits were diluted in the same buffer such that the desired amount of subunit is
contained in 1-5 µl. Aliquots of membrane and G proteins were mixed and incubated at
25 °C for 15 minutes and then held on ice until the start of the binding assay.

Radioligand binding assays.

For [3H]-NMS saturation binding assays, 5-20 µg

membrane aliquots were incubated with [3H]-NMS in a concentration range of 0.02 to 10
nM. For high-affinity [3H]-Oxo-M binding assays and [3H]-NMS competition binding
assays, membranes were first reconstituted with purified G proteins as indicated in the
text at 25 °C for 15 minutes. The reconstitution mixtures were diluted 10-fold with
binding buffer prior to the start of the binding assay such that the desired amount of
membranes (5 - 25 µg/assay tube) were contained in 50 - 150 µl. Aliquots of diluted
membranes were incubated with a single concentration (~5 nM) of [3H]-Oxo-M for the
high-affinity [3H]-Oxo-M binding assays; and a single concentration (~ 3 nM) of [3H]NMS and increasing concentrations of unlabeled Oxo-M as a competitor with a range
from 10-1 M to 10-12 M for the [3H]-NMS competition binding assays. Non-specific
binding was determined by addition of 103-fold or greater excess of atropine. The binding
experiments were all performed in the binding buffer at 25 °C for 1.5 hours to achieve
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equilibrium in a temperature-controlled shaker. The determination of binding was carried
out as described (Clawges et al., 1997).

Data analysis. The [3H]-NMS saturation binding data were fit to one- and two-site
binding models and compared by F-test. Without reconstitution with G proteins, one-site
binding was the best-fit model in every assay performed for mAChRs in both the treated
and non-treated Sf9 cell membranes. Thus, the receptor expression level (Bmax) and the
affinity for [3H]-NMS (Kd) were computed from the one-site binding model with the
GraphPad software and expressed as pmol/mg membrane protein and nM, respectively.
To assess the apparent affinities between mAChRs and their coupling G proteins, the
[3H]-Oxo-M binding data were fit to a one-site interaction model between receptor and G
protein and analyzed with GraphPad Prism software to calculate EC50 values, which
represent the apparent affinity between G protein and receptor. [3H]-NMS competition
binding data were first fitted into one- and two-site competition models to determine the
best-fit model with F-test. The dissociation constants (Ki) for Oxo-M and the fractions of
receptors in the high-affinity state were then computed from the best-fit curve with the
Cheng-Prusoff correction.
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Results

Expression and characterization of mAChRs in Sf9 cell membrane.

Five

recombinant human muscarinic receptors were expressed in Sf9 cells using recombinant
baculoviruses containing their cDNAs. The postnuclear Sf9 cell membrane fractions
containing the expressed mAChRs were prepared and characterized by [3H]-NMS
saturation binding assay as described in “Methods”. The [3H]-NMS binding sites on these
membranes ranged from 2.2 to 33.2 pmol/mg membrane protein. The dissociation
constants (Kd) for [3H]-NMS binding were between 0.25 nM and 1.44 nM (Table 1),
which were in good agreement with those obtained on muscarinic receptors expressed in
native tissues, transfected mammalian cell lines and Sf9 cells (Buckley et al., 1989;
Hulme et al., 1990; Dorje et al., 1991; Dong et al., 1995; Kukkonen et al., 1996).
Previous studies have demonstrated that urea-extraction of the membranes is required for
reconstitution of functional coupling to Gq (Hartman, IV and Northup, 1996; Hellmich et
al., 1997; Lindorfer et al., 1998; McIntire et al., 2002). Consistent with previous studies,
urea-extraction of the Sf9 cell membranes containing expressed mAChRs removed about
60% of the total membrane protein. However, the relative density of the mAChRs,
expressed as pmol/mg membrane protein, was only significantly increased for M4
receptors. For each muscarinic receptor, urea-extraction did not significantly alter the
dissociation constant for [3H]-NMS binding (p<0.05, t test) (Table 1).
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High-affinity agonist binding on mAChR membranes. Based on the well-accepted
ternary complex model (Samama et al., 1993), GPCRs can be stabilized in their highaffinity agonist binding state by their coupling G proteins. Thus, using a single, low
concentration of agonist which is near the high-affinity Kd of the agonist, functional
receptor-G protein coupling may be readily detected as enhanced agonist binding on the
receptors (Clawges et al., 1997; McIntire et al., 2002; Windh and Manning, 2002). To
assess the functional coupling between the expressed muscarinic receptors and G
proteins, we reconstituted the Sf9 cell membranes containing individual expressed
muscarinic receptors with at least a 100-fold molar excess of purified G protein
heterotrimers. As shown in Figure 1, without urea-extraction, addition of G proteins
significantly enhanced agonist binding on M2 receptors (solid bar in the “Non-extracted”
group, 5.42 fold over the control binding, p<0.05), but only poorly enhanced agonist
binding on M1 receptors (1.29 fold over the control binding, p<0.05). Addition of G
proteins was unable to enhance agonist binding on the other muscarinic receptors (M3,
M4 and M5). When G protein coupled receptors are expressed in recombinant cells,
endogenous G proteins are often able to couple with the expressed receptors. As shown in
Figure 1, in the presence of 50 µM GTPγS, agonist binding was significantly reduced on
all the “Non-extracted” receptor membranes except the M3 receptor membrane (striped
bars in “Non-extracted” groups), indicating that some of the expressed muscarinic
receptors coupled with endogenous G proteins in Sf9 cell membranes. The agonist
binding was reduced about 40% on M1 and M5 receptor membranes and about 86% on
M2 and M4 receptor membranes (Figure 1).
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Several groups have successfully applied high concentrations of urea to reduce
endogenous G protein coupling and improve functional coupling between membrane
expressed receptors and purified G proteins in reconstitution (Hartman, IV and Northup,
1996; Hellmich et al., 1997; Lindorfer et al., 1998; Lim and Neubig, 2001). As shown in
Figure 1, after the Sf9 cell membranes were treated with urea-extraction, addition of G
proteins significantly improved the high-affinity agonist binding on both M1 and M2
receptors (6.64 vs. 1.29 fold for M1 and 175.37 vs. 5.42 fold for M2, respectively,
p<0.05). On the extracted membranes containing M4 and M5 receptors, addition of G
proteins significantly enhanced agonist binding to these receptors (7.64 fold for M4 and
5.29 fold for M5 of their controls, p<0.05). However, after urea-extraction, addition of G
proteins still could not stabilize the high-affinity agonist binding on the M3 receptors.
Addition of GTPγS did not reduce agonist binding on the extracted M3 and M4 receptor
membranes (p>0.05) but still could significantly reduce agonist binding on the extracted
M1, M2 and M5 receptor membranes (18%, 25% and 12% less than the controls,
respectively, p<0.05) (Figure 1). Compared with the non-extracted membranes, this
uncoupling effect was significantly decreased in the extracted membranes (compare
striped bars in “Non-extracted” and “Extracted” groups).

G protein concentration-dependent high-affinity agonist binding on reconstituted
membrane mAChRs. To further characterize the G protein coupling properties of five
muscarinic receptors (mAChRs), we assessed apparent affinities of G proteins for five
mAChRs. Urea-extracted Sf9 cell membranes containing individual mAChR subtypes
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were reconstituted with increasing concentrations of Gq or Gi1 proteins. The highaffinity agonist binding on these receptors stabilized by G proteins at different
concentrations were determined with a single, low concentration (~ 5 nM) of [3H]-OxoM. As shown in Figure 2, the G protein-stabilized high-affinity agonist binding on 4 out
of 5 mAChRs tested exhibited a G protein concentration-dependent pattern. The EC50 for
G proteins was determined by fitting the binding data to a one-site interaction model
between G proteins and receptors and represents the apparent affinity of the receptor for
the G protein heterotrimer. As shown in Figure 2A, the M1 and M5 mAChRs had EC50
values of 65.6 ± 0.4 and 87.8 ± 19.2 nM for Gq, respectively, which are not significantly
different (p>0.05). Consistent with the results in Figure 1, the M3 receptor could not be
stabilized in the high-affinity agonist binding state by Gq protein even at a very high
concentration (313 nM). Under the same conditions, Gq was also unable to enhance
agonist binding to urea-extracted M2 and M4 receptor membranes (data not shown).
When reconstituted with Gi1 (Figure 2B), an EC50 of 412.3 ± 5.5 and 423.4 ±
51.3 nM was obtained for M2 and M4 receptors, respectively, which are not significantly
different (p>0.05). Enhanced agonist binding was also observed for M1 and M5 receptors
when reconstituted with Gi1 protein (Figure 2C) with EC50 values of 97.8 ± 40.29 nM
and 45.0 ± 20.8 nM, respectively. Interestingly, the EC50 values with which M1 and M5
receptors interact with Gi1 and Gq do not differ significantly, however, the M1 and M5
receptors interact with G proteins with significantly higher affinity than do the M2 and
M4 receptors. Again, the M3 receptor was unique in that Gi1, even at a concentration of
400 nM, did not enhance high-affinity agonist binding.
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Competition analysis of G protein stabilized agonist affinity states on reconstituted
mAChRs. Agonist affinities of five mAChRs in urea-extracted Sf9 cell membranes were
investigated with competitive inhibition of [3H]–NMS binding by non-labeled Oxo-M.
Without G protein reconstitution, competition binding data were consistent with a onesite competition model for all five mAChRs (Figure 3, control curves). As summarized in
Table 2, without G protein reconstitution, four mAChRs (M1, M2, M4 and M5) have the
same low affinity for Oxotremorine-M (Ki-Low) (p>0.05, Tukey’s test). However, the
M3 receptor has a significantly lower affinity for Oxotremorine-M than the other
receptors (p<0.05, Tukey’s test).
When reconstituted with high concentrations of Gq proteins (more than 600-fold
molar excess over receptors), the competition binding curves fit a two-site model best for
M1 and M5 receptors but fit a one-site model best for M2, M3 and M4 receptors. About
18% of both M1 and M5 receptors could be stabilized in the high-affinity agonist binding
state (Table 2). The proportions of receptors in the high-affinity state and the highaffinity dissociation constants (Ki-High) were not significantly different between M1 and
M5 receptors (p>0.05, t test) (Table 2). For the low agonist affinities (Ki-Low) among
five mAChRs in Gq reconstitutions, only M3 receptor was different from others (p<0.05,
Tukey’s test) (Table 2).
All four mAChRs could be stabilized in the high-affinity agonist binding state by
Gi1 reconstitution and their binding curves fit a two-site model best (Figure 3 and Table
2). However, the receptor proportions that could be stabilized in the high-affinity agonist

84

binding state by Gi1 were different among them (M4>M2=M5>M1) (Table 2). Again, for
the low-affinity state with Gi1 reconstitution, only the Ki-Low from M3-Gi1
reconstitution was different from those of others (p<0.05, Tukey’s test) (Table 2). The
high-affinity dissociation constants (Ki-High) did not differ among M1, M2 and M5
receptors, but the Ki value for the M4 receptor was significantly greater than the others
(Ki-High, 92.35 nM, p<0.05, Tukey’s test) (Table 2).
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Discussion
The baculovirus expression system has been a useful tool to study GPCR-G
protein coupling. It has been used to express high levels of GPCRs and/or G proteins
(Graber et al., 1992; Graber et al., 1994; Kozasa and Gilman, 1995; Windh and Manning,
2002). The muscarinic acetylcholine receptors (mAChRs) expressed in Sf9 cells have
been reported to retain their structural integrity, ligand binding pharmacology and G
protein coupling properties (Parker et al., 1991; Dong et al., 1995; Vasudevan et al.,
1995; Kukkonen et al., 1996; Weill et al., 1997). In the present study, we expressed five
human mAChRs in Sf9 cells. Although the five mAChRs were expressed and
characterized under the same conditions, their [3H]–NMS binding sites ranged from 2.2
to 33.2 pmol/mg protein in a 28,000 x g postnuclear membrane preparation (Table 1).
The M2 and M3 mAChR binding sites were expressed at higher levels in comparison
with other three mAChRs. A similar difference between M1 and M2 mAChR binding
sites was reported using the same baculoviruses (Parker et al., 1991). The reason for the
difference in their expression levels is not well understood, but Parker et al suggests that
it may be due to both the nucleotide and amino acid sequence of individual GPCRs.
Despite their different expression levels in Sf9 cells, all five mAChRs displayed a single
affinity state for [3H]–NMS binding with Kd values of 0.25 nM to 1.44 nM. These values
were in close agreement with those from previous studies using native tissues, transfected
mammalian cells as well as Sf9 cells (Buckley et al., 1989; Hulme et al., 1990; Dorje et
al., 1991; Dong et al., 1995; Kukkonen et al., 1996).
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Previous studies indicate that mAChRs display differential G protein coupling
properties not only between Gi- and Gq-coupled mAChRs but also among mAChRs
coupled to the same G protein. In this study, we examined the potential difference in the
G protein coupling properties of five closely related mAChRs in a Sf9 cell based
reconstitution system. Based on the extended ternary complex model (Samama et al.,
1993), the high-affinity agonist binding on mAChRs stabilized by their coupling G
proteins was measured to assess the functional coupling between G proteins and
mAChRs. As shown in Figure 1, when the purified G proteins reconstituted with the
(non-extracted) membranes containing the M1 and M2 mAChRs, an enhanced agonist
binding level was detected, which was well explained by the model. However, such a
functional coupling was not established for the M3, M4 and M5 mAChRs in the (nonextracted) Sf9 cell membranes. To circumvent this problem, we adapted a urea-extraction
protocol based on previous reports. After urea-extraction, about 60% total membrane
proteins were lost. In contrast with the reports by Northup’s group (Hartman, IV and
Northup, 1996), urea-extraction did not significantly increase the relative abundance of
[3H]–NMS labeled mAChR sites except for M4 receptor membranes. It is not known if
this resulted from the removal of receptor proteins from the membrane or the inactivation
of some receptor binding sites. As reported by Parker et al, it seems that not all receptor
proteins expressed in Sf9 cell membranes could be labeled by radioligand from the
comparison of immunoblot and radioligand labeling data (Parker et al., 1991). For each
mAChR subtype expressed in Sf9 cell membranes, urea-extraction did not significantly
alter their binding affinity for [3H]–NMS (Table 1). However, their endogenous G protein
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coupling was significantly decreased (Figure 1). Hartman et al reported that the GTPγS
binding level was reduced 75% on the extracted Sf9 cell membranes, reflecting the
removal or inactivation of the endogenous G proteins (Hartman, IV and Northup, 1996).
Consistent with their results, ours showed that urea-extraction also decreased the
endogenous G protein-stabilized, high-affinity, agonist binding on the extracted
membranes (Figure 1). More importantly, urea-extraction greatly improved the mAChR
coupling with the purified G proteins added in reconstitution (Figure 1). Thus, the
extracted mAChR-containing Sf9 cell membrane combined with radiolabeled agonist
binding assay may provide an alternative tool to analyze mAChR-G protein coupling.
Intriguingly, G protein-stabilized, high-affinity, agonist binding was not observed
for M3 mAChR in either the extracted or the non-extracted Sf9 cell membranes (Figure 1
and 2). Competition binding analysis revealed that the M3 receptor only showed a
relatively low agonist binding affinity regardless of G protein reconstitution (Figure 3 and
Table 2). The functional G protein coupling of M3 receptors have been demonstrated
when using intact Sf9 cells infected with recombinant baculoviruses expressing M3
receptors. For example, Kukkonen et al showed that stimulation of M3 receptor could
increase phosphoinositide hydrolysis and Ca++ mobilization (Kukkonen et al., 1996) and
Vasudevan et al showed M3 receptor activation could couple to K+ channel in a pertussis
toxin-sensitive way (Vasudevan et al., 1992). Thus, it appears that M3 receptor may
functionally couple to both Gq and Gi proteins in intact Sf9 cells. In contrast, Guo et al
showed that stimulation of Gq-fused M3 receptors in Sf9 cell membrane could not
catalyze guanine nucleotide exchange on Gq (Guo et al., 2001). Taken together, these
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results suggest that the functional M3-G protein coupling may require additional cellular
component(s) that may be eliminated during membrane preparation. As in the
conventional G protein signaling model (Gilman, 1987; Neer, 1995), it was believed that
activation of GPCRs upon agonist binding may catalyze the guanine nucleotide exchange
on Gα subunits, resulting in the dissociation of GTP-bound Gα from Gβγ subunits,
which are both able to interact with downstream effectors. Based on accumulating
evidence, Chidiac questioned the generality of this model and proposed three possible
mechanisms explaining GPCR-G protein-Effector (R-G-E) coupling process (Chidiac,
1998). One of these mechanisms proposes the existence of stable R-G-E complexes,
possibly containing more than one copy of each component. Though direct evidence is
needed to verify this model, current evidence indicates the existence of oligomeric
receptors (Hebert and Bouvier, 1998), receptor-G protein complexes (Rodbell, 1980)
(Wreggett and Wells, 1995) and effectors (Tang et al., 1995), suggesting the possibility
of such complexes. For M3 mAChRs, Zeng and Wess’ study showed that M3 receptors
were able to form dimers and multimers independently of agonist interaction (Zeng and
Wess, 1999). As shown in the present study, the G protein coupling properties of M3
receptors is clearly different from other two Gq-coupling mAChRs (M1 and M5) in an
identical environment. Upon reconstitution with either Gq or Gi1 proteins, the highaffinity agonist binding state could be restored for both M1 and M5 receptors but not for
M3 receptors. Thus, in future studies it will be very interesting to test whether or not
addition of effectors (such as PLC-β in the M3-Gq protein signaling cascade) could
restore high-affinity agonist binding on M3 receptors with our approach presented here.
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Verification of this issue may provide strong evidence for the stable R-G-E complex
model proposed by Chidiac (Chidiac, 1998).
Quantitation of G protein signaling components in vivo reveals that GPCRs are
outnumbered by excessive G proteins in the plasma membrane (Post et al., 1995).
Kenakian et al discussed that the alteration in GPCR-G protein stoichiometry in
heterologous systems may produce abnormal GPCR-coupling properties compared with
in vivo situations, while Neubig emphasized the accessibility between GPCRs and G
proteins in native cells may be a regulating factor for GPCR-G protein coupling (Neubig,
1994; Kenakin, 1997). Consistent with these conclusions, an earlier work from our
laboratory showed that the agonist binding on 5-HT receptors was enhanced in a G
protein concentration-dependent manner, suggesting that the strength in GPCR signaling
may depend on the amount of available G proteins (Clawges et al., 1997). In addition, for
four different 5-HT1 receptor subtypes that can couple to the same G protein, their
difference in G protein coupling could be distinguished by their apparent affinities for G
protein (Clawges et al., 1997). For mAChR subtypes, although promiscuous G protein
coupling has been observed, their selective G protein coupling is more predominant. For
example, Offermanns et al reported that M1, M2 and M3 receptors could activate Gi1
proteins when expressed in transfected HEK 293 cell membranes; however, much higher
agonist concentrations were needed for Gi1 activation by M1 and M3 receptors in
comparison with M2 receptors (Offermanns and Schultz, 1994). Provided that mAChRs
have the identical access to G proteins, would their interaction with G protein be different
at the biochemical level? To address this question, we assessed the apparent affinity of G
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proteins in stabilizing the high-affinity agonist binding on mAChRs. Our data showed
that M2 and M4 receptors could not couple to Gq protein in the urea-extracted Sf9 cell
membranes but they had a similar apparent affinity for Gi1 protein coupling (Figure 2B).
Similar apparent affinities were observed for M1 and M5 receptors in their interactions
with either Gq or Gi1 proteins (Figure 2A&C). These results are in good agreement with
the well-established G protein coupling preferences for mAChRs by other approaches
(Caulfield and Birdsall, 1998). In general, the even-numbered muscarinic receptors (M2
and M4 receptors) predominantly couple to pertussis toxin-sensitive Gi/o proteins, while
the odd-numbered muscarinic receptors (M1, M3 and M5 receptors) preferentially couple
to pertussis toxin-insensitive Gq/11 proteins. However, this G protein coupling selectivity
is not absolute but relative. For example, Burford et al demonstrated that, when expressed
in CHO cells, M1 and M3 receptors also could stimulate GTPγS binding to G proteins in
a pertussis toxin-sensitive way (Burford et al., 1995b). Our results show that both M1 and
M5 receptors can be stabilized in high-affinity agonist binding state by Gi1 proteins. In
addition, they seem to have a stronger interaction with Gi1 than M2 and M4 receptors do.
However, M3 receptors clearly have different G protein-coupling properties from those
of M1 and M5 receptors as discussed above.
In competition binding assays (Figure 3 and Table 2), without G protein
reconstitution, only a single, low-affinity agonist binding state was observed for all five
mAChRs in the urea-extracted Sf9 cell membranes, which can be well explained by the
ternary complex model. For Gi-coupled M2 and M4 receptors, their high-affinity agonist
binding states were stabilized when reconstituted with Gi1 proteins but not Gq proteins,
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confirming that they are Gi-selective coupled receptors. Similarly, a high-affinity agonist
binding state was observed for M1 and M5 receptors when reconstituted with Gq proteins
as well as with Gi1 proteins. When reconstituted with Gi1 proteins, M1 and M5 receptors
have similar agonist binding affinities but M2 and M4 receptors are significantly different
in their high binding affinities (Ki-High) for Oxo-M.
M3 receptors not only had one agonist affinity state regardless of Gq or Gi1
reconstitution but its Ki at low-affinity state for Oxo-M was much higher than others (at
least 10-fold). It was different from the previous observations by others. For example,
using radioligand binding assays on the S9 cell membranes without urea-extraction, Dong
et al reported that less than 10-fold difference in ligand binding affinity was observed
among a variety of antagonists and agonists including Oxotremorine (Dong et al., 1995).
It may suggest that agonist binding properties of M3 receptors may be dramatically
affected by the membrane-environment and the availability of other cellular components.
As discussed by others, caution should be taken when interpreting the results
obtained from heterogeneous system due to varied receptor-G protein stoichiometry,
membrane environment and signaling component repertoire in different systems (Neubig,
1994; Kenakin, 1997). Experimental conditions in reconstitution may not exactly reflect
the situations in vivo, but do provide a basis to study the functional differences among
closely related GPCRs. As presented in this study, our data clearly demonstrated that five
G protein coupled muscarinic receptors could potentially be stabilized in different ligand
binding affinity states by the same G protein population in an identical environment.
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In summary, five closely related mAChRs can be distinguished in their G protein
coupling properties at the biochemical level. M1 and M5 receptors couple to both Gq and
Gi1 proteins but only Gi1 protein coupling was observed for M2 and M4 receptors in
reconstitution. For M1 and M5 receptors, their apparent affinities were not different for
either Gq or Gi1 coupling. Similarly, for M2 and M4 receptors, they were not different in
their apparent affinities for Gi1 coupling but could not couple to Gq. Between the oddnumbered and even-numbered muscarinic receptors, it appears that M1 and M5 receptors
have a stronger interaction for Gi1 coupling. Interestingly, M3 receptors could not couple
to either Gq or Gi1 proteins in reconstitution, suggesting that it may employ a unique G
protein coupling mechanism. In conclusion, our data demonstrate that the five closely
related muscarinic receptors exhibit different agonist binding and G protein coupling
behaviors in an identical membrane environment.
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Table 1. Saturation binding parameters of five human mAChRs expressed in Sf9 cell membranes with or without urea
extraction.
Recombinant human mAChRs were expressed in Sf9 cells with baculoviruses and the membranes were prepared with or
without 6 M urea extraction as described in “Methods”. 10 – 25 µg membrane protein per tube was used in binding assay in
the presence of 0.02 – 10 nM [3H]-NMS in a final volume of 500 µl. Kd values (nM) were generated by fitting the data to onesite model and expressed as mean ± SEM with the number of preparations indicated in the parentheses.

Receptor

M1

M2

M3

M4

M5

Non-extracted

0.25 ± 0.10 (5)

0.72 ± 0.05 (3)

0.83 ± 0.05 (3)

0.56 ± 0.38 (3)

0.38 ± 0.08 (7)

Extracted

0.27 ± 0.05 (10)

0.67 ± 0.12 (3)

1.44 ± 0.27 (7)

0.45 ± 0.17 (2)

0.64 ± 0.11 (4)
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Table 2. Competition binding parameters of reconstituted Sf9 cell membranes
containing individual mAChR subtypes.
Inhibition of [3H]NMS (3 nM) binding on the reconstituted Sf9 cell membranes
containing individual mAChR subtypes was determined and analyzed as indicated in
Figure 3. Binding parameters were computed from the best-fit competition model and
represented as Mean ± SEM from the number of independent experiments shown in the
parentheses.
Subtype

Reconstitution

M1

Control
Gq
Gi1

M2

Control
Gq
Gi1

R-High (%)a

Ki-Low (µM)

Ki-High (nM)

18.00 ± 2.30 (2)
12.85 ± 3.85 (2)

17.16 ± 2.43 (3)
14.33 ± 2.93 (2)
6.05 ± 2.15 (2)

14.09 ± 12.2 (2)
8.91 ± 8.89 (2)

38.49 ± 5.61 (3)

8.60 ± 2.20 (2)
6.11 ± 0.01 (2)
3.27 ± 0.87 (3)

2.59 ± 2.15 (3)

M3

Control
Gq
Gi1

188.7 ± 37.52 (3)
135.3 ± 8.90 (2)
125.1 ± 26.98 (3)

M4

Control
Gq
Gi1

70.89 ± 3.34 (3)

11.25 ± 3.82 (3)
4.72 ± 1.77 (3)
16.34 ± 2.14 (3)

92.35 ± 7.53 (3)

M5

Control
Gq
Gi1

18.37 ± 1.58 (3)
33.78 ± 0.10 (2)

8.08 ± 1.98 (2)
17.41 ± 9.20 (3)
10.46 ± 2.24 (2)

2.88 ± 2.52 (3)
0.16 ± 0.05 (2)

a

percentage of receptors stabilized in high-affinity agonist binding state by the indicated

G protein.
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Figure Legends
Figure 1. Determination of high-affinity agonist binding on mAChR-containing Sf9
cell membranes stabilized by purified G proteins in reconstitution. Urea-extracted or
non-extracted Sf9 cell membranes containing individual mAChR subtypes were
reconstituted in the presence (solid bars) or absence (open and striped bars) of at least
100-fold molar excess of G proteins as indicated. After reconstitution, the membranes
were diluted in binding buffer with (striped bars) or without (open and solid bars) 50 µM
GTPγS and the high-affinity agonist binding were determined in the presence of a single
concentration (~ 5 nM) of 3H-Oxo-M. The binding data were normalized as folds over
the binding on the control membranes (open bars) and expressed as Mean ± SEM from at
least three separated experiments. a, p < 0.05 compared with the control within each
group; b, p < 0.05 compared with the corresponding binding within the non-extracted
group.

Figure 2. G protein concentration dependence of high-affinity agonist binding on
reconstituted mAChR membranes. Aliquots of urea-extracted Sf9 cell membranes
expressing individual mAChR subtypes were reconstituted with increasing concentrations
of their coupling G proteins. After reconstitution, membranes were diluted in binding
buffer and incubated with a single concentration (~ 5 nM) of 3H-Oxo-M in a final volume
of 150 µl. Non-specific binding was determined in the presence of 0.6 mM atropine. The
final concentrations of G protein in the binding ranged from 0 to ~ 600 nM and receptor
concentrations were 0.95 nM, 0.85 nM, 1.80nM, 1.25 nM and 0.90 nM for M1 to M5
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receptors, respectively. Data points were from a representative experiment with triplicate
determinations. The apparent affinity was represented as EC50 for G proteins, at which the
G protein-stabilized high-affinity agonist binding reached the half-maximal level. EC50
values were generated by fitting data into a one-site interaction model between G protein
and receptor and expressed as Mean ± SEM from 2-8 independent experiments as
indicated in the parentheses.

Figure 3. Inhibition of [3H]NMS binding on the reconstituted Sf9 cell membranes
containing individual mAChRs by Oxo-M.
Sf9 cell membranes containing individual mAChR subtypes were reconstituted with
control buffer (•• control) or Gq proteins (∆
∆ Gq or ! Gi1). After dilution in binding
buffer, inhibition of [3H]NMS (3 nM) binding on the reconstituted membranes was
determined with increasing concentrations (10-1 to 10-12 M) of unlabeled Oxo-M. The
final concentrations in binding of G proteins were 300 nM Gq or 200 nM Gi1. M1-M5
receptor concentrations were 0.5nM, 0.5nM, 0.3 nM, 0.3 nM and 0.4nM, respectively.
Binding data were normalized as percent of maximum and each point represented
average value from 2 – 4 separate experiments with standard error less than 10%. After
fitting the data to one- or two-site competition model, the inhibition curves were
generated from the best-fit model determined by F test. Oxo-M affinities (Ki-low and Kihigh) and the receptor fractions in the high-affinity binding state were computed from the
best-fit model corresponding with GraphPad software and summarized in Table 2.
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Abbreviations and Textual Footnotes The abbreviations used are: 5-HT,
5-hydroxytryptamine;

AGS3,

activator

of

G

protein

3-(3-cholamidopropyl)dimethylammonil)-1-propanesulfonic

signaling
acid;

3;

CHAPS,

GDI,

guanine

nucleotide dissociation inhibitor; GoLoco motif, Gi/o-Loco interaction motifs; GPCRs,
G protein coupled receptors; GPR, G protein regulatory; GST, glutathione S-transferase;
MOI, multiplicity of infection; Pins, partner of inscuteable; PVDF, polyvinylidene
fluoride; SDS-PAGE, sodium dodecylsulfate-polyacrylamide gel electrophoresis; Sf9,
Spodoptera frugiperda; TPR, tetratricopeptide repeats.
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Abstract
Activator of G protein signaling 3 (AGS3) activates the Gβγ mating pathway in
yeast independently of heptahelical receptors. It competes with Gβγ subunits to bind
GDP-bound Gi/oα subunits via four repeated G protein regulatory (GPR) domains in the
carboxyl terminal half of the molecule. However, little is known about the functional
role of AGS3 in cellular signaling. Here the effect of AGS3 on receptor-G protein
coupling was examined in an Sf9 cell membrane-based reconstitution system. A GSTAGS3-GPR fusion protein containing the four individual AGS3-GPR domains inhibits
receptor coupling to Gα subunits as effectively as native AGS3 and more effectively than
GST fusion proteins containing the individual AGS3-GPR domains. While none of the
GPR domains distinguished among the three Giα subunits, both individual and full length
GPR domains interacted more weakly with Goα than Giα. Cytosolic AGS3, but not
membrane-associated AGS3, can interact with Giα subunits and disrupt their receptor
coupling. Immunoblotting studies reveal that cytosolic AGS3 can remove Giα subunits
from the membrane and sequester Giα subunits in the cytosol. These findings suggest
that AGS3 may down-regulate heterotrimeric G protein signaling by interfering with
receptor coupling.
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Heterotrimeric G proteins, located on the cytoplasmic face of the plasma
membrane, are widely used to transduce extracellular signals through heptahelical
GPCRs to intracellular signaling networks. According to the widely accepted ternary
complex model (1-3), agonist occupied GPCRs stimulate the release of GDP and binding
of GTP to the Gα subunit of a heterotrimer. The conformational changes associated with
GTP binding dissociate the ternary complex and both the GTP-bound Gα subunit and
Gβγ dimer are then free to modulate downstream effectors including enzymes and ion
channels.

This signaling is in part terminated by GTP hydrolysis and subunit

reassociation. A diverse array of proteins distinct from GPCRs, G-proteins and effectors
are now known to regulate this signaling process at multiple levels (4-7). Among the
newest family of accessory proteins are the Activators of G protein Signaling, or AGS
proteins (8;9). A member of this family, AGS3, belongs to a novel class of proteins
containing G protein regulatory (GPR) motifs, also known as GoLoco motifs (10). AGS3
has four repeated GPR sequences in its carboxyl-terminal half and seven tetratricopeptide
repeat (TPR) sequences in its amino-terminal half.

AGS3, via its GPR domains,

selectively interacts with the GDP-bound conformation of alpha subunits of the Gi/o
family (9;11-15) and effectively competes with Gβγ subunits for binding to Gα (13).
Studies in Drosophila melanogaster, Caenorhabditis elegans and several cultured
cell lines indicate that GPR containing proteins related to AGS3 are involved in cell
polarity and asymmetric cell division (16-20), but little is known about the influence of
AGS3 and related proteins on signal processing by GPCRs. Since AGS3 can potentially
disrupt G protein heterotrimers and stabilize the GDP-bound conformation of Gα
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subunits, we hypothesized that AGS3 might interfere with receptor-G protein coupling.
To examine the effect of AGS3 on receptor-G protein coupling, we used an Sf9 cell
membrane based reconstitution system. Relatively few GPCRs expressed in Sf9 cells are
coupled to endogenous G proteins (21-24). Reconstitution of the expressed receptors
with appropriate, purified, exogenous G proteins couples the majority of the expressed
receptors. This functional receptor-G protein coupling is readily detected as an enhanced
level of agonist binding using a radiolabeled agonist at concentrations near the highaffinity KD of the receptor (21;24).

The abilities of cytosolic AGS3, membrane-

associated AGS3, and individual GPR domains to interfere with receptor-G protein
coupling were assessed in reconstitution assays.
In this study, we report that cytosolic AGS3, but not membrane-associated AGS3,
interferes with 5-HT1A receptor-Gi/o protein coupling.

In interactions with Gi/oα

subunits, the GPR domain alone is as effective as the native AGS3 protein. Although all
four individual AGS3-GPR domains bind Giα more tightly than Goα, they do not
distinguish among the three Giα subunits. Taken together, our results demonstrate that
AGS3 affects receptor-G protein coupling by dissociating Gα subunits from the
membrane and sequestering Gα subunits in the cytosol.
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Experimental Procedures
Expression and purification of proteins. Recombinant Gi1,2,3α and Goα and
Gβ1γ2 subunits were purified after expression in Sf9 cells using recombinant
baculoviruses as described (25;26). Cytosolic AGS3 was prepared as a 100,000 g extract
from Sf9 cells infected at an MOI of 2 with recombinant baculoviruses encoding AGS3
(9). The infected Sf9 cells were then cultured, harvested and fractionated as previously
described (21) except that harvested cells were thawed in 5× (rather than 15×) their wet
weight of ice-cold homogenization buffer (10 mM Tris-Cl, pH 8.0 at 4°C, 25 mM NaCl,
10 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 20 µg/ml of benzamidine and
2 µg/ml of each of aprotinin, leupeptin and pepstatin A). The 100,000 g crude cytosol
was concentrated to a final protein concentration of 5-7 mg/ml in a pressurized Amicon
Cell using a YM-30 membrane. Control cytosol was prepared from uninfected Sf9 cells
in the same fashion. The GST-AGS3 fusion proteins containing all four AGS3-GPR
domains, GST-AGS3-GPR (Pro463-Ser650) or individual AGS3-GPR domains, GSTAGS3-GPR-I (Pro463-Glu501), GST-AGS3-GPR-II (Ser516-Leu555), GST-AGS3-GPR-III
(Gly563-Thr602), and GST-AGS3-GPR-IV (Thr602-Ser650) were expressed and purified as
previously described (13). Protein concentrations were determined with the bicinchonic
acid method (Pierce Chemicals).
Preparation of Sf9 cell membranes containing expressed 5-HT1A receptors.
To prepare membranes containing 5-HT1A receptors, Sf9 cells were infected with
recombinant baculoviruses expressing 5-HT1A receptor at an MOI of 2. To prepare
membranes containing both 5-HT1A receptors and AGS3, Sf9 cells were co-infected with
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recombinant baculoviruses expressing 5-HT1A receptor and AGS3 at MOIs of 1 and 3,
respectively. Sf9 cells were cultured and harvested; membranes were prepared and
analyzed to determine 5-HT1A receptor numbers as described (21) except that membranes
co-expressing AGS3 were washed once rather than thrice during preparation.
Reconstitution

of

Sf9

cell

membranes

with

purified

G-proteins.

Reconstitution was performed as previously described (21). Briefly, 50 µg membrane
protein and 1-2 µl containing the desired amount of G protein heterotrimer were
resuspended in reconstitution buffer plus 0.04% CHAPS (Calbiochem) prior to the
addition of the indicated additional components. The mixtures were incubated at 25°C
for 15 minutes and then held on ice until the start of the binding assay, or pelleted in a
refrigerated microcentrifuge at 12,000 rpm, 4°C for 10 minutes for immunoblotting
assay.
To allow soluble, cytosolic AGS3 or exogenous G protein heterotrimers to
associate with membranes, membranes containing 5-HT1A receptors were first incubated
(25°C, 15 minutes) with cytosol containing AGS3 or purified G protein heterotrimers,
respectively. The membranes were then pelleted in a refrigerated microcentrifuge at
12,000 rpm, 4°C for 10 minutes and washed thrice with 100 µl reconstitution buffer. The
resulting membranes were then used in a second reconstitution with the indicated
additional components as described above.
[3H]-5-HT binding assay.

Just prior to the start of the binding assay the

reconstitution mixture was diluted 10-fold with binding assay buffer (50 mM Tris/HCl, 5
mM MgCl2, 0.5 mM EDTA, pH 7.5) such that the desired amount of membranes (~15
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µg/assay tube) was contained in 50-100 µl. High affinity agonist binding was measured
with 1-2 nM [3H]-5-HT (25.5Ci/mmol, Perkin Elmer), which is near the high affinity KD
of 5-HT1A receptor, in a final volume of 150-300 µl.

Non-specific binding was

determined in the presence of a million-fold excess of unlabeled 5-HT. Incubation was
performed at 25°C for 1.5 hours in a temperature controlled shaker and terminated by
filtration over Whatman GF/C filters (Brandel Inc.) using a Brandel Cell Harvester
(Brandel Inc.). The filters were rinsed thrice with 4 ml ice cold washing buffer (50 mM
Tris-Cl, 5 mM MgCl2, 0.5 mM EDTA, 0.01% sodium azide, pH 7.5), placed in 4.5 ml
CytoScint (ICN Pharmaceuticals) and counted to constant error in a scintillation counter.
The binding data were analyzed using GraphPad PRISM (GraphPad Software).
Preparation of rat brain membranes. One rat brain was homogenized on ice
in a Dounce glass homogenizer with 40 ml lysis buffer (5 mM Tris, pH 7.4, 5 mM
EDTA, 5 mM EGTA, and protease inhibitors) for 8 strokes.

The homogenate was

centrifuged at 1,000 g for 10 minutes to remove debris. The resulting supernatant was
centrifuged at 40,000 g for 30 min at 4°C. The resulting pellet was homogenized (in 40
ml) and centrifuged (at 40,000 g) four times: twice in high salt buffer (50 mM Tris, pH
7.4, 0.6 mM EDTA, 5 mM MgCl2, 500 mM NaCl) and twice in no salt buffer (50 mM
Tris, pH 7.4, 0.6 mM EDTA). The resulting pellet was resuspended in 1 ml no salt buffer
using a glass homogenizer.
Immunoblot analysis.

To determine the amount of AGS3 in membrane or

cytosolic fractions, 0.5 µg protein was resolved by 12% SDS/PAGE and transferred to a
PVDF membrane (Millipore). The membrane was probed with AGS3 antisera P-32 (13)
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and visualized with ProtoBlot AP immunoblotting system (Promega). The levels of
AGS3 were estimated by comparing the band intensities with known amounts of purified
GST-AGS3-GPR (Pro463-Ser650) fusion protein standard using FluorChemTM 8000 system
(Alpha Innotech Corp.).

To determine the amounts of protein that associated with

membranes during reconstitution, the reconstitution mixtures were pelleted and washed
three times as described above. The washed pellets or one-tenth volume of the first
supernatant were electrophoresed, transferred to PVDF membranes and probed with antiGαi1/2 (Calbiochem), anti-Gβ antibody (NEN Products) and AGS3 antisera P-32,
respectively, as indicated in the text. The antibody detection and visualization were
performed with a ProtoBlot AP kit as described above. Band intensities were analyzed
with FluorChemTM 8000 system (Alpha Innotech Corp.) and quantified within the linear
range of a standard curve prepared from known quantities of Gi1α or GST-AGS3-GPR
(Pro463-Ser650).
To perform the fractionation experiments depicted in Figure 5, rat brain
membranes were incubated with homogenization buffer (10 mM Tris-Cl, pH 8.0 at 4 °C,
25 mM NaCl, 10 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 20 µg/ml of
benzamidine and 2 µg/ml of each of aprotinin, leupeptin and pepstatin A), control
cytosol, or AGS3 transfected cytosol for 30 minutes at room temperature, rotating. The
incubation mixture was then centrifuged at 100,000 g for 30 minutes at 4°C.

The

resulting supernatant was termed the 100,000 g supernatant (S). The remaining pellet
was resuspended in no salt buffer then centrifuged at 12,000 rpm in a microcentrifuge for
30 minutes. The resulting pellet was termed the 100,000 g pellet (P). Samples were then
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mixed with Laemmlli buffer and boiled prior to loading on 10% SDS-PAGE gels.
Proteins were transferred to PVDF, immunoblotted with Gα specific anitsera 976 and
visualized with ECL reagents (PerkinElmer Life Sciences, Inc., Boston, MA).
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Results
Membrane-expressed AGS3 does not interfere with receptor-Gi protein
coupling Protein-protein interaction studies indicate that AGS3 can bind GDPcontaining Giα subunits (9;13), and thus membrane localized AGS3 might disrupt Gprotein heterotrimers by interactions with Giα and thereby interfere with their coupling to
receptors. To test this possibility, membranes were prepared from Sf9 cells expressing 5HT1A receptors alone or co-expressing AGS3. In both crude membrane preparations, 5HT1A receptors were expressed at 3.5-5.5 pmol/mg membrane protein as determined by
saturation radioligand binding. In preparations co-expressing AGS3, AGS3 was present
in the membranes at a 518 molar excess over 5-HT1A receptors as quantitated by
immunoblotting.
Membrane preparations with and without co-expressed AGS3 were reconstituted
with increasing amounts of Gi1 heterotrimers to stabilize the high affinity agonist binding
state of the receptors. As shown in Figure 1A, the high affinity [3H]-5-HT binding to
both membranes reached the maximum level at a Gi1 concentration of about 85 nM.
Interestingly, there was no right-ward curve shift observed for the membranes with coexpressed AGS3 even though it was present in a 1.2-fold molar excess over the highest
concentration of G protein used. The EC50 values for Gi1 were not significantly different
between the two membrane preparations, 6.07 ± 0.58 nM for the membranes expressing
5-HT1A receptors alone and 6.53 ± 1.44 nM for the membranes with co-expressed AGS3
(p > 0.05, student t test). These results suggest that the membrane-expressed AGS3 does
not interfere with receptor-Gi protein coupling. Additional evidence is shown in Figure
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1B. Reconstitution with Gi1 did not alter the amount of AGS3 in the membrane fraction
(panel B, lane 7 vs. 8, p > 0.05, one-sample t-test, n = 3) and equivalent amounts of Gi1
associated with membranes expressing or not expressing AGS3 (panel B, lane 4 vs. 8, p >
0.05, one-sample t-test, n = 3). Taken together, these results indicate that even when
present in excess over receptors and G proteins, membrane-expressed AGS3 does not
interfere with receptor-Gi1 protein coupling.
Cytosolic AGS3 interferes with receptor-Gi protein coupling by sequestering
Giα and blocking its membrane-association during reconstitutionAlthough a
subpopulation is found loosely associated with a membrane fraction, AGS3 is primarily
localized in the 100,000 g supernatant of native tissue lysates and various transfected cell
lines (13;15;20). To determine if cytosolic AGS3 interferes with receptor-Gi protein
coupling, a 100,000 g crude cytosol preparation was obtained from Sf9 cells infected
with a recombinant baculovirus expressing AGS3.

As a control, a similar cytosol

preparation was obtained from uninfected Sf9 cells. As shown in Figure 2A, the cytosol
preparation containing AGS3 significantly inhibited 5-HT1A receptor-Gi1 protein
coupling but lost its activity after being heated at 99 oC for 5 minutes. In contrast, the
control cytosol preparation, reconstituted at the same total protein concentration, did not
alter agonist binding significantly, demonstrating the specificity of the AGS3 effect.
Cytosolic AGS3 may interfere with receptor-G protein coupling by inhibiting the
membrane association of heterotrimeric G-proteins or by stabilizing a conformation of
Giα-GDP that is not capable of interacting with receptors. We addressed this issue by
first determining the effect of cytosolic AGS3 on the membrane-association of Gi1α and
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Gβγ subunits in immunoblotting experiments. Cytosolic AGS3 blocks the membraneassociation of Gi1α subunits, but has no effect on the membrane association of Gβγ
subunits (Figure 2B lane 10 vs. 13). These data indicate that cytosolic AGS3 sequesters
Gi1α subunits during reconstitution and prevents their association with the membrane
thus interfering with receptor coupling to G-proteins.
Cytosolic AGS3 associates with the membrane and loses its ability to interfere
with receptor-G protein couplingA portion of the cytosolic AGS3 associates with Sf9
cell membranes in a concentration-dependent manner regardless of the presence of
receptors in the membrane (data not shown). Although the nature of this association is
not understood, to rule out the possibility that the inactivity of the membrane associated
AGS3 expressed in Sf9 cells shown in Figure 1 was due to denaturation or aggregation, it
was important to know if the cytosolic AGS3 retains its ability to interfere with receptorG protein coupling following membrane association. To accomplish this, membranes
expressing 5-HT1A receptors were first pre-incubated with or without sufficient cytosol
containing AGS3 to allow an excess of AGS3 over receptors to associate with the
membrane. After thorough washing the membranes were reconstituted with or without
Gi1 heterotrimers and receptor coupling was assessed by measuring high affinity agonist
binding.
As shown in Figure 3A, equivalent amounts of AGS3 remained associated with
the membranes following the pre-incubation whether or not the membranes were
subsequently reconstituted with Gi1 (compare AGS3 band in lanes 5 and 6). Figure 3A
also shows that the pre-incubation with the AGS3 containing cytosol did not alter (p >
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0.05, one-sample t-test, n = 3) the amount of Gi1α that associated with the membranes
during reconstitution (compare Gi1α band in lanes 4 and 6).

Quantitation of the

immunoblots indicates that the AGS3 that remained associated with the membranes was
in 29-fold molar excess over receptors and 69-fold molar excess over reconstituted Gi1α.
As shown in Figure 3B, the partition of cytosolic AGS3 to the membrane did not alter
high-affinity agonist binding to the receptors following reconstitution with Gi1. Taken
together, the results shown in Figures 2 and 3 suggest that although cytosolic AGS3 can
prevent receptor-G protein coupling during reconstitution, it does not do so once it
associates with the membrane.
Cytosolic AGS3 interacts with membrane-associated Gi1α subunitsIn a
physiological setting G proteins are associated with the inner face of the plasma
membrane. To understand if cytosolic AGS3 could interact with membrane-associated
Giα subunits and interfere with their coupling to receptors, Sf9 cell membranes
expressing 5-HT1A receptors were first reconstituted with Gi1 heterotrimers to allow their
association with the membrane. The membranes were washed three times to remove
unassociated Gi1 heterotrimers and incubated with crude Sf9 cell cytosol containing
expressed AGS3 or with an equivalent amount of Sf9 cell cytosol from uninfected cells
or buffer as controls. As an additional control, membranes were reconstituted with or
without Gi1 and not subjected to a second incubation.

The amount of Gi1α that

remained in the membranes following these treatments was determined by
immunoblotting. The lanes from a representative immunoblot repeated four times are
shown in Figure 4A. As shown in lane 4, no Gi1α was detected in the membrane pellet
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without reconstitution with exogenous Gi1. As shown in lane 5, an estimated 1.75 pmol
Gi1α subunits associated with 33 µg membrane protein following the first round
reconstitution with Gi1 heterotrimers. Pelleting, washing, and a second reconstitution
with either control buffer (lane 6) or 245 µg of cytosolic proteins from normal Sf9 cells
(lane 8) did not significantly decrease the amount of membrane-associated Gi1α
subunits, indicating a strong association of G proteins with the membrane. Interestingly,
lane 7 shows a significant decrease in membrane-associated Gi1α following the addition
of the AGS3 containing cytosol in the second reconstitution (p < 0.05, Tukey’s Test, n =
4).
The high affinity agonist binding to membranes following these treatments from a
representative experiment repeated 3 times with similar results are shown in the bar graph
in Figure 4B. The binding data are consistent with the immunoblotting data, and also
indicate that the association of G proteins with the membrane during reconstitution is
quite strong. Control binding to membranes lacking exogenous G proteins (vertically
striped bar in Figure 4B) was less than all other groups (p < 0.01, Tukey’s Test, n = 3).
Pelleting, washing, and the second incubation with control buffer did not lower the high
affinity agonist binding, which reflects receptor-G protein coupling (compare the white
versus black bars in Figure 4B). However, incubation with both control and AGS3
containing cytosol led to a significant decrease (p < 0.01, Tukey’s Test, n = 3) in high
affinity agonist binding (grey and horizontally striped bars in Figure 4B). In titration
experiments the IC50 for inhibition of high affinity agonist binding of the AGS3 cytosol
was significantly lower than the IC50 of the control cytosol (4.6 ± 0.7 vs. 34.6 ± 6.8 ng/µl,
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n = 2, p < 0.05, data not shown) indicating the significant contribution of the cytosolic
AGS3 protein. Thus, the results show that cytosolic AGS3 can dissociate Gi1α subunits
from the membrane and interfere with receptor coupling. The nature of the inhibitory
activity in the normal Sf9 cell cytosol is unknown but may represent an endogenous
GPR-containing protein.

The AGS3 antibody cross-reacts with several faint bands

present in the normal Sf9 cytosol (Figure 4, lanes 12 and 13). Though it did not reach the
level of statistical significance, the normal Sf9 cell cytosol did slightly reduce high
affinity agonist binding, and this effect was reversed upon boiling (Figure 2A). To
demonstrate that cytosolic AGS3 is capable of dissociating endogenous G proteins from a
native membrane, a preparation of rat brain membranes was incubated in the presence of
buffer, 40 µg of control cytosol from uninfected Sf9 cells and 40 µg of cytosol from Sf9
cells expressing AGS3 (0.3 pmol/µg protein). As shown in Figure 5, only the AGS3
containing cytosol was able to redistribute a significant amount of Gi/oα to the 100,000 g
supernatant following fractionation of the incubation mixtures. Clearly AGS3 is capable
of extracting Gi/oα subunits from their native membrane environment.
Selective inhibition of receptor-Gi protein coupling by GST-AGS3-GPR fusion
proteins
The general domain structure of mammalian AGS3 is shown in Figure 6A.
The carboxyl terminal GPR domain of AGS3, which consists of four homologous
repeated motifs, is known to bind Giα subunits (9;13) but little is known about possible
functional roles for the amino-terminal TPR domain. The role of each individual GPR
motif and their relative selectivity for specific G-proteins is also poorly understood. The
latter issues were addressed using GST fusion proteins that contain all four GPR motifs
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or individual GPR motifs. The GST-AGS3-GPR (Pro463-Ser650) fusion protein inhibited
5-HT1A receptor coupling to all four G-proteins tested (Figure 6B). The IC50 for Go is
significantly different from the values obtained with Gi (p < 0.05, Neuman-Keuls Test).
The native cytosolic AGS3 protein exhibited an IC50 of 29 ± 6 nM (n = 3) for Gi1 (data
not shown) indicating that the presence of amino terminal TPR domains did not alter the
apparent affinity of the GPR domains for Gi.
Each of the four individual AGS3-GPR domains inhibited 5-HT1A receptor-G
protein coupling (Figure 6C), although not to the same extent as the complete AGS3GPR domain (p < 0.05, Tukey’s Test). Two-way ANOVA of the inhibition of 5-HT1A
receptor coupling to different G proteins by individual AGS3-GPR domains indicates that
all four AGS3-GPR domains interact more weakly with Go than with Gi proteins (p <
0.01), while there is no significant difference among individual AGS3-GPR domains for
their interactions with Gi/o proteins (p > 0.05). These results suggest that the individual
GPR domains do not differ from one another in their interactions with Gα subunits and
that all of them interact more weakly with Goα than with the Giα subunits.
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Discussion
The recent discoveries of diverse proteins that interact with various components
of heterotrimeric G-protein mediated signaling pathways provide additional insights into
the regulation of this signaling process. In particular, the identification of the AGS
family of proteins suggests that inputs other than GPCRs are capable of activating these
pathways.

AGS3 was initially identified as a receptor-independent activator for G

protein signaling in a yeast-based functional screen (9). Sequence analysis reveals that
AGS3 has four repeated GPR motifs (also termed GoLoco motifs) in the carboxylterminal half of the protein. This GPR sequence is conserved among various proteins
from different species. Although these proteins have diverse functions, they share the
ability to bind α subunits of the Gi family via their GPR domains. Biochemical studies
from different groups have demonstrated that the GPR motif acts as a GDI to stabilize
Giα subunits in a GDP-bound form (11-15;27-29).
Recent studies indicate that GPR containing proteins are involved in cell polarity
and asymmetric cell division (16-20) but little is known about the physiological role of
AGS3 in GPCR signaling. The effects of AGS3 on receptor-G protein coupling and
potential mechanisms were the subjects of this study. We hypothesized that because
Gαβγ heterotrimers are required on the cytoplasmic face of the plasma membrane for
coupling with heptahelical GPCRs, AGS3 might interfere with receptor-Gi protein
coupling since AGS3 can disrupt G protein heterotrimers by competing with Gβγ to bind
GDP bound Giα. The majority of cellular AGS3 is found in the cytosol but a small
portion is associated with membrane fractions (13;15;20). In a cellular context either
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fraction might be capable of disrupting G protein heterotrimers and interfere with
receptor coupling. Our results indicate that membrane localized AGS3 does not appear to
interact with Gα subunits and has no effect on the reconstitution of receptor-G protein
coupling (Fig 1). To exclude the possibility that the membrane expressed AGS3 failed to
block receptor coupling because it was aggregated or denatured, we demonstrated that
cytosolic AGS3, which has the ability to block reconstitution of receptor-G protein
coupling (Figure 2), lost its ability to do so following association with the membrane
fraction (Figure 3). Our data do not exclude the possibility of a signaling mechanism that
would allow membrane associated AGS3 to interact with Gα subunits and modulate
receptor coupling. Although it is not well understood how AGS3 associates with the
membrane, the amino-terminal TPR domains have been implicated in subcellular
localization (11) perhaps through an as yet undefined mammalian binding partner.
Interestingly, the subcellular localization of a short form of AGS3, lacking the TPR
domains, may be determined in part by a regulated interaction with Giα (11). However,
Yu and colleagues (30) reported that both carboxyl-terminal GPR and amino-terminal
TPR domains are required for the apical membrane targeting of Pins, an AGS3/LGN
ortholog from Drosophila.
The localization of G protein heterotrimers at the plasma membrane involves a
complex interplay among several processes including post-translational modifications,
subunit assembly and direct protein-membrane interactions (31-40).

It is clear that

assembly with Gβγ is required for localization of Giα at the plasma membrane
(33;35;37). A recent model proposes that all three G protein subunits are synthesized in
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the cytosol on free polysomes and that Gα and Gβγ associate on the cytosolic face of the
Golgi prior to transport from an endosome to the plasma membrane (37). Since AGS3
can compete with Gβγ subunits to bind Giα subunits, cytosolic AGS3 might disturb the
assembly of Gβγ with Giα subunits and thereby decrease the amount of G protein
heterotrimer at the plasma membrane. As reviewed by Geyer and Wittinghofer (41), the
GDIs for small G proteins generally complex with small G proteins in the cytosol and
prevent their translocation to the membrane. Our results suggest the possibility of a
similar role for AGS3 with heterotrimeric G proteins. In reconstitution assays, AGS3 in a
cytosol fraction binds Giα subunits and prevents the membrane association of Giα, but
not Gβγ (Figure 2). Cytosolic AGS3 actually interacted with membrane-associated Giα
subunits, dissociating them from the membrane and interfering with receptor coupling
(Figure 4). While disruption of G protein heterotrimers is sufficient to inhibit receptor
coupling in a reconstitution system, in a cellular context there must be an appropriate
signal regulating the access of AGS3 to membrane localized G proteins. In the few
existing studies on cellular functions of related GPR containing proteins it is clear that the
distributions and functions of these proteins are regulated by signals during the cell cycle
(18-20).
The AGS3 carboxyl-terminal domain containing four repeated GPR motifs is the
region responsible for binding Giα subunits (13). The carboxyl-terminal GPR domain is
as potent as full-length AGS3 in interactions with Giα subunits. Our results also confirm
a weak interaction between AGS3-GPR and Goα subunits (12;13;15).

While it is

tempting to interpret the reduced apparent affinity for Goα in terms of selectivity, it is
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perhaps more likely that the reduced affinity ensures that only appropriate amounts of
AGS3 and Goα form complexes in a cellular setting. For example, in brain membranes
Goα is by far the most abundant Gα subunit (42;43).
It is clear that amino acids within both the GPR domain and the Gα subunit
contribute to the selectivity of the interaction. Peterson et al. have defined critical amino
acids within the core GPR domain and demonstrated differential effects on interactions
with Giα vs. Goα (27) while the crystal structure of Gαi1-GDP bound to the RGS14 GPR
motif peptide (44) and functional studies with chimeric G proteins (45) demonstrate that
the helical domain of Gα subunits contribute to the selectivity of Gα-GPR interactions.
However, for proteins such as Pins, LGN and AGS3 that contain multiple GPR motifs the
possibility of selectivity for different Gi/o α subunits has not been previously addressed.
Interestingly, our data indicate that although all four individual AGS3 GPR motifs
interact more strongly with Giα than Goα, they do not discriminate among the three Giα
subunits (Figure 6B). Each AGS3-GPR motif can bind Giα subunits and the complete
GPR domain actually binds multiple subunits at the same time suggesting a possible
scaffolding function for the complete AGS3-GPR domain (13). Our results are consistent
with this interpretation and show that each AGS3-GPR domain can interfere with
receptor-G protein coupling but that at equal concentrations (near the IC50 for GSTAGS3-GPR (Pro463-Ser650), the complete GPR domain inhibits coupling to a greater
extent than any individual GPR domain (Figure 6C).
In summary, our data show that AGS3 can interfere with receptor-G protein
coupling by disrupting Gαβγ heterotrimers in the cytosol as well as by removing Gα
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subunits from the plasma membrane. The disruption of G protein heterotrimers might
also serve to initiate Gβγ-mediated signaling events. Similarly, there may be as yet
unappreciated roles in cellular signaling for the AGS3-Gα-GDP complex. Interestingly,
membrane associated AGS3 appears not to interact with Gα subunits, although our study
does not exclude the possibility that such interactions may require an initiating signal.
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Figure Legends
Figure 1. Effect of membrane expressed AGS3 on receptor-G protein coupling and
association of Gi1α
α with the membrane. (A) Sf9 cell membranes expressing 5-HT1A
receptors (110 fmol) or co-expressing AGS3 (110 fmol receptor, 57 pmol AGS3) were
reconstituted with increasing concentrations of Gi1 heterotrimers (2-42 pmol) in 17 µl.
Following dilution into binding buffer, high affinity agonist binding was determined with
1 nM [3H]-5-HT and normalized as the percent of maximal binding achieved with a
saturating amount of Gi1 (85 nM). Final conditions in the binding assay were 0.2 nM
receptor with or without 104 nM AGS3 and the indicated concentrations of Gi1 in 150 µl.
Data are the mean ± SEM from 3 independent experiments. The EC50 values for Gi1
were not significantly different for membranes expressing 5-HT1A receptors or coexpressing AGS3 (p > 0.05, student t test). (B) Sf9 cell membranes (50 µg, ~225 fmol
receptor) expressing 5-HT1A receptors (lanes 1-4) or co-expressing AGS3 (lanes 5-8)
were reconstituted with 50 pmol of Gi1 heterotrimers in a volume of 20 µl. The amounts
of Gi1α and AGS3 associated with the soluble and membrane fractions were estimated
by immunoblotting. For each membrane condition the lanes contained: T: 10% of the
reconstitution before pelleting; S: 10% of the supernatant after pelleting in a refrigerated
microcentrifuge; cP: the entire membrane pellet (after washing 3x) from control
membranes without reconstitution with Gi1; P: the entire membrane pellet (after washing
3x) from membranes reconstituted with Gi1. An estimated 2.5 pmol of Gi1α and 90
pmol of AGS3 remained associated with the membranes as determined by densitometry
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in comparison with standards. In three separate experiments there was no significant
difference in either the amount of AGS3 associated with the membrane in the presence or
absence of Gi1 or the amount of Gi1α associated with membrane in the presence or
absence of AGS3.

Figure 2. Effect of cytosolic AGS3 on receptor-G protein coupling and association of
Gi1 with the membrane. (A) Sf9 cell membranes expressing 5-HT1A receptors (655
fmol) were reconstituted with 2.75 pmol Gi1 heterotrimers and 71 µg of crude cytosol
from Sf9 cells expressing AGS3 (23 pmol) or from uninfected Sf9 cells in 32 µl.
Following dilution into binding buffer, high affinity agonist binding was determined with
1 nM [3H]-5-HT. Final conditions in the binding assay were 1 nM receptor, 4.2 nM Gi1
with or without 35 nM AGS3 in 200 µl. Binding to membranes in the absence of
exogenous G proteins was 360 ± 8 fmol/mg in the experiment depicted (data not shown).
The open bar represents control binding to membranes reconstituted with Gi1 without
either Sf9 cell cytosol. The black bars represent binding to membranes reconstituted with
Gi1 in the presence of the indicated cytosol fractions. The striped bars represent cytosol
fractions that were boiled prior to reconstitution. Data are the mean ± SD of triplicate
determinations from a representative experiment that was repeated three times with
similar results. Only the non-boiled AGS3 cytosol was different from the Gi1 control (*:
p < 0.01, Tukey’s Test). (B) Membranes expressing 5-HT1A receptors were reconstituted
as in (A) with the indicated components. The G-protein subunits associated with the
soluble and membrane fractions were estimated by immunoblotting. The lane labeled I
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contained 1 pmol Gi1 heterotrimer (40 ng Gi1α and 36 ng Gβ1) as standards. For each
reconstitution the lanes contained: T: 10% of the reconstitution before pelleting; S: 10%
of the supernatant after pelleting in a refrigerated microcentrifuge; P: the entire
membrane pellet (after washing 3x). Immunoblots were repeated 3 times with similar
results.

Figure 3. Association of cytosolic AGS3 with membranes and its effect on receptorG protein coupling. Sf9 cell membranes expressing 5-HT1A receptors (655 fmol) were
pre-incubated with or without cytosolic AGS3 (64 pmol) in 40 µl to allow AGS3 to
associate with the membranes. Following pre-incubation the membranes were pelleted,
washed and resuspended. Pre-incubated membranes were reconstituted with or without
5.5 pmol Gi1 heterotrimers in 33 µl. (A) The amounts of Gi1α and AGS3 associated
with the soluble and membrane fractions from membranes pre-incubated and
reconstituted under the indicated conditions were estimated by immunoblotting. The
lanes contained: T: 10% of the reconstitution before pelleting; S: 10% of the supernatant
after pelleting in a refrigerated microcentrifuge; cP and P: the entire membrane pellet
(after washing 3x). Lanes 9 and 10 represent 10% of the total and supernatant from the
first pre-incubation with AGS3 cytosol and should not be compared with lanes 7 and 8
respectively which are following the second incubation with Gi1. An estimated 19 pmol
of AGS3 (lanes 5 and 6) and 275 fmol Gi1α (lanes 4 and 6) remained associated with the
membrane pellets. In three separate experiments there was no significant difference in
either the amount of AGS3 associated with the membrane in the presence or absence of
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Gi1 or the amount of Gi1α associated with membrane in the presence or absence of
AGS3. (B) Membranes treated as in (A) were diluted in binding buffer and high affinity
agonist binding was determined with 1.0 nM [3H]-5-HT. The bars correspond to lanes 36 in panel A. Final conditions in the binding assay were 1 nM receptor with or without
8.5 nM Gi1 and with or without 29 nM AGS3 in 200 µl. Data are the mean ± SD of
triplicate determinations from a representative experiment that was repeated three times
with similar results.

Figure 4. Effect of cytosolic AGS3 on membrane-associated Gi1. Sf9 cell membranes
expressing 5-HT1A receptors (620 fmol) were reconstituted with or without 35 pmol Gi1
heterotrimers in 45 µl. After pelleting and washing an estimated 1.75 pmol of Gi1α
remained associated with the membranes reconstituted with Gi1.

Membranes

reconstituted with Gi1 were incubated a second time with buffer, 245 µg cytosolic
proteins from Sf9 cells expressing AGS3 (+AGS3, 78 pmol total), or 245 µg cytosolic
proteins from uninfected Sf9 cells (+NSf9) in a volume of 45 µl. (A) The amounts of
Gi1α and AGS3 associated with the soluble and membrane fractions from membranes
reconstituted as described above were estimated by immunoblotting.

The lanes

contained: T: 10% of the reconstitution before pelleting; S: 10% of the supernatant after
pelleting in a refrigerated microcentrifuge; cP and P: the entire membrane pellet (after
washing 3x). In four separate experiments the amount of Gi1α (expressed as pmol/mg
membrane protein) in lane 7 was less than that in lanes 5, 6 and 8 (p < 0.05, Tukey’s test)
while the amount in lanes 5 and 6 did not differ from one another (p > 0.05, Tukey’s
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test). (B) Membranes treated as described above were diluted into binding buffer and
high affinity agonist binding was determined with 1.5 nM [3H]-5-HT. Final conditions in
the binding assay were 0.6 nM receptor in the presence or absence of 2 nM Gi1. The
vertically striped bar represents binding to control membranes without exogenous G
proteins while the black bar represents binding to membranes after a single reconstitution
with Gi1. The white, grey, and horizontally striped bars represent binding to membranes
after the second incubation in the presence of buffer, cytosol containing 84 nM AGS3
(final concentration), or control cytosol from uninfected Sf9 cells, respectively. Binding
in the Gi1 controls (black and white bars) is not significantly different (p > 0.05, Tukey’s
test). The * indicates p < 0.01 vs. +Buffer (Tukey’s test) while the # indicates p < 0.05
vs. +NSf9 (Tukey’s test). Data are the mean ± SD of triplicate determinations from a
representative experiment repeated 3 times with similar results.

Figure 5. Effect of cytosolic AGS3 on subcellular distribution of Gi/oα from native
rat brain membranes. Rat brain membranes (10 µg) were incubated in 50 µl with
buffer, 40 µg of crude cytosol protein from uninfected Sf9 cells (NSf9) or from Sf9 cells
expressing AGS3 (AGS3) at 0.3 pmol/µg.

After incubation the mixtures were

fractionated into a 100,000 g supernatant (S) and 100,000 g pellet (P). Lane 1 contained
2.5 µg of membrane protein without incubation. Lanes 8 and 9 (AGS3 –membrane) are
supernatant and pellet fractions from 40 µg AGS3 containing cytosol incubated without
the addition of membranes. After SDS-PAGE membrane transfers were immunoblotted
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for G-proteins using the Gα specific antisera 976. The immunoblot is representative of
results obtained in four independent experiments.

Figure 6. Effect of GST-AGS3-GPR domains on receptor-G protein coupling. (A)
The general domain structure of mammalian AGS3 is shown with striped boxes for the
amino-terminal TPR domains and grey boxes for the carboxyl-terminal GPR domains
known to interact with G protein α subunits. (B) Sf9 cell membranes expressing 5-HT1A
receptors (187 fmol) were reconstituted with the indicated Gi/o proteins (4.25 pmol) in 17
µl.

Increasing concentrations (0.1–1,163 pmol) of GST-AGS3-GPR (Pro463-Ser650)

fusion protein containing all four individual AGS3-GPR domains were added to the
reconstitution mixtures. Following dilution with binding buffer, high affinity agonist
binding was determined with 1 nM [3H]-5-HT binding and expressed as the percent
maximum binding in the absence of GST-AGS3-GPR (Pro463-Ser650) for each G protein.
Final conditions in the binding assay were 0.4 nM receptor, 8 nM G protein and the
indicated concentrations (0.2–2,281 nM) of GST-AGS3-GPR in 150 µl. The data shown
are the mean ± SD of triplicate determinations from a representative experiment and the
IC50 values are the mean from the indicated number of independent experiments. The
IC50 for Go is significantly different from the others (p < 0.05, Tukey’s test). (C) Sf9 cell
membranes expressing 5-HT1A receptors (655 fmol) were reconstituted with 9 pmol
individual Gi/o proteins and 250 pmol of the indicated GST-AGS3 fusion proteins in 17
µl. Following dilution into binding buffer, high affinity agonist binding was determined
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with 2 nM [3H]-5-HT. The bars represent the percent inhibition by the GST-AGS3 fusion
proteins relative to the maximum binding observed after reconstitution with the indicated
G proteins in the absence of GST-AGS3 fusion proteins. Data are the mean ± SEM from
two independent experiments. For each G protein, the inhibition by the complete AGS3GPR domain is greater than any individual AGS3-GPR domains (p < 0.05, Tukey’s test).
Two-way ANOVA indicates that there is no significant difference among individual
AGS3-GPR domains for their interactions with G proteins although the inhibition with all
four AGS3-GPR is least with Go (p < 0.01).
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CHAPTER 4. DISCUSSION
The overall objective of this project is to investigate molecular mechanisms in
GPCR-G protein coupling. Two basic aspects of GPCR-G protein coupling were studied
in the present work. One was to examine the potential G protein coupling differences
among closely related muscarinic receptors; the other was to explore a novel regulatory
mechanism in GPCR-G protein coupling.

A variety of extracellular stimuli cause cellular responses by interacting with a
superfamily of cell surface receptors known as G protein coupled receptors (GPCRs).
GPCRs convey the extracellular signals into the intracellular signaling network by
coupling to heterotrimeric G proteins. Upon interaction with signal molecules, GPCRs
undergo conformational changes, which enable them to interact with heterotrimeric G
proteins. Although it has been studied for many years, the exact molecular mechanism
governing the GPCR-G protein coupling process is still not completely understood. A
variety of models have been developed in an attempt to explain the mechanism of ligandreceptor and receptor-G protein interactions. An early model proposed that G protein
activation was initiated upon the formation of an agonist/receptor/G-protein (ARG)
ternary complex (De Lean et al., 1980). However, it could not explain the observed basal
activities in the absence of agonist. Based on the studies of a mutated β2-adrenergic
receptor, this ternary complex model was extended by including the concept of a
constitutively active state of the receptor (Samama et al., 1993). This extended ternary
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complex model proposed that GPCRs could spontaneously isomerize between an
inactive, resting conformation and an active conformation that is capable of interaction
with G proteins. The basal activity and the mutation-induced constitutive activity of
GPCRs could be well explained by the formation of the active receptor conformation.
Agonists and G proteins were believed to stabilize GPCRs in the active conformation. In
recent years, accumulating evidence indicates that this model is still not enough to
explain the exact nature of agonist/receptor/G-protein interactions. The concept of
multiple active receptor conformations has rapidly emerged. Several models have been
proposed to incorporate the current observations. For example, Kenakin proposed an
“agonist-trafficking” model, in which an agonist by its own can induce or select the
specific receptor conformation with which it can interact (Kenakin, 1995); while Leff et
al introduced a “three-state” receptor model, in which one inactive and two active
receptor states were assumed to exist (Leff et al., 1997).
It is now realized that actions of ligands on receptor-G protein coupling may
depend on the nature of every component involved. In a recent review, Strange discussed
the possible difference between multiple receptor active states and a single receptor
active state that might be stabilized to different extents by different agonists (Strange,
1999). He further suggested that the organization of receptors and G proteins may also
affect the receptor-G protein coupling properties. As pointed out by Neubig (Neubig,
1994) and Chidac (Chidiac, 1998), receptors and G proteins in cell membranes may exist
in a higher order array. Kenakin discussed the effects of stoichiometry between receptor
and G proteins on the ligand-receptor interaction, indicating that alteration in the
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receptor-G protein stoichiometry in recombinant receptor system may lead to abnormal
ligand binding parameters as compared with those obtained from native tissues (Kenakin,
1997). Chidiac further pointed out that not only the interaction between receptors and G
proteins but also the interactions within receptor/G-protein/effector complexes can affect
the agonist binding to receptors (Chidiac, 1998). In summary, a specific receptor-G
protein coupling process may be affected by multiple factors such as the nature of
agonists, specificity of receptors, G proteins and effectors, arrangement of each
component and the stoichiometry among them. Therefore, examination of each aspect of
receptor-G protein coupling is needed to define the exact mechanisms for a specific
receptor function and also may reveal the functional significance of the redundancy for
GPCR subtypes and multiplicity of G protein subunits.
In this project, the G protein-coupling properties of five closely related muscarinic
acetylcholine receptors (mAChRs) were examined in an attempt to define the potential
difference in their signaling mechanisms. An Sf9 cell membrane based reconstitution
system was employed to allow well-controlled stoichiometry among receptors and G
proteins. An interesting finding was that M3 receptors were significantly different from
other mAChRs in their G protein coupling mechanisms in an identical membrane
environment (Chapter 3, Section 1). With reconstitution, the functional and selective
coupling between the purified G proteins and mAChRs expressed in Sf9 cell membranes
were well-established for all other mAChRs except M3 receptors as assessed by G
protein-stabilized high-affinity agonist binding. The functional G protein coupling for
four mAChRs (M1, M2, M4 and M5) could be explained by the extended ternary
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complex model such that addition of G proteins could stabilize receptors in a highaffinity state for agonist binding. However, the G protein behavior of M3 receptors did
not fit this model. As previously reported, M3 receptor retained its G protein coupling
function and pharmacological properties when assessed in the intact Sf9 cells but lost its
G protein coupling ability in the membrane preparations (Vasudevan et al., 1992;
Kukkonen et al., 1996; Guo et al., 2001). This may suggest that the functional G protein
coupling of M3 receptors may require additional cellular components.
Since no direct in vivo evidence has shown that Gα and Gβγ subunits can actually
dissociate from each other upon activation by active GPCRs, it was speculated that the G
protein subunits do not have to go through the “GTPase cycle” (See Figure 2 in Chapter
1) to convey the signals from receptors to effectors (Chidiac, 1998). Thus, how signals
are transduced along this pathway may depend on the types and amounts of the R-G-E
entities and additional determinants, which may include cell architecture and accessory
proteins. As proposed by Chidiac, three possible mechanisms may be applied to explain
how signals propagate along the R-G-E axis. Agonist interaction may promote the
formation and the dissociation of R-G-E complexes or may interact with stable R-G-E
complexes. Supporting evidence showed that receptors, G proteins and effectors were all
able to segregate into oligomeric complexes in vivo (Post et al., 1995; Huang et al., 1997;
Oh and Schnitzer, 2001; Gazi et al., 2002) and their organization in cells appears in a
higher order (Neubig, 1994; Chidiac, 1998). In this study, we noticed the inability of M3
receptors to interact with G proteins in an isolated environment. Unlike other mAChRs,
M3 receptors probably employ a distinct G protein coupling mechanism, for example, it
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may need the co-existence of effectors (or maybe other accessory proteins) in order to
functionally couple to G proteins. The reconstitution system set up for M3 receptors will
likely serve as a useful tool to screen the possible, additional components required for
M3-G protein coupling. In will be of interest to test if the addition of effectors such as
PLC-β could restore the functional coupling between M3 receptor and Gq protein.
Verification of this issue will provide strong evidence for the possible “stable R-G-E
complexes” model as proposed by Chidiac (Chidiac, 1998).
It has been noticed that the stoichiometry between GPCRs and G proteins can
affect their interactions. For example, receptors at high concentrations can activate G
protein in the absence of agonists and different R-G ratios had different effect on their
ligand binding properties as assessed in transfected cell lines or in reconstitution systems
(Gudermann et al., 1996). As demonstrated from in vivo studies, receptors were found to
be outnumbered by G proteins and the accessible receptor and G protein repertoires
appear to be limited in microdomains in cells (Neubig, 1994; Post et al., 1995; Oh and
Schnitzer, 2001). For GPCRs with highly homologous subtypes such as mAChRs, when
they have the access to the same G protein population, will their interactions with G
proteins be different? Understanding of this mechanism will be helpful to define the
functional significance of a specific receptor subtype. Jakubik et al reported that different
R-G ratios in reconstitution had different effects on G protein activation and receptor
ligand binding properties and that the densities of receptors and G proteins had little
effect on ligand binding if their ratios were kept constant (Jakubik et al., 1998).
Therefore, they concluded that in vivo R-G ratios may also remain constant even though
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they cluster in the cell microdomains. In this study, we examined the apparent affinities
of G proteins for their interactions with mAChRs. The high-affinity agonist binding on
mAChRs was not only dependent on the nature, but also the concentration, of the G
proteins. For example, M1 and M5 receptors could be stabilized in a high-affinity agonist
binding state by both Gq and Gi1 proteins in a concentration dependent manner (Figure 2
in Chapter 3, Section 1). However, Gi1 was less effective than Gq in stabilizing highaffinity agonist binding. Gq-coupled M1 and M5 receptors had similar apparent affinities
for Gq while Gi-coupled M2 and M4 receptors had similar apparent affinities for Gi1.
However, the apparent affinities for a same G protein such as Gi1 appear to be different
between the Gq- and Gi-coupled mAChRs. These results indicate that the difference in
their apparent affinities may correlate to their G protein coupling selectivity.
As for Gi coupling, previous studies showed that the saturating responses could
be achieved with picomolar concentrations of purified Gi or nanomolar concentrations
(<30 nM) of purified Gβγ subunits when examining the K+ channel activation using
isolated membrane patches from either atrial cells or endocrine GH3 cells (Yatani et al.,
1987; Codina et al., 1987; Cerbai et al., 1988). In previous studies from our laboratory,
nanomolar concentrations of G protein heterotrimers were shown to be able to saturate
the high-affinity agonist binding on 5-HT receptors and with EC50 values around 10 nM
(Clawges et al., 1997). In this study, Gi-coupled M2 and M4 receptors required several
hundred nanomolars of G protein heterotrimers to achieve their saturating response. A
significant difference in the mAChR reconstitution was that urea-extraction of receptor
membranes was required for their coupling to exogenous G proteins. We showed that

151

urea-extraction dramatically improved the functional coupling between the membrane
mAChRs and the purified G proteins in reconstitution and reduced the endogenous G
protein coupling in the membranes. However, the apparent affinities for G protein
coupling were also altered after urea-extraction. For non-extracted M2 receptor
membranes, the EC50 of Gi1 protein was about 47 nM (Slessareva, 2003), which was
much lower than the 412 nM required for the extracted M2 receptor membrane. An
unsolved question is why urea-extraction dramatically changed the apparent affinities
between Gi-coupled mAChRs. The possible explanation could be that the extraction
released the restraints for the access of M2 receptors to the added G proteins such as the
removal (or inactivation) of the endogenous G proteins or other possible peripheral
proteins. Consequently, the proportion of M2 receptors that was available for G protein
interactions increased. As reported by Hartman and colleagues, after urea-extraction of
Sf9 cell membrane, 60-70% of the membrane-associated proteins were removed and the
GTPγS binding on the extracted membranes was reduced by 75% (Hartman, IV and
Northup, 1996). However, Lim and Neubig reported that urea-extraction only partially
removed Gβγ but not Giα subunits from the membrane and that the uncoupling effect by
urea was due to the inactivation of the endogenous G proteins. Studies from our
laboratory indicate that only a small portion of Gq-coupled receptors couple to the
endogenous G proteins (Slessareva, 2003). Thus, the removal or inactivation of
endogenous G proteins can not completely explain the successful establishment of the
functional coupling between the muscarinic receptors and the exogenous G proteins after
urea-extraction. Another possibility is that the lipid membrane environment was changed
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so that more receptors could be stabilized in the high-affinity state by the exogenous G
proteins. Further investigation is necessary to explore the effects of urea-extraction on the
membrane proteins and membrane architecture. It should be kept in mind that the
biochemical characteristics revealed in reconstitution studies may not reflect those in vivo
situations. However, five mAChRs clearly displayed different biochemical features in an
identical environment and their selective G protein coupling profiles were in good
agreement with those obtained from a variety of systems. They exhibited differences not
only in their apparent affinities for G protein interactions but also in their agonist binding
states when coupled to G proteins. Our data showed that M3 receptors only had a low
affinity state regardless of the G protein reconstitution (Figure 3 in Chapter 3 Section 1).
M1 and M5 receptors were not different in their binding parameters when reconstituted
with Gq proteins, but were different when reconstituted with Gi1 proteins. For Gicoupled M2 and M4 receptors, their agonist binding affinities were not different when
they were reconstituted with control buffer or Gq proteins. When reconstituted with Gi1
proteins, M4 receptors had a lower agonist binding affinity but a higher proportion of
receptors that were in high-affinity state as compared with M2 receptors. Therefore, even
for the same agonist, mAChRs displayed subtype- and G-protein-specific affinity states.
Taken together, these results indicate that the intrinsic G protein coupling properties vary
among different GPCRs that even share high similarities in their sequences, structures
and signal transduction pathways.
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Another aim of this project was to study a novel regulatory mechanism in GPCRG protein coupling. It has now been appreciated that G protein mediated signal
transduction pathways are subject to regulation at multiple levels. To specify appropriate
cellular responses upon GPCR activation, many accessory proteins and a variety of
mechanisms have been employed in addition to those confined to the agonist-receptor-G
protein interface as discussed above.
The actions of agonists on GPCRs are usually rapidly attenuated. Some accessory
proteins have been identified to regulate the GPCR attenuation process, including GRKs
(G-protein receptor kinases), PKA (protein kinase A), PKC (protein kinase C), arrestins,
GRPs (GPCR phosphatases) and recoverin. GRKs are a family of protein kinases that
recognize the agonist-occupied, activated GPCRs and disrupt their coupling to G proteins
by phosphorylating GPCRs (see Pitcher et al., 1998 for review). Another family of
proteins called arrestins is also involved in GRK-mediated signal termination (Krupnick
and Benovic, 1998). They can interact with phosphorylated GPCRs and direct the
subsequent GPCR internalization. In addition to agonist-dependent phosphorylation by
GRKs, some second messenger dependent kinases such as PKA and PKC also participate
in GPCR phosphorylation and desensitization, but in an agonist-independent way
(Lefkowitz, 1993). GRK-phosphorylated GPCRs may be dephosphorylated by specific
GPCR phosphatases (GRP) (Palczewski et al., 1989; Pitcher et al., 1995). A unique
protein call recoverin has been found to regulate photoreceptor, rhodopsins (Dizhoor et
al., 1991). Besides these regulatory proteins, internalization and down-regulation of cell
surface GPCRs also serve as important regulatory mechanisms in attenuating GPCR
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mediated signaling (Bohm et al., 1997). As discussed above, the specific expression,
organization and stoichiometry of the primary components in G protein signaling
pathway all influence the specific signaling initiated on GPCRs.
Heterotrimeric G protein activity is also subject to regulation by multiple
processes. G proteins switch to their active state upon the guanine nucleotide exchange
on their α subunits. Proteins called GEFs (guanine nucleotide exchange factors) stimulate
the guanine nucleotide exchange on Gα subunits (Luo and Denker, 1999; Cismowski et
al., 2000). Once GTP is bound to Gα subunits, the intrinsic GTPase activity of Gα
subunits catalyzes GTP hydrolysis to ensure the termination of signaling. A superfamily
of proteins, RGS (regulators of G protein signaling) have been found to act as GAPs
(GTPase activating proteins) to accelerate the GTP hydrolysis (Berman and Gilman,
1998; Hepler, 1999). Recently, a novel class of proteins has been identified, which can
activate G protein signaling independently of GPCRs. (Cismowski et al., 1999; Takesono
et al., 1999). In yeast with a GPCR-defect genetic background, these proteins were found
to activate the Gβγ-mediated growth and mating pathway. Collectively, they were called
activators of G protein signaling (AGS). A member of this family, AGS3 has been found
to belong to a novel class of proteins containing G protein regulatory (GPR) motifs (also
termed GoLoco domains). Although these proteins have diverse functions, they share the
ability to bind Gα subunits of the Gi family via their GPR domains (De Vries et al.,
2000; Natochin et al., 2000; Peterson et al., 2000; Bernard et al., 2001; Kimple et al.,
2001; Natochin et al., 2001; Pizzinat et al., 2001; Peterson et al., 2002).
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Little is known of the functional role of AGS3 in cellular signaling. Biochemical
studies showed that AGS3 could effectively compete with Gβγ subunits for binding to
Giα subunits (Bernard et al., 2001). Since G protein signaling requires a G protein
heterotrimer at the inner surface of the plasma membrane and AGS3 can disrupt the G
protein heterotrimer, we hypothesized that AGS3 might interfere with receptor coupling
to Gi proteins. In this study, we examined the effects of AGS3 on receptor-Gi protein
coupling using a membrane based reconstitution system. Previous work from our
laboratory successfully established the functional coupling between purified Gi proteins
and 5-HT1A receptors expressed in Sf9 cell membranes (Clawges et al., 1997). It was
shown that the functional G protein coupling of 5-HT1A receptors required the presence
of complete Gi protein heterotrimers. Therefore, it provides an effective system to test
the effects of AGS3 on functional receptor-Gi protein coupling. Our results from both
high-affinity agonist binding assays and immunoblot assays indicated that AGS3 can
sequester Giα subunits in the cytosol fraction, thus decreasing the amounts of G protein
heterotrimers in the membrane (Figure 2 in Chapter 3, Section 2). The receptor-G protein
coupling was consequently inhibited. Consistent with other studies (Bernard et al., 2001),
AGS3 did not affect the Gβγ subunit membrane partition. However, when AGS3 was
expressed in the membrane, it was unable to interact with Gi protein. After the functional,
soluble, AGS3 partitioned in the membrane, it also lost its activity to interact with Giα,
indicating that the function of AGS3 is affected by its membrane interaction. The
remaining questions are how AGS3 associates with the membrane and how its membrane
association may regulate its function in a cellular setting. Pizzinat et al speculated that the
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amino terminal half of AGS3 molecule, which contains seven repeated TPR
(tetratricopeptide repeat) sequences, might determine its subcellular localization (Pizzinat
et al., 2001). However, another group reported that both the carboxyl-terminal GPR and
amino-terminal TPR domains are required for the apical membrane targeting of Pins, an
AGS3/LGN ortholog from Drosophila (Yu et al., 2002). With regard to the inability of
membrane AGS3 to sequester Giα, it can not be excluded that unidentified signaling
inputs may initiate the interaction of membrane-partitioned AGS3 with Gα subunits.
On the other hand, the majority of cellular AGS3 is in the cytosol fraction and
appears to co-localize with some unidentified subcellular microdomains (De Vries et al.,
2000; Bernard et al., 2001). Considering that G protein heterotrimers are translocated to
the plasma membrane after synthesis in the cytosol, it may suggest that the function of
AGS3 is related to the Giα trafficking. In fact, the GDIs for small G proteins generally
complex with small G proteins in the cytosol and prevent their translocation to the plasma
membrane. Our results suggest the possibility of a similar role for AGS3 with
heterotrimeric G proteins. When G protein heterotrimers were incubated with AGS3 in
the cytosol, AGS3 completely blocked the membrane-partition of Giα subunits with no
effect on Gβγ membrane-partition. In a cellular setting, this role might have two possible
outcomes, either resulting in inhibition of the signaling mediated by G protein
heterotrimers at the plasma membrane as observed in our reconstitution studies, or
resulting in up-regulation of Gβγ-specific signaling as observed in the yeast-based
functional studies (Takesono et al., 1999). However, it can not be excluded that the
resulting AGS3-Gα-GDP complex may also be a functional entity in cells. Furthermore,
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our data showed that cytosolic AGS3 not only disrupted the membrane partition of Giα
but also dissociated Giα from the membrane (Figure 4 in Chapter 3, Section 2).
Therefore, it is possible that AGS3 may regulate the basal activity in G protein signaling
by balancing the available amounts of G protein heterotrimers at the plasma membrane or
the cellular AGS3 level may be up-regulated in response to unidentified signaling inputs
that will lead to the down-regulation of G protein signaling at the plasma membrane.
Future studies are required to confirm the physiological relevance of AGS3 in a cellular
setting. It would be interesting to test if AGS3 and Giα may mutually interfere with their
subcellular distribution in co-expression experiments. Clearly our studies provide new
insights and starting points for the possible functions of AGS3 in regulating G proteinmediated signaling.
Sequence analysis reveals that the AGS3 molecule has four GPR domains. This
GPR sequence is the unique feature of a variety of proteins with diverse functions and
conserved in different species (Kimple et al., 2002). These proteins contain one to four
GPR sequences. For proteins containing multiple GPR sequences, GPR sequences are
repeated in tandem arrays. Characterization of GPR sequences reveals that it acts as a
GDI for the α subunits from Gi protein family (De Vries et al., 2000; Natochin et al.,
2000; Peterson et al., 2000; Bernard et al., 2001; Kimple et al., 2001; Natochin et al.,
2001; Pizzinat et al., 2001). GPR domains selectively interact with GDP-bound Giα units
and inhibit the GDP dissociation from Giα subunits. Bernard et al reported that the four
GPR domains of AGS3 were all able to compete with Gβγ for Giα binding (Bernard et
al., 2001). Consistent with that work, our results showed that the four GPR domains were
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also able to interfere with receptor-Gi protein coupling (Figure 6 in Chapter 3, Section 2).
In Bernard’s report, it was noticed that the full-length GPR domain could bind multiple
copies of Giα subunits at the same time (Bernard et al., 2001), suggesting a possible
scaffolding function for the complete GPR domain. Our results indicated that the fulllength GPR domain was more effective than individual GPR domains, which was
consistent with Bernard’s interpretation. However, the effects of the full-length GPR in
inhibition of receptor-Gi coupling did not exactly correlate with numbers of GPR
domains when compared with individual GPR domains at equal concentrations (Figure 6
in Chapter 3, Section 2). Possibly, the spatial arrangement of four GPR domains may
have an impact on their stoichiometry in Giα interactions. In contrast to the conclusion of
Kimple and colleagues (Kimple et al., 2002), our results showed that GPR domains also
could interact with Goα, although with a lower affinity than those for other Giα subunits
(Figure 5 & 6 in Chapter 3, Section 2). Considering the fact that Goα is by far the most
abundant Gα subunit in brain membranes (Sternweis and Robishaw, 1984; Huff et al.,
1985) and that AGS3 in enriched in brain tissues (De Vries et al., 2000; Bernard et al.,
2001; Pizzinat et al., 2001), it is perhaps more likely that this weak interaction ensures
that only appropriate amounts of AGS3 and Goα form the complexes in a cellular setting.

In summary, the present work studied the difference in the G protein coupling
properties of five closely related muscarinic receptors, the effects of AGS3 on receptor-G
protein coupling and its possible molecular mechanisms in regulating G protein signaling.
Our results indicate that at biochemical level five mAChRs displayed different G protein
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coupling behaviors. Among them, M3 receptors may have a unique G protein coupling
mechanism. AGS3 can selectively interfere with receptor coupling to Gi/o proteins.
Cytosolic AGS3 can remove Giα from the membrane and sequester Giα in the cytosol,
suggesting that it may down-regulate heterotrimeric G protein signaling by interfering
with receptor coupling.
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APPENDIX I.

CONSTRUCTION OF CHIMERIC G PROTEIN α SUBUNITS
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Introduction

Heterotrimeric G proteins mediate the signaling transduction across the plasma
membrane from a superfamily of heptahelical cell surface receptors (GPCRs). A striking
characteristic in this signal transduction system is the redundancy of each component.
Highly conserved sequence and structure features exist in both heterotrimeric G proteins
and GPCRs. Thus, an important question is how selective interactions between G proteins
and GPCRs are achieved to ensure appropriate responses. Two most important concepts
developed so far are that the selective G protein coupling results from the cooperative
contribution of multiple intracellular regions and that the relative contributions of
different intracellular domains vary among individual receptors (Wess, 1998).
A great number of studies have been done to determine the structural basis of G
proteins for their selective coupling to GPCRs. Although both Gβ and Gγ subunits have
also been shown to directly interact with GPCRs (Phillips and Cerione, 1992; Heithier et
al., 1992; Kisselev et al., 1994; Kisselev et al., 1995; Taylor et al., 1996; Azpiazu et al.,
1999; Ernst et al., 2000), most Gβγ complexes appear to function similarly (Clapham and
Neer, 1997). Extensive efforts have been made on Gα subunits because it has been
demonstrated that Gα subunits are the primary determinant of heterotrimeric G proteins
for their selective coupling to GPCRs. In attempt to delineate the Gα subunit domains
that determine their selective coupling to the five highly homologous muscarinic
acetylcholine receptors (mAChRs), our laboratory designed, constructed and applied a
variety of chimeric Gα subunits. As recently reported by Slessareva (Slessareva and
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Graber, 2003), a unique 6 amino acid extension at the amino terminus and 35 amino acids
at the carboxyl terminus of Gq α subunit was critical for its selective coupling to
muscarinic M1 receptors. When both of these regions on Gqα displaced those on Gi1α
subunit, the resulting chimeric Gi1α, Gi1/q-6N35C (see Figure 1 A&B), lost its coupling
to M2 receptors but gained coupling to M1 receptors. When either the amino or carboxyl
terminus was replaced alone, none of the resulting chimeras (Gi1/q-6N and Gi1/q-35C)
was able to gain M1 receptor coupling, indicating that both regions are required for M1
receptor coupling. To test the generality of these regions on Gα subunits in their selective
mAChR-coupling, we constructed a series of chimeric Gα subunits in pair as depicted in
Figure 1 A&B and summarized below.
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Methods

The construction of the Gi1-based chimeras, Gi1/q-35C and Gi1/q-6N35C has
been described (Slessareva and Graber, 2003). To further define the critical role of the
short amino terminal region on Gα subunits in determining selective coupling to
muscarinic receptors, we designed another Gi1-based chimera, Gi1/q-37N35C, in which
the amino terminal region was extended to cover the whole αN helix was replaced (see
Figure 1A&B). To construct this Gi1/q-37N35C chimera, the coding region for the Nterminal 37 amino acid residues of Gαq was amplified with PCR using human Gαq
cDNA as a template. An upstream Nco I site and a silent Dra III site at the 37th amino
acid residue position were introduced into the forward and reverse primers, respectively
(See below).
Forward primer: 5’— CTTGGTACCATGGATGACTCTCGAG
Nco I
Reverse primer: 5’— CAGTTTTAGATCACGACGTGCGTCC
Dra III
The Gαi1 internal fragment from the 32nd to 217th amino acid residue were also
amplified with PCR by using the Gi1/q-35C construct as a template to take advantage of
a unique Bam HI site at the 217th amino acid residue position. A Dra III site and a Bam
HI site were introduced into the forward and reverse primer, respectively.
Forward primer: 5’ — ATGGAGAAAAAGCACGTCGTGAGG
Dra III
Reverse primer: 5’ — CAAAGCAGTGGATCCACTTCTTCC
Bam HI
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After digestion with their corresponding restriction enzymes, the two PCR products were
ligated into the pVLKD-Gi1/q-6N35C construct (Slessareva and Graber, 2003), which
had the Nco I -- Bam HI fragment removed before ligation.
As the counterparts of Gi-based chimeras, three Gq-based chimeras were also
constructed. To construct Gq/i1-31N25C, three DNA fragments were amplified with
PCR using human Gαq and rat Gαi1 cDNAs as templates, correspondingly:
1) the coding region for the N-terminal 31 amino acid residues of Gαi1 was
amplified with a forward primer containing an upstream Bam HI site and a
reverse primer containing a silently introduced Xma I site at the 31st amino
acid residue position;
Forward primer (fp1): 5’ -- CATCGCTAGCGGATCCAT
Bam HI
Reverse primer (rp1): 5’ -- GATTTCCCGGGCTGCCTT
Xma I
2) the coding region for the N-terminal 38th to the –25th amino acid residues of
Gαq was amplified with the following primers:
Forward primer (fp2): 5’ -- GATATACCCCGGGAGCTCAA
Xma I
Reverse primer (rp2): 5’ -- gcgcATGTGAAGTGGGAGTA
(The lower cases in the reverse primer above indicate the RNA components in
this hybrid DNA/RNA primer. The RNA sequence was used as a template to
obtain its DNA complementary sequence by reverse transcriptase and then
was hydrolyzed with 0.5 N NaOH to generate a 3’ DNA overhang for the
following ligation step)
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A silent Xma I site was introduced at the 38th amino acid residue position and
a 3’ DNA overhang at the –25th amino acid residues position was generated
with the DNA overhang cloning method (Coljee et al., 2000);

3) the coding region for the C-terminal 25 amino acid residues of Gαi1 with a 3’
DNA overhang DNA overhang at the –25th amino acid residue position and a
downstream Pst I site was amplified with the following primers:
Forward primer (fp3): 5’ -- gcgcAACGGATACGAAGAAT
Reverse primer (rp3): 5’ -- CTACGCGTCTGCAGAGCTTA
Pst I
(The lower cases in the forward primer above indicate the RNA components
in this hybrid DNA/RNA primer.)
The second and the last PCR fragments were first ligated at their complementary 3’overhang sites and PCR-amplified with the primers fp2 and rp3. After digestion with
Xma I and Pst I, this jointed fragment was ligated into pVL1393 vector together with the
first PCR fragment, which was pre-digested with Bam HI and Xma I before ligation.
The construction of other two Gq-based chimeras began with the construct of
pVL1393-Gq, in which the Gαq cDNA was excised from its pCDNA3.1+ vector
(obtained from Guthrie cDNA resource center, Sayre, PA) at Nhe I and Pst I sites and
ligated into pVL1393 vector at Xba I and Pst I sites. Nhe I and Xba I sites are compatible
but both are destroyed after ligation. The Gq/i1-25C construct was obtained by replacing
the Eco RI--Pst I fragment of the pVL1393-Gq with that from the Gq/i1-31N25C
construct. The Gq/i1-5N25C was constructed by first removing the 11 N-terminal amino
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acid coding region from the Gq/i1-25C at an upstream Bam HI site and an Eco NI site
located at the 12th residue.

The removed fragment was then replaced with an

oligonucleotide linker coding the 5 N-terminal amino acid residues of Gαi1.
Oligonucleotide linker:
5'—GATCCTAGGATGGGCTGCACACTGA ---3'
3'---- GATCCTACCCGACGTGTGACTC --5'

All constructs were confirmed by restriction analysis and DNA sequencing before they
were used to produce recombinant baculoviruses.
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Future studies

The availability of the chimeric Gα constructs described above has made a basis
for further delineating of the structural determinants of G proteins for their selective
mAChR (muscarinic acetylcholine receptor) coupling and examining the generality of the
defined domains in future experiments. For M1 and M2 receptors, the proper context on
both amino and carboxyl terminal regions of Gα subunits has been shown to be sufficient
to specify their coupling from the studies on a chimeric Gα subunit, Gi1/q-6N35C
(Slessareva and Graber, 2003). Our preliminary data show that this chimera can also gain
the coupling to M5 receptors and lose the coupling to M4 receptors. Thus, by further
characterizing these domains and testing their generality in mAChR-G protein coupling,
the common structural requirements for the selective G protein-mAChR coupling may be
revealed or the structural determinants may be identified that can distinguish mAChR
subtypes, which share the same G protein coupling selectivity.
A potential problem could hinder the characterization of Gq-based chimeras
(Gq/i1-25C, Gq/i1-5N25C and Gq/i1-31N25C, Figure 1) with purified proteins in
reconstitution. Initial characterization of their expression in Sf9 cells indicated that these
chimeras are largely found in the membrane fraction as are the wild type Gqα subunits.
As reported previously (Kozasa and Gilman, 1995; Slessareva and Graber, 2003),
possible contamination by the endogenous Gi proteins may occur during protein
purification from the membranes. Receptor coupling of the endogenous Gi protein can
be abolished with pertussis toxin treatment, which can catalyze the ADP-ribosylation at a

193

carboxyl terminal cysteine residue in Gi/o α subunits (corresponding to the cysteine
residue at –4 position of Gi1α in Figure 1B) and uncouple Gi/o protein from GPCRs
(West, Jr. et al., 1985). Since the ADP-ribosylation site is present in these chimeras, the
gain of their Gi activity is unlikely to be distinguished from the endogenous Gi
contamination by the pertussis toxin treatment. Thus, alternative approaches may be
needed to examine their coupling selectivity. For example, an alanine can be used to
replace the cysteine residue by point mutation in order to get rid of the ADP-ribosylation
site. Or, their selective receptor coupling activity can be examined in whole-cell assay
system. In fact, preliminary data (not shown) from our collaborators showed a robust
response in testing the M2 receptor coupling to the Gq-based chimera, Gq/i1-5N25C
using a whole-cell based assay system, in which the M2 receptor coupling activity is
amplified by a reporter gene. However, such a response was not observed for the M2
coupling to another Gq-based chimera, Gq/i1-31N25C. In addition, when the amino
terminal region in the Gi1/q-6N35C was extended to cover the αN helix region (Figure
1A&B), the resulting chimera, Gi1/q-37N35C lost its activity as both Gi1 and Gq (data
not shown). Taken together, these data suggest that the short region (5 residues in Gi1
and 11 residues in Gq) at Gα amino terminus is critical in determining their selective
coupling to mAChRs. Thus, it will be interesting to test the critical role of this sort region
in G protein-mAChR selective coupling in future experiments and it will also be
interesting to test if this role may apply for other GPCRs.
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Figure 1. Schematic representation of Gα
αi1, Gα
αq and their chimeras and sequence
alignment of their amino and carboxyl terminal regions. 1A. To explore the structural
determinants of selectivity in receptor-G protein coupling, chimeric Gα subunits
comprised of various regions of Gi1α and Gqα were constructed. Numbers at the end of
each α subunit structure indicate the total amino acid residues. The bottom diagram
depicts the secondary structural domains common to Gα subunits. 1B. Amino acid
sequence alignments at the amino (upper panel) and carboxyl (lower panel) termini of
Gi1 and Gq α subunits. The letters in bold indicate the different amino acid residues
between these two α subunits. The shaded regions represent the sequences that form the
corresponding secondary structures (α-helix or β-sheet) as indicated at the top portions in
each panel. The numbers point to the positions of the amino acid residues counted either
from the amino terminus or the carboxyl terminus. N’, the amino terminus; C’, the
carboxyl terminus.
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Abbreviations and Textual Footnotes— 1The abbreviations used are: GPCRs, G protein
coupled receptors; GTPγS, guanosine 5'-3-O-(thio)triphosphate; OXO-M, OxotremorineM; 5-HT, Hydroxytryptamine; CCPA, chloro-N6-cyclopentyladenosine, R-PIA, Rphenylisopropyl adenosine.
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ABSTRACT

The molecular basis of selectivity in receptor-G protein coupling has been explored by
comparing the abilities of G protein heterotrimers containing chimeric Gα subunits,
comprised of various regions of Gi1α, Gtα and Gqα, to stabilize the high affinity state of
serotonin, adenosine and muscarinic acetylcholine receptors. The data indicate that
multiple and distinct determinants of selectivity exist for individual receptors. While the
A1 adenosine receptor does not distinguish between Gi1α and Gtα sequences, the 5HT1A and 5-HT1B serotonin and M2 muscarinic receptors can couple with Gi1 but not Gt.
It is possible to distinguish domains that eliminate coupling and hence are defined as
“critical”, from those that impair coupling and hence are defined as “important”.
Domains within the N terminus, α4 helix, and α4 helix-α4/β6 loop of Gi1α are involved
in 5-HT and M2 receptor interactions. Chimeric Gi1α/Gqα subunits verify the critical
role of the C terminus in receptor coupling, however, the individual receptors differ in the
Gα amino acids that are required for coupling. Furthermore, the EC50 for interactions
with Gi1 differ among the individual receptors. These results suggest that coupling
selectivity ultimately involves subtle and cooperative interactions among various
domains on both the G protein and the associated receptor as well as the G protein
concentration.
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INTRODUCTION

A large number of diverse seven transmembrane spanning cell surface receptors
mediate signaling to a variety of intracellular effectors by coupling to the heterotrimeric
guanine nucleotide-binding regulatory proteins (G proteins) (Pierce et al., 2002). The
mechanisms responsible for selectivity in G protein mediated signaling pathways are not
fully understood (Wess, 1998; Albert and Robillard, 2002). Although it is known that at
the molecular level the selectivity in G protein-receptor coupling is determined by amino
acid sequences of both receptor and G protein, the individual amino acids involved in
this selective recognition have not been completely identified. Different receptor
systems and different methodologies indicate that the in the Gα subunit C terminus and
α5 helix (Hamm et al., 1988; Conklin et al., 1993; Gilchrist et al., 1998; Natochin et al.,
2000), N terminus and αN helix (Hamm et al., 1988; Hepler et al., 1996; Kostenis et al.,
1997; Swift et al., 2000), α4 helix and α4/β6 loop (Bae et al., 1997; Natochin et al.,
1999; Blahos et al., 2001), α2 helix and α2/β4 loop (Lee et al., 1995), α3/β5 loop
(Grishina and Berlot, 2000), αN/β1 loop (Blahos et al., 2001) and amino acids 110-119
from the α helical domain (Krieger-Brauer et al., 1999) are involved in receptor
coupling selectivity. Some of these domains contact the receptor directly, while others
regulate receptor coupling selectivity indirectly by playing a role in nucleotide
exchange. Despite the fact that many of the receptor interacting domains have been
identified, the relationship between receptor subtypes and Gα domains involved in
receptor coupling has not been clearly established. Thus, it is difficult to predict which
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Gα domains will be utilized by a specific receptor. Here we propose that individual
receptors recognize specific patterns formed by amino acids of Gα thus making G
protein interface look different for different receptors. The C terminus of Gα is a well
accepted receptor recognition domain, which contacts receptors directly (Conklin and
Bourne, 1993). Although individual C terminal amino acids important for receptor
coupling have been identified in several Gα subunits, the specific Gα amino acids
participating in receptor recognition may differ among receptors. The α4 helix-α4/β6
loop domain, first described as an effector domain, has been shown to be important for
5-HT1B receptor coupling to Gi1 (Bae et al., 1997). Later it was demonstrated that
Gln304 and Glu308 in the α4 helix of Gi1α are important for 5-HT1B receptor coupling
(Bae et al., 1999). However the generality of the role for the α4 helix-α4/β6 loop
domain in receptor coupling selectivity has not been determined.
Gi1α and Gtα are closely related Gα subunits, which belong to the Gi/o class of
G protein α subunits, share 68% homology, and have nearly identical overall structures.
Although the 5-HT1B receptor discriminates between Gi1 and Gt (Skiba et al., 1996; Bae
et al., 1997) the fact that their C termini are identical render Gi1α/Gtα chimeras useless
for exploring the role of this domain in receptor coupling. However, the extreme C
terminus of Gqα differs from that of Gi1α by four amino acids, while their α5-helixes
differ by additional nine amino acids. Thus Gi1α/Gqα chimeras are ideal for studying
the role of this domain in coupling. Since several different GPCRs1 can couple to the
same G protein, we wanted to test the hypothesis that individual receptors utilize slightly
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different domains on Gα subunits to achieve coupling. G protein-receptor coupling
selectivity may also be regulated at the level of G protein concentration. In fact, Clawges
et al. demonstrated that 5-HT1A and 5-HT1B receptors distinguish themselves by the
affinity with which they interact with G proteins (Clawges et al., 1997). Therefore we
also wanted to test the generality of this mechanism with different receptors. Here we
compare the coupling behavior of four Gi/o-coupled receptors (5-HT1A and 5-HT1B
serotonin, A1 adenosine and M2 muscarinic) by reconstituting them with G protein
heterotrimers containing native or chimeric Gα’s composed of Gαi1, Gαt and Gαq. Our
data demonstrate that selective coupling between Gi1 and the members of Gi/o-coupled
receptor family is directed by multiple and distinct Gα domains and is regulated at the
level of G protein concentration.
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EXPERIMENTAL PROCEDURES
Materials. [3H]-Oxotremorine-M Acetate ([3H]-OXO-M) (85.8 Ci/mmol), [3H]Hydroxytryptamine Binoxalate ([3H]-5-HT) (25.5 Ci/mmol) and [3H]-Chloro-N6cyclopentyladenosine ([3H]-CCPA) (30 Ci/mmol) were from New England Nuclear Life
Science Products, Inc. (Boston, MA). Atropine Sulfate, 5-Hydroxytryptamine (5-HT)
and R-phenylisopropyl adenosine (R-PIA) were from Sigma-Aldrich Corporation (St.
Louis, MO). Adenosine deaminase was from Roche Molecular Biochemicals
(Indianapolis, IN). The BCA Protein Assay reagents were from Pierce (Rockford, IL).
All other chemicals were from Sigma-Aldrich Corporation (St. Louis, MO) or EMD
Biosciences (formerly Calbiochem-Novabiochem Corporation; San Diego, CA).
Expression and purification of proteins. The expression and purification of the
Gαi1 and Gβγ subunits was as previously described (Graber et al., 1992a; Graber et al.,
1992b). The chimeric Gαi1/Gαt subunits were constructed, expressed in E. coli and
purified as described (Skiba et al., 1996). The Gi1/Q3C, Gi1/Q5C and Gi1/Q11C
chimeras were made from pHis6Gαi1 using the silent BamHI site introduced at amino acid
position 212 (Skiba et al., 1996). The pHis6Gαi1 cDNA was amplified by PCR reaction
with primer oligonucleotides containing the desired mutations. The PCR products were
digested with BamHI and HindIII, and the BamHI-HindIII fragment was used to replace
the coresponding fragment from pHis6Gαi1. To construct Gi1/Q35C, the C-terminal
portion of a Gqα cDNA was amplified by PCR reaction, followed by digestion with BglII
and HindIII. The digested PCR fragment was inserted into the BglII and HindIII sites of
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the Chi13 plasmid (Bae et al., 1997). Functional characterization of all bacterial subunits
included GTPγS binding, AlF4--dependent conformational change (measured as an
increase in intrinsic tryptophan fluorescence) or binding to the cGMP phosphodiesterase γ
subunit (Skiba et al., 1996; Bae et al., 1997; Bae et al., 1999).
Preparation of Sf9 membranes containing expressed receptors. Sf9 cells were
infected with a recombinant baculovirus expressing the desired receptor, cultured and
harvested as previously described (Graber et al., 1992b). To prepare membranes,
harvested cells were thawed in 15x their wet weight of ice cold homogenization buffer (10
mM Tris-Cl, pH 8.0 at 4 °C, 25 mM NaCl, 10 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.1
mM PMSF, 20 µg/ml of benzamidine and 2 µg/ml of each of aprotinin, leupeptin and
pepstatin A) and burst by nitrogen cavitation (600 psi, 20 minutes). Cavitated cells were
centrifuged at 4 °C for 10 minutes at 500 x g to remove the unbroken nuclei and cell
debris. The supernatant from the low speed spin was centrifuged at 4 °C for 30 min at
28,000 x g. The supernatant was discarded and the pellets were resuspended and pooled in
35 ml of HE buffer (5 mM NaHEPES, l mM EDTA, pH 7.5) containing the same protease
inhibitors as used in the homogenization buffer. Adenosine receptor HE buffer included
100 mM NaCl in addition to the above components. The membranes were washed twice in
HE, resuspended in the same buffer at a concentration of 1-3 mg protein/ml, aliquoted,
snap frozen in liquid nitrogen, and stored at -70 °C.
Reconstitution of receptors with exogenous G-proteins. Frozen membranes were
thawed, pelleted in a refrigerated microcentrifuge (10 min, 12,000 rpm) and resuspended
at about 10 mg/ml in a reconstitution buffer consisting of 5 mM NaHEPES, 100 mM
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NaCl, 5 mM MgCl2, 1 mM EDTA, 500 nM GDP, 0.04% CHAPS (0.08% CHAPS for M2
receptor), pH 7.5. G protein subunits were diluted in the same buffer such that the desired
amount of subunit was contained in 1-5 µl. Typically, 1-2 µl of G protein subunits were
added to 40 µl of membrane suspension, the mixture was incubated at 25 °C for 15
minutes and held on ice until the start of the binding assay.
Radioligand binding. Just prior to the start of the binding assay the reconstitution
mixture was diluted 10-12 fold with binding assay buffer appropriate to the receptor of
interest such that the desired amount of membranes (5-25 µg/assay tube) were contained
in 10-50 µl. Binding buffer for 5-HT and M2 receptors was 50 mM Tris, 5 mM MgCl2,
0.5 mM EDTA, pH 7.5. Binding buffer for A1 adenosine receptor was 10 mM HEPES, 5
mM MgCl2, 1 mM EDTA, pH 7.4. Radioligand binding in the affinity shift assay was
determined in the presence of the [3H]-OXO-M for M2 muscarinic receptor, [3H]-5-HT for
5-HT serotonin receptors and [3H]-CCPA for A1 adenosine receptor. Adenosine
deaminase was added to the [3H]-CCPA solution at 12 µg/ml in binding buffer. Nonspecific binding was determined by addition of 1000-fold excess of unlabeled ligand– 5HT for 5-HT receptors, atropine sulfate for M2 receptor and R-PIA for A1 receptor.
Incubations were for times sufficient to achieve equilibrium in a temperature controlled
shaker (1 hr for M2 receptor, 1.5 hrs for 5-HT receptors, 2 hrs for A1 receptor) and were
terminated by filtration over Whatman GF/C filters using a Brandel Cell Harvester. The
filters were rinsed thrice with 4 ml ice cold 50 mM Tris-Cl, 5 mM MgCl2, 0.5 mM EDTA,
0.01% NaAzide, pH 7.5 at 4 °C, placed in 4.5 ml CytoScint (ICN Pharmaceuticals, Costa
Mesa, CA) and counted to constant error in a scintillation counter. For reconstitution of
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high affinity agonist binding in affinity shift assays, a single concentration of radioligand
near the high affinity KD of the receptor of interest was used in a final volume of 150 µl.
[3H]-5-HT radioligand purity was monitored by HPLC or TLC using an appropriate
mobile phase. Radioligands were repurified or replaced when the radiochemical purity
fell below 85%.
Affinity shift activity assay. The Sf9 cell membranes expressing individual
receptors were reconstituted with saturating amounts of native or chimeric Gi1 protein
heterotrimers (≥25 nM or 40-400 fold molar excess over receptors) to achieve the
maximal specific binding during the binding assays. Because the magnitude of the affinity
shifts observed with native Gi1 protein heterotrimers varied significantly among the
individual receptors affinity shift activity was normalized to Gi1 activity and expressed as
% affinity shift activity, which is (Chimera Reconstituted Binding - Control Binding/Gil
Reconstituted Binding - Control Binding) x100.
Analysis of the data. Data analysis was done using the GraphPad Prism software
package (GraphPad Software, San Diego, CA). For affinity shift assays, triplicate
determinations were used within each experiment and experiments were repeated 3 or
more times. Data represent the mean ± SEM from multiple experiments. One-way
ANOVA with Tukey’s multiple comparison post test was used to compare the activities
of chimeras.
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RESULTS

Previously we have shown that amino acids 299-318 and 1-219 of Gi1α are
molecular determinants of 5-HT1B receptor coupling (Bae et al., 1997) and that two
amino acids in the α4 helix of Gi1α (Gln304 and Glu308) are especially important for 5HT1B receptor coupling (Bae et al., 1999). The goal of the present study was to examine
the generality of the these findings among closely related members of the Gi/o-coupled
receptor family. Our general strategy involves reconstitution of purified G proteins
containing chimeric α subunits with receptors expressed in Sf9 insect cell membranes
and comparison of the abilities of these chimeric G proteins to stabilize the high affinity
agonist binding state of the receptors in an affinity shift activity assay. In the present
study we compared the coupling behavior of four different Gi/o-coupled receptors: 5HT1A and 5-HT1B serotonin receptors, M2 muscarinic receptors and A1 adenosine
receptors.
Affinities of individual receptors for G proteins- First we determined the
concentration of G proteins in the binding assay that produced the maximum affinity
shift for each receptor. Increasing amounts of G protein heterotrimers were reconstituted
with individual receptors and EC50 values for reconstitution of high affinity agonist
binding were determined. The data indicate that A1, 5-HT1A, 5-HT1B and M2 receptors
have different EC50 values for Gi1 (Figure 1). A1 receptors have the highest apparent
affinity (0.4 nM) and M2 receptors have the lowest apparent affinity (47 nM) for the Gi1
heterotrimer. 5-HT receptors have intermediate EC50 values of 3.7 nM and 16.2 nM for
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the 5-HT1A and 5-HT1B receptors respectively. Titration experiments similar to those
shown in Figure 1 were used to determine the concentration of chimeric G proteins
needed to saturate affinity shift activities with individual receptors. For individual
receptors, the EC50 values of the active chimeras were not significantly different and
even high concentrations (>600 nM) of inactive chimeras did not have affinity shift
activity (data not shown). All affinity shift activities were determined with saturating
concentrations of G proteins.
Affinity shift activity of chimeric Gα subunits- Figure 2 depicts the secondary
structures of the Gi1α/Gtα chimeras used in this study. All of these chimeras have been
previously described and were used to study Gi1α domains involved in 5-HT1B receptor
coupling (Skiba et al., 1996; Bae et al., 1997; Bae et al., 1999). Figure 3, in which 100%
activity corresponds to the affinity shift activity of Gi1, shows the per cent affinity shift
activity of Chi2, Chi3, Chi6, Chi13 and Chi21. Chi6 was constructed as a soluble analog
of Gtα and has the same functional properties as Gtα (Skiba et al., 1996). Chi6 is
primarily Gtα in character as it includes N- terminal amino acids 1-215 and C- terminal
amino acids 295-350 of Gtα with the amino acids corresponding to 216-294 from
Gi1α to maintain solubility. In this region there are just 26 amino acids that differ
between Chi6 and Gtα. As shown in Figure 3, Chi6 was inactive with 5-HT1A, 5-HT1B
and M2 muscarinic receptors. Earlier experiments with native transducin demonstrated it
also failed to couple with the 5-HT receptors (Clawges et al., 1997). In contrast, the data
in Figure 3 demonstrate Chi6 was 74% active with the A1 adenosine receptor, indicating
that A1 adenosine receptor doesn't discriminate well between Gt and Gi1 sequences.
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Although the activity of Chi6 with the A1 adenosine receptor was significantly lower
(p<0.001) than the activity of Gi1, the magnitude of the difference was too small to be of
use in identifying the precise domains responsible for the reduced activity. However, the
inability of the 5-HT1A, 5-HT1B and M2 muscarinic receptors to couple with Chi6
allowed us to use additional chimeras containing less Gtα sequence to more precisely
identify the domains required for coupling.
We first examined whether the N- terminal or C- terminal portion of Gi1α was
critical for receptor coupling. Chi21 has N- terminal amino acids 1-215 of Gtα with the
rest of the molecule Gi1α sequence (Figure 2). Chi21 was fully active with the A1
adenosine receptor, indicating that the A1 receptor does not distinguish between Nterminal amino acid sequences of Gi1α and Gtα (Figure 3). The activity of Chi21 with
5-HT1A, 5-HT1B and M2 receptors was significantly (p<0.001) reduced (44%, 57% and
42% respectively, Figure 3) demonstrating that amino acids 1-219 of Gi1α contain an
important determinant of Gi coupling with these receptors. Chi2 has the C- terminal
amino acids 295-350 of Gtα with the rest of the chimera Gi1α sequence (Figure 2).
Figure 3 demonstrates that amino acids 299-354 of Gi1α contain residues critical for 5HT1A, 5-HT1B and M2 receptor coupling because the affinity shift activity of Chi2 with
these receptors (2%, 9% and 23% respectively) was not significantly different from Chi6
activity. In contrast, Chi2 was fully active with A1 adenosine receptors supporting our
conclusion that A1 adenosine receptor does not distinguish well between Gi1α and Gtα
sequences. To further evaluate the role of amino acids 299-354 of Gi1α in 5-HT and M2
receptor coupling we tested two additional chimeras, Chi3 and Chi13 (Figure 2). Chi3
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has amino acids 299-319 of Gi1α replaced with the corresponding amino acids of
Gtα (amino acids 295-315) while Chi13 has the 35 C-terminal amino acids of Gi1α
replaced with the corresponding amino acids of Gtα. As shown in Figure 3, the affinity
shift activities of Chi3 show that amino acids 299-319 of Gi1α (α4-helix and α4/β6loop) are critical for 5-HT1A, 5-HT1B and M2 receptor coupling, but not for A1
adenosine receptor coupling. In contrast, Chi13, with six amino acids variant from Gi1α,
was active with all four receptors indicating that the 35 C-terminal amino acids of Gi1α
and Gtα are functionally interchangeable in coupling these receptors. Nevertheless, the
significantly (p<0.01) reduced activity of Chi13 (85.9%) with the M2 receptor and the
significantly (p<0.01) increased activity with both 5-HT1A (128%) and 5-HT1B (124.5%)
receptors suggest subtle differences in the coupling mechanism of these receptors. The
role of the extreme C-terminus of Gi1α cannot be evaluated with these chimeras because
the eight C-terminal amino acids of Gi1α and Gtα are identical.
Role of the α4-helix and α4/β6-loop of Gi1α in receptor coupling- In order to
investigate α4-α4/β6 region of Gi1α in more detail we used several additional chimeras
to subdivide this region (Figure 4). Chi22 has the α4 helix of Gi1α replaced with that
from Gtα while Chi25 has the α4/β6 loop of Gi1α replaced with that from Gtα. Chi23
has the α4/β6 loop of Gi1α replaced with that from Gtα and also switches the Glu in
Gi1α at the end of the α4 helix for the Leu found in Gtα. Chi24 has the central part of
the α4/β6 loop with two variant amino acids switched between Gi1α and Gtα. These
chimeras were fully active with the A1 adenosine receptor (data not shown), supporting
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our conclusion that the A1 receptor does not use the α4-α4/β6 region to distinguish
between Gt and Gi1 (see Figure 3). Figure 5 shows the affinity shift activity of these
chimeras with 5-HT1A, 5-HT1B and M2 receptors. Chi22 had low affinity shift activity
with all three receptors indicating that a critical determinant of coupling selectivity for
these receptors is located in the α4 helix of Gi1α (Figure 5). For the 5-HT1B receptor,
the activity of Chi22 was significantly higher than the activity of Chi3 (p<0.01),
indicating that the α4/β6 loop may also play a role in 5-HT1B receptor coupling. This
conclusion is supported by the Chi25 activity with the 5-HT1B receptor (73%), which
was significantly (p<0.001) lower than the activity of Gi1 (100%). However, Chi25 was
91% as active with M2 muscarinic receptor) which was not significantly different
(p>0.05) from Gi1 activity) and was 121% as active with the 5-HT1A receptor (which
was significantly (p<0.001) higher than Gi1).

Clearly the α4/β6 loop is utilized

differently by these receptors. Chi24 was fully active with all three receptors (Figure 5)
which suggests that the reduced activity of Chi25 with the 5-HT1B receptor is due to the
replacement of Asp309 by Glu at the beginning of the α4/β6 loop (Figure 4). Figure 5
also shows the affinity shift activity of Chi23 was significantly reduced (p<0.001)
compared with the activity of both Gi1 and Chi25 for all three receptors. Chi23 differs
from Chi25 by just one amino acid (replacement of Glu308 from Gi1α for Leu from
Gtα) indicating that Glu308 is important for coupling to 5-HT1A, 5-HT1B and M2
receptors. Taken together, the data indicate that the α4 helix (Glu308 in particular) is
important for all three receptors, and that the α4/β6 loop (probably Asp309) is also
important for 5-HT1B receptors.
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Defining individual amino acids in the α4-α4/β6 region of Gi1α− To prove the
role of Glu308 in receptor coupling and also to study the role of other amino acids in the
α4-α4/β6 region of Gi1α we used chimeras in which amino acids Ala301, Gln304,
Cys305, Glu308, Lys312 and Thr316 of Gi1α were replaced individually or in
combinations with the corresponding amino acids of Gtα. All of the mutants used here
have been previously described (Bae et al., 1999). First we studied the role of these
amino acids with a loss of function assay. Mutants in which amino acids of Gi1α were
replaced individually or in combinations with the corresponding amino acids of
Gtα would be expected to exhibit reduced affinity shift activities if these amino acids
were important for coupling. Replacement of Ala301 with Asn did not reduce activity
(Gi1A301N, Figure 6) demonstrating that Ala301 is not important for coupling any of
the receptors tested. When Gln304 was changed to Lys (Gi1Q304K, Figure 6) activity
with 5-HT1A and M2 receptors was significantly (p<0.001) reduced, but as reported
previously (Bae et al., 1999), this single amino acid replacement did not significantly
reduce affinity shift activity with 5-HT1B receptors (Figure 6). The activity of Gi1C305V
shows that Cys305 is important for M2 muscarinic receptors (67% activity, p<0.001) but
not important for either 5-HT receptor (Figure 6). Glu308 is an important amino acid for
all three receptors as the Gi1E308L mutant displays 62%, 73% and 61% of activity with
5-HT1A, 5-HT1B and M2 receptors respectively (p<0.001) (Figure 6). Lys312 and
Thr316 are not important for coupling these receptors and the increased activity of
Gi1K312M and Gi1T316V with the 5-HT1A receptor (p<0.001) is consistent with the
increased activity of Chi25 with this receptor.
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Data obtained with three double mutants (Gi1Q304K/C305V, Gi1Q304K/E308L,
Gi1C305V/E308L) and a triple mutant (Gi1Q304K/C305V/E308V) support the
conclusions drawn from the point mutants (Figure 6). The activity of the
Gi1Q304K/E308L mutant was lower than the activity of either Gi1Q304K or Gi1E308L
for all receptors supporting the importance of both Gln304 and Glu308 in receptor
coupling. The role of Cys305 in M2 receptor coupling is supported by the observation
that the activity of Gi1Q304K/C305V mutant was significantly lower than the activity of
the Gi1Q304K mutant (p<0.05). Furthermore, the activity of the triple mutant
(Gi1Q304K/C305V/E308V) was the lowest of all with the M2 receptor, supporting the
idea that Gln304, Cys305 and Glu308 are all important for M2 receptor coupling. On
the other hand, the conclusion that Cys305 is not important for coupling the 5-HT1A and
5-HT1B receptors is supported by the observations that the 304/305 and 305/308 double
mutants have similar activities with these receptors as the Q304K and E308L single
mutants and the 304/305/308 triple mutant is similar in activity to the 304/308 double
mutant with these receptors.
Gain of function assays, in which amino acids from Gi1α replaced those from
Gtα in Chi22 were used to confirm the role of the amino acids identified in the loss of
function assay. The data in Figure 7 demonstrate that substituting back Ala301 does not
lead to gain of function with any of the receptors tested, supporting the conclusion that
Ala301 of Gi1α is not important for receptor coupling. Substituting back Gln304
(Chi22K300Q) resulted in significant (p<0.001) gain of activity with 5-HT1B receptors
which is in contrast to the absence of a loss of activity with 5-HT1B receptors when

216

Gln304 was mutated to Lys in Gi1α. Similarly, substituting back Cys305 in the
Chi22V301C mutant also resulted in significant (p<0.05) gain of activity with 5-HT1B
receptors. The precise reasons for these anomalies are unknown but may be related to
the actual role of these amino acids in the context of their neighbors. Substituting back
Glu308 alone (Chi22L304E) resulted in a gain of affinity shift activity of 48% with 5HT1A receptors (p<0.001), 38% with 5-HT1B receptor (p<0.001) but only 17% (p>0.05)
with M2 receptors. However, when both Gln304 and Glu308 were substituted back into
Chi22 sequence (Chi22K300Q/L304E), a full gain of activity was observed with 5-HT1A
and 5-HT1B receptors, as Chi22K300Q/L304E activity was not significantly different
from activity of Gi1 (100%). The gain of function with M2 receptors was significant
(45% gain of activity, p<0.001), though still less than the activity of Gi1. Taken
together, the data indicate that Gln304 and Glu308 of Gi1α are important for 5-HT1A, 5HT1B and M2 receptor coupling, and that Cys305 of Gi1α is important for M2 receptor
coupling in addition to Gln304 and Glu308.
Role of C terminus of Gi1α in receptor coupling- Alignment of the C-terminal
sequences of Gi1α and Gtα indicates that their extreme eight C-terminal amino acids are
identical (Figure 8). Because numerous studies have indicated the C terminus of Gα
plays a significant role in receptor coupling, we decided to investigate the role of C
terminus of Gi1α in 5-HT1A, 5-HT1B, A1 and M2 receptor coupling using Gi1α/Gqα Cterminal chimeras. As shown in the sequence alignments in Figure 8, the extreme Cterminus of Gqα differs from that of Gi1α in just four amino acids. Loss of function
experiments may demonstrate partial or complete loss of activity. As shown in Figure 9,

217

replacement of just two of these amino acids with those from Gqα in the Q3C mutant
significantly lowers the affinity shift activity with all four receptors. The nearly
complete loss of affinity shift activity (0.3% and 11.2%, respectively) with 5-HT1B
serotonin and A1 adenosine receptors suggests that these amino acids are critical for
coupling, while the more modest decrease in activity (65% and 68% activity,
respectively) with the 5-HT1A and M2 receptors suggest these amino acids are important,
but not critical, for coupling. Substitution of the five C-terminal amino acids of Gi1α
with those from Gqα eliminates coupling with the A1 adenosine receptor while
substitution of 11 C-terminal amino acids are required for complete loss of 5-HT1A
receptor coupling (Figure 9). These data indicate that the 5-HT1A, 5-HT1B, A1 adenosine
and M2 muscarinic receptors differ in their utilization of the C-terminal amino acids of
Gi1α for coupling.
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DISCUSSION
G protein-receptor coupling can be regulated by a variety of mechanisms (Wess,
1998; Albert and Robillard, 2002). At the G protein-receptor interface, the selectivity of
coupling is regulated by the amino acid sequences of both receptor and G protein. By
comparing the coupling mechanism of four closely related receptors to the same G
proteins, we found that receptors use multiple domains on Gα to achieve selective
coupling. Coupling selectivity is also regulated by the G protein concentration as
demonstrated by the significant differences among the EC50 values for Gi1-receptor
interactions. This suggests that in living cells the expression levels of specific G protein
subunits may regulate receptor coupling preferences.
At the level of Gα domains, the major difference we found is that the A1
adenosine receptor does not discriminate well between Gi1α and Gtα sequences. In
contrast, the 5-HT and M2 receptors couple with Gi1 but fail to couple with Gt. This
selectivity allowed us to use Gi1α/Gtα chimeras to define domains on Gi1α important
for coupling with these receptors. Our findings indicate that amino acids especially
important for receptor coupling are located in the α4 helix. In addition, the 5-HT1B
receptor may require Asp309 at the beginning of α4/β6 loop for optimal coupling. The
corresponding amino acid in Gtα is Glu305, and while both are negatively charged,
glutamate is one -CH2 group bigger than aspartate. Thus replacement of aspartate with
glutamate may decrease 5-HT1B receptor coupling because of the change in the size of
the receptor interacting surface on Gα. In addition, we demonstrated that within the α4
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helix–α4/β6 loop region of Gi1α the amino acids that are involved in receptor coupling
differ slightly among the receptors. While all three receptors utilize Gln304 and Glu308,
the M2 receptor also uses Cys305 and the 5-HT1B receptor may use Asp309.
Interestingly, interaction of the 5-HT1A receptor with the K312M mutant actually leads
to an increased affinity shift. This increase in affinity shift activity may represent tighter
coupling of the receptor with the chimera. Other investigators have also demonstrated
the importance of this region of Gα in receptor coupling. Natochin et al. demonstrated
the role of Arg310 and Asp311 in interaction of Gtα with rhodopsin (Natochin et al.,
1999). Blahos et al. demonstrated that α4-α4/β6-β6-α5 region of Gα16 is important but
not critical for interaction with metabotropic glutamate receptor 8 (Blahos et al., 2001).
In contrast, the work of Grishina and Berlot shows that α4/β6 loop of Gαs is not
important for interactions with β2 adrenergic receptor (Grishina and Berlot, 2000).
Using gain of function experiments, Ho and Wong demonstrated that incorporation of
α4/β6 loop of Gαz into a Gαt backbone was not sufficient for δ-opioid receptor
coupling (Ho and Wong, 2000). Taken together, these results support the idea that even
if different receptors recognize the same general domain on Gα subunits, the specific
amino acids involved in receptor interactions may be different.
Another region of Gi1α important for 5-HT and M2 receptor coupling is the N
terminus, as affinity shift activity with Chi21 was lower than with Gi1 for these
receptors. According to the literature, the amino acids that bind to the receptor map to
approximately positions 1-30 of the α subunits (Hamm et al., 1988). This region, which
includes the N terminus and the αN helix, contains the most differences between
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Gi1α and Gtα with 15 variant amino acids compared with just 9 variants from amino
acids 31 to 219. Another significant difference between Gi1α and Gtα is that the αN
helix of Gtα is 4 amino acids shorter than the αN helix of Gi1α. Thus it is possible that
amino acids 1-30 are important but not critical for 5-HT and M2 receptor coupling.
Although the C terminus of Gα subunits is postulated to directly contact the
receptor and mediate receptor coupling selectivity, our data show that the specific amino
acids involved in this recognition differ among the receptors studied. Cys351 (position
−4), Gly352 (position −3) and Phe354 (position −1) in Gi family members have been
shown to be important for mediating selectivity of receptor coupling (reviewed in)
(Wess, 1998). Gain of function studies with Gq/i chimeras (Conklin et al., 1993;
Conklin et al., 1996) indicate that five C terminal amino acids of Gi are sufficient for
coupling to A1 and M2 receptors while three C terminal amino acids of Gi are not
enough for A1 receptor coupling (Conklin et al., 1993). Although so far it has not been
possible to successfully solve the structure of the Gα C terminus in the context of the
whole molecule (the C terminus is disordered in the crystal), the structure of the Cterminal undecapeptide of Gtα bound to activated rhodopsin has been resolved by NMR
spectroscopy (Koenig et al., 2002). In this C- terminal decapeptide, the first eight
residues form an α helix which is terminated by an αL type C-cap (Aurora et al., 1994)
with C terminal glycine (Gly348 in Gtα, Gly352 in Gi1α) in the center of the reverse
turn (Kisselev et al., 1998). Thus the observation that in case of A1 receptor three C
terminal amino acids of Gi1α are critical in the loss of function experiments but five C
terminal amino acids are required to gain coupling may be explained by the fact that this
221

αL C-cap, which is disrupted in Gi1/Q3C chimera, is required for A1 receptor coupling.
This is probably also true for the 5-HT1B receptor. Our M2 receptor data indicate that
although this αL C-cap structure is important, it is not critical for receptor coupling. For
the 5-HT1A receptor three C terminal amino acids of Gi1α are important while amino
acids at the positions −4 and −5 (Asp350 and Cys351) are not important (activities of
Gi1/Q3C and Gi1/Q5C are the same). Gi/Q5C and Gi/Q11C are different in three amino
acids, which are probably involved in 5-HT1A receptor coupling. Some additional amino
acids involved in 5-HT1A receptor coupling are located in the α5 helix (see Figure 8) as
evident from the activity of Gi1/Q35C chimera. Taken together, our results support the
idea that different receptors may recognize a specific pattern of amino acids which form
receptor recognition surfaces.
Figure 10 depicts the structure of the Gαi1β1γ2 G protein heterotrimer. Six amino
acids from the C terminus and four amino acids from the N terminus are missing in this
structure (Wall et al., 1995). The domains of Gi1α discussed herein are surface exposed
and located on the G protein surface that is presumed to face the receptor. They are
therefore available for receptor coupling. However, while some amino acids may be
involved in coupling by making direct contact with receptors, others may be involved
indirectly by playing a role in guanine nucleotide exchange. Amino acids Glu304,
Glu308 and Asp309 are surface exposed and so are also available for receptor coupling.
Molecular modeling indicates that Gi1Q304K, Gi1E308L and Gi1304/308 mutations
alter the surface potential (Bae et al., 1999), while Gi1D309E mutation alters steric
interactions because Glu is one CH2 group larger then Asp (water-accessible surfaces of
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native Gi1 and Gi1D309E were constructed and superimposed in Insight II; not shown).
Therefore, structural considerations are consistent with our conclusions. In summary,
here we demonstrated that four closely related Gi/o coupled receptors distinguish
themselves by the affinity with which they interact with Gi1 and by their use of multiple
domains of Gi1α for selective coupling.
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Figure 1.

FIGURE 1. Concentration dependence of Gi1 in affinity shift assays for individual
Gi1-coupled receptors. Sf9 cell membranes expressing the indicated Gi1-coupled
receptors were reconstituted with increasing concentrations of Gi1 heterotrimer. The
affinity shift activities, percent of Gi1 for each receptor were fit to a single-site interaction
between receptor and G protein. Saturation was achieved for each receptor, however for
visual purposes the curves have been extended to a common endpoint. Shown are the data
from representative experiments. EC50 data are the mean ± SEM from 3 or more
independent experiments.
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Figure 2.

FIGURE 2.

Secondary structure of Gα
α subunits. Numbers above the chimeric

structures indicate the junction points of Gαt and Gαi1 sequences and refer to the amino
acid positions in Gtα. Numbers for the wild type forms of Gtα and Gi1α represent their
total amino acid residues. The bottom diagram depicts the secondary structural domains
common to Gα subunits.
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Figure 3.

FIGURE 3. Functional coupling of receptors to the indicated Gi1/Gt chimeras. Sf9
cell membranes expressing individual receptors were reconstituted with the indicated
chimeric Gα and βγ subunits. Data represent the affinity shift activities, percent of Gi1
as mean ± SEM from 3 or more independent experiments for each receptor. Exogenous G
proteins were present in 40-200 fold molar excess over receptors during reconstitution to
achieve the maximal specific binding during the binding assays.
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Figure 4.

FIGURE 4. Primary sequence alignment of the α4-α
α4/β
β6 loop region of Gi1α
α and
Gtα
α. The boxes indicate the regions of Gi1α that were substituted with the corresponding
sequences from Gαt to generate the indicated Gi1α/Gtα chimeras.
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Figure 5.

FIGURE 5. Functional coupling of receptors to the indicated Gi1/Gt chimeras. Sf9
cell membranes expressing individual receptors were reconstituted with the indicated
chimeric Gα and βγ subunits. Data represent the affinity shift activities, percent of Gi1 as
mean ± SEM from 3 or more independent experiments for each receptor. Exogenous G
proteins were present in 40-200 fold molar excess over receptors during reconstitution to
achieve the maximal specific binding during the binding assays.
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Figure 6.

FIGURE 6. Functional coupling of receptors to the indicated Gi1α
α point mutants.
Sf9 cell membranes expressing individual receptors were reconstituted with the indicated
chimeric Gα and βγ subunits. Data represent the affinity shift activities, percent of Gi1
as mean ± SEM from 3 or more independent experiments for each receptor. Exogenous G
proteins were present in 40-200 fold molar excess over receptors during reconstitution to
achieve the maximal specific binding during the binding assays.
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Figure 7.

FIGURE 7. Functional coupling of receptors to the indicated Chi22 point mutants.
Sf9 cell membranes expressing individual receptors were reconstituted with the indicated
chimeric Gα and βγ subunits. Data represent the affinity shift activities, percent of Gi1 as
mean ± SEM from 3 or more independent experiments for each receptor. Exogenous G
proteins were present in 40-200 fold molar excess over receptors during reconstitution to
achieve the maximal specific binding during the binding assays.
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Figure 8.

FIGURE 8. Sequence alignment of 35 C terminal amino acids of Gtα
α, Gi1α
α and
Gqα
α. The sequences of Gtα and Gqα are compared to Gi1α sequence. Depicted in bold
are amino acids of Gtα and Gqα that are different from corresponding amino acids of
Gi1α.
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Figure 9.

FIGURE 9. Functional coupling of receptors to the indicated Gi1/Gq chimeras. Sf9
cell membranes expressing individual receptors were reconstituted with the indicated
chimeric Gα and βγ subunits. Data represent the affinity shift activities, percent of Gi1
as mean ± SEM from 3 or more independent experiments for each receptor. Exogenous G
proteins were present in 40-400 fold molar excess over receptors during reconstitution to
achieve the maximal specific binding during the binding assays.
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Figure 10.

FIGURE 10. Spacefilling representation of the Giαβ
αβ1γ
αβ γ2 heterotrimer. The image was
generated using GRASP (developed by A. Nicholls and B. Honig, Columbia University)
with coordinates from Wall et al. (Wall et al., 1995). The α subunit is shown in metallic
blue and the βγ dimmer is in yellow. The regions involved in receptor coupling as
discussed herein are the α4-helix and α4/β6-loop in pink, Gln304 in red, Glu308 in
green, Asp309 in blue, the C-terminus in cyan, and the N-terminus and αN-helix in gray.
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ABSTRACT
The G-protein regulatory (GPR) motif in AGS3 was recently identified as a
region for protein binding to heterotrimeric G-protein α subunits.

To define the

properties of this ~20 amino acid motif, we designed a GPR consensus peptide and
determined its influence on the activation state of G-protein and receptor coupling to Gprotein. The GPR peptide sequence (28 amino acids) encompassed the consensus
sequence defined by the four GPR motifs conserved in the family of AGS3 proteins. The
GPR consensus peptide effectively prevented the binding of AGS3 to Giα1,2 in protein
interaction assays, inhibited GTPγS binding to Giα and stabilized the GDP-bound
conformation of Giα. The GPR peptide had little effect on nucleotide binding to Goα and
brain G-protein indicating selective regulation of Giα. Thus, the GPR peptide functions
as a guanine nucleotide dissociation inhibitor for Giα. The GPR consensus peptide also
blocked receptor coupling to Giαβγ indicating that although the AGS3-GPR peptide
stabilized the GDP-bound conformation of Giα, this conformation of GiαGDP was not
recognized by a G-protein coupled receptor. The AGS3-GPR motif presents an
opportunity for selective control of Giα-and Gβγregulated effector systems and the GPR
motif allows for alternative modes of signal input to G-protein signaling systems.
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INTRODUCTION

The G-protein regulatory (GPR) motif or GoLOCO repeat is a ~20 amino acid
domain found in several proteins that interact with and/or regulate G-proteins (1,2). Such
proteins include the activator of G-protein signaling AGS3, the AGS3-related protein
PINS in Drosophila melanogaster, two members of the RGS family of proteins and three
proteins (LGN, Pcp2 and Rap1GAP) isolated in yeast two hybrid screens using Giα or
Goα as bait. Rat AGS3 was isolated in a yeast-based functional screen designed to
identify receptor-independent activators of heterotrimeric G-protein signaling (1). The
AGS3-related protein PINS is required for asymmetric cell division of neuroblasts in D.
melanogaster and it is found complexed with Gi/Go (3,4), but neither the signal input or
output for this complex are known. Some insight as to how PINS may regulate Gi/Go is
provided by studies with AGS3 (1).

In the yeast-based system, AGS3 selectively

activated Giα2 and Giα3, but it did not function in Gsα, Gα16 or Gpa1 genetic
backgrounds. The action of AGS3 as a G-protein activator in the yeast-based system was
independent of nucleotide exchange as it was not antagonized by overexpression of
RGS4 and it was still observed following replacement of Giα2 with Giα2-G204A, a
mutant that is deficient in making the transition to the GTP-bound state (1,5). Both of
these manipulations effectively prevent receptor-mediated activation of G-protein
signaling in the yeast system and block the action of AGS1, which was isolated in the
same screen and apparently behaves as a guanine nucleotide exchange factor for
heterotrimeric G-proteins (5,6). These data indicate that the interaction of AGS3 with G-
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protein influences a unique control mechanism within the activation /deactivation cycle
of heterotrimeric G-proteins.
AGS3 exists as a 650 amino acid protein enriched in brain and a 166 amino acid
protein (AGS3-SHORT) enriched in heart (1).1,2 The 650 amino acid protein consists of
two functional domains defined by a series of seven amino terminal tetratricopeptide
repeats (TPR) and four carboxyl terminal GPR motifs. The shorter variant enriched in
heart contains at least three GPR motifs but lacks the TPR domains.2 Site directed
mutagenesis, protein interaction studies and subcellular localization experiments
indicated that the GPR motifs of AGS3 were likely responsible for binding G-protein,
whereas the TPR domain is a site for binding of regulatory proteins (1,3,4).1 AGS3
preferentially binds to Gα in the presence of GDP (1). AGS3-GPR effectively competed
with Gβγ subunits for binding to Gtα and inhibited GTPγS binding to Giα1.1 Such an
activity likely has significance in a number of aspects of G-protein mediated signaling
events and presents a novel opportunity to control the basal activity of G-protein
signaling as well as influence receptor-mediated activation of G-protein.

These

observations also raise many interesting questions relative to basic aspects of G-protein
structure/function and alternative modes of regulation and functional roles for G-protein
signaling systems in the cell. To address these issues, we generated a series of peptides
based upon the consensus GPR motif in AGS3 and evaluated their effects on the
nucleotide binding properties of Giα. A 28 amino acid GPR peptide effectively blocked
the interaction of AGS3 with Giα and inhibited GTPγS binding to Giα by a mechanism
that involved stabilization of the GDP-bound conformation of Giα. Thus, the AGS3-GPR
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peptide is actually a guanine nucleotide dissociation inhibitor (GDI) for the Gi family of
proteins. The GPR consensus peptide also blocked receptor coupling to Giαβγ indicating
that although the AGS3-GPR peptide stabilized the GDP-bound conformation of Giα,
this conformation of GiαGDP was not recognized by a G-protein coupled receptor.
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EXPERIMENTAL PROCEDURES

Materials
[35S]GTPγS (1250 Ci/mmol), [3H]GDP (29.6 Ci/mmol) and [3H] 5-HT (21.8 Ci/mmol)
were purchased from Dupont/NEN (Boston, MA).

Peptides were synthesized and

purified by Bio-Synthesis, Inc. (Lewisville, TX) and peptide mass verified by matrixassisted laser desorption ionization mass spectrometry. Guanosine diphosphate (GDP),
guanosine 5'-O-(3- thiotriphosphate (GTPγS) and 5-hydroxy tryptamine (5-HT) were
obtained from Sigma (St. Louis, MO). Acrylamide, bis-acrylamide, Bio-rad protein assay
kits and sodium dodecyl sulfate were purchased from Bio-Rad (Hercules, CA). Ecoscint
A was purchased from National Diagnostics (Manville, NJ). CytoScint was purchased
from ICN Pharmaceuticals (Costa Mesa, CA). Thesit (polyoxyethylene-9-lauryl ether)
was obtained from Boehringer-Mannheim (Indianapolis, IN). Polyvinylidene difluoride
(PVDF) membranes were obtained from Pall Gelman Sciences (Ann Arbor, MI).
Nitrocellulose BA85 filters were purchased from Schleicher and Shuell (Keene, NH).
Whatman GF/C FP200 filters were purchased from Brandel Inc.(Gaithersburg, MD).
Purified bovine brain G-protein was kindly provided by Dr. John Hildebrandt
(Department of Pharmacology, Medical University of South Carolina) (7). All other
materials were obtained as described elsewhere (1,8).

Protein interaction assays The GPR domain of AGS3 (P463-S650) containing the four
GPR motifs was generated as a glutathione-S-transferase fusion protein by polymerase
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chain reaction (PCR) using the full length cDNA of AGS3 as a template. The AGS3P463-S650 segment was also cloned into the pQE-30 vector (Qiagen, Valencia, CA) to
generate an amino-terminal HIS-tagged protein.

HIS-tagged AGS3 was expressed in

and purified from bacteria using a nickel affinity matrix (ProBond Resin, Invitrogen –
Carlsbad, CA). The HIS-tagged AGS3 was eluted from the matrix with imidazole and
desalted by centrifugation as with the GST fusion protein (1). The interaction of GSTAGS3-GPR and HIS-tagged AGS3-GPR with G-proteins was assessed by protein
interaction experiments using purified G-protein as previously described (1). Giα1-3 and
Goα were purified from Sf9 insect cells infected with recombinant virus as described (8).
All purified G-proteins used in these studies were isolated in the GDP-bound form and Gprotein interaction assays contained 10 µM GDP. The GST-AGS3-GPR fusion protein or
HIS-tagged AGS3-GPR (300 nM) was incubated with purified G-protein (75 nM) for 1
hr at 24oC in a total volume of 250 µl. Glutathione-sepharose or nickel ProBond Resin
(12.5 µl packed resin) was added and the mixture rotated at 4 oC for 20 min after which
the affinity matrix was pelleted and washed three times with 500 µl of incubation buffer
(20 mM Tris-HCl, pH 7.5, 0.6 mM EDTA, 1 mM DTT, 70 mM NaCl, 0.01% Thesit).
Proteins retained on the matrix were solubilized in 2x Laemmli loading buffer and
separated by electrophoresis on denaturing, 10% polyacrylamide gels. Proteins were
transferred to PVDF membranes for immunoblotting. Each blot was checked by
immunoblot with AGS3 antisera to verify equal loading of fusion proteins.
A separate series of protein interaction experiments was designed to determine if
the Giα complexed with AGS3 contained bound GDP. Giα1 (100 nM) was loaded with
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3

H-GDP (0.5 µM, 2.0 x 104 dpm/pmol) by incubation for 20 min at 24oC in binding

buffer (50 mM Hepes-HCl pH 7.5, 1 mM EDTA, 1 mM dithiothreitol, 50 µM adenosine
triphosphate and 10 µg/ml bovine serum albumin). The 3H-GDP loaded Giα1 was
incubated with 300 nM GST or GST-AGS3-GPR in the presence and absence of 10 µM
GPR peptide and processed as described above. The washed resin containing bound
proteins was transferred to vials for measurement of 3H-GDP by liquid scintillation
spectroscopy.

GTPγS binding assays GTPγS binding assays were generally conducted as described (9).
G-proteins (100 nM) were preincubated for 20 min at 24oC in the presence and absence
of GPR peptides. Binding assays (duplicate determinations) were initiated by addition of
0.5 µM GTPγS (4.0 x 104 dpm/pmol) and incubations (total volume = 50 µl) continued
30 min at 24°C. Both preincubations and GTPγS binding assays were conducted in
binding buffer containing 2 mM MgCl2. Reactions were terminated by rapid filtration
through nitrocellulose filters (S&S BA85) with 4 x 4 ml washes of stop buffer (50 mM
Tris-HCl, 5 mM MgCl2, 1 mM EDTA, pH 7.4, 4°C). Radioactivity bound to the filters
was determined by liquid scintillation counting. Nonspecific binding was defined by 100
µM GTPγS.

GDP dissociation assays Giα1 (100 nM) was loaded with 3H-GDP (0.5 µM, 2 x 104
dpm/pmol) by incubation for 20 min at 24oC in binding buffer without MgCl2. Forty five
µl aliquots of the preincubation mixture (~500,000 dpm) were then added to incubation
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tubes containing 10 µl of vehicle or peptide and samples incubated for 30 minutes at
24oC. Two sets of tubes were set up for each time point to be analyzed. Each set
contained duplicate samples for determination of total binding, nonspecific binding or
binding in the presence of peptide. For each time point, one set of tubes served as an
internal time control whereas the other set received added GTPγS or GDP to initiate
dissociation. Data are expressed as % of control where control represents the level of 3HGDP binding at each time point in the set of tubes that did not receive added nucleotide
to initiate dissociation. The amount of

3

H-GDP bound following the 20 min

preincubation (~30,000 dpm) was identical to that observed at the 30 min incubation time
point following addition of vehicle or peptide. 3H-GDP dissociation was initiated by
addition of GTPγS or GDP in a volume of 5 µl (final concentration - 100 µM). Reactions
were terminated at specified time points by rapid filtration through nitrocellulose filters
(S&S BA85) with 4 x 4 ml washes of stop buffer. Radioactivity bound to the filters was
determined by liquid scintillation counting. Nonspecific binding was defined by 100 µM
GDP.

High Affinity Agonist Binding Sf9 cell membranes expressing 5-HT1A receptors were
reconstituted with Gαβγ and high affinity agonist binding measured with 3H-5-HT as
previously described (8,10). Membrane aliquots (100 µg membrane protein, 85 nM
receptor) were preincubated for 15 minutes at 25oC with G-proteins (2125 nM Gαβγ)
with or without GPR peptides in a total volume of 17 µl (reconstitution buffer - 5 mM
NaHEPES, 100 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 500 nM GDP, 0.04% CHAPS,
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pH 7.5). The reconstitution mixtures were then diluted 10-fold with binding buffer (50
mM Tris-HCl, 5 mM MgCl2, 0.5 mM EDTA, pH 7.5) and 50 µl added to binding tubes
(total volume = 150 µl) containing 2 nM 3H 5-HT. The final concentrations of receptor,
G-protein and peptide in the binding tubes were 2.8 nM, 70.8 nM and 114 µM,
respectively. Non-specific binding was determined in the presence of 100 µM 5-HT.
Binding reactions were incubated at 25 °C for 1.5 hr and terminated by filtration over
Whatman GF/C FP200 filters using a Brandel Cell Harvester. The filters were rinsed
thrice with 4 ml ice cold washing buffer (50 mM Tris-Cl, 5 mM MgCl2, 0.5 mM EDTA,
0.01% sodium azide, pH 7.5 at 4 °C), placed in 4.5 ml CytoScint and counted to constant
error in a scintillation counter.
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RESULTS AND DISCUSSION

The ~20 amino acid GPR motif is repeated four times in AGS3 related proteins,
with the exception of the three repeats found in the Drosophila protein PINS (Fig 1).
Alignment of the four GPR repeats from five species revealed a GPR consensus sequence
(Fig 1). The GPR consensus sequence is characterized by the upstream negative charge
(EE) and hydrophobic cluster (FF), L/M10, L/I11, Q15, S/A16, R18, M/L19 and the
DDQR sequence at the carboxyl end of the motif. Helical wheel and Chou-Fasman
analysis indicated that this region is capable of existing as an amphipathic helix. Each of
the GPR motifs illustrated in figure 1 possess a varying number of proline residues just
after and in some cases before the core consensus sequence, which may exert an
important influence within the overall organization of the four GPR motifs. As part of an
effort to define the structural basis of the interaction of AGS3 with Giα and the
functional consequences of this interaction, we asked if a peptide containing this
consensus sequence effectively interacted with Giα.
The core GPR consensus sequence was bracketed by additional residues (three –
amino terminus, five - carboxyl terminus) derived from AGS3-GPR-IV and the carboxyl
terminus was amidated (Fig 1). The 28 amino acid GPR consensus peptide completely
blocked the binding of Giα1 or Giα2 to GST-AGS3-GPR with an IC50 of ~200 nM (Fig
2A,B). The GPR consensus peptide also inhibited GTPγS binding to Giα1 and Giα2
(IC50~200 nM) (Fig 2C,D) consistent with the preferential binding of AGS3 to Giα in the
presence of GDP (1). The inhibitory effect of the GPR consensus peptide on GTPγS
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binding was selective for Giα as it only minimally effected nucleotide binding to Goα or
brain G-protein (Fig 2D). The activity of the GPR consensus peptide in both the protein
interaction assays and GTPγS binding assays was lost upon substitution of F for the
highly conserved R23 (Fig 2B,C,D). However, substitution of A for the invariant Q15
did not alter the activity of the GPR peptide (Fig 2B)3. Similar results were obtained
when these amino acid substitutions were made in the context of GST-AGS3 fusion
protein which contained the terminal 74 amino acids of AGS3 including part of GPR III
and all of GPR IV (1).1
We then addressed the mechanism by which the GPR consensus peptide inhibited
GTPγS binding to Giα2 and determined the effect of the GPR motif on receptor coupling
to G-protein. The inhibition of GTPγS binding to Giα by the GPR consensus peptide may
reflect a reduction in the rate of nucleotide exchange.

Indeed, the rate of GDP

dissociation was markedly diminished in the presence of the GPR consensus peptide (Fig
3A).4 The R23F mutation, which eliminated the effectiveness of the peptide to block
interaction of AGS3 with Giα and GTPγS binding to Giα, also did not alter GDP
dissociation (Fig 3B). The inhibition of GDP dissociation by the GPR consensus peptide
suggests that the GPR motif is stabilizing the GDP-bound conformation of Giα. To
address this issue we evaluated the interaction of GST-AGS3-GPR with Giα2, which had
been preloaded with 3H-GDP. Subsequent analysis of the G-protein complexed with
AGS3-GPR on the glutathione affinity matrix indicated that the nucleotide binding site of
G-protein bound to AGS3 indeed contained GDP (Fig 3B). GiαGDP binding to AGS3GPR was blocked by the GPR consensus peptide (Fig 3B) consistent with the ability of
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this peptide to inhibit interaction of GST-AGS3-GPR with Giα1/2 as detected by
immunoblotting (Fig 2A,B).
The stabilization of the GDP-bound conformation of Giα by the GPR consensus
peptide indicates that the AGS3-GPR motif can influence subunit interactions by
interfering with Gβγ binding to Giα.1 This apparent effect may account for the results
obtained in protein interaction assays using GST-AGS3-GPR and brain lysates, where
Gβγ is absent from the AGS3-Giα complex (1). The influence of the GPR motif on
subunit interactions would have significant implications for signal processing. First,
interaction of the AGS3-GPR motif with Gαβγ would release Gβγ for regulation of
downstream signaling events, while stabilizing GαGDP (1). Such a mode of signal input
may be of utility where there is a need for selective regulation of Gβγ-sensitive effectors.
The time frame for termination of such a signaling event (i.e. reassociation of Gβγ with
Giα GDP) likely differs from that of a more typical signaling event in which there has been
an exchange of nucleotide bound to Giα and signal termination involves GTP hydrolysis
along with subunit reassociation. A second implication of stabilization of GαGDP by a
GPR domain is related to receptor G-protein coupling.

We addressed this issue

experimentally using a membrane assay system where receptor - G-protein coupling is
reflected as high affinity binding of agonists. The high affinity binding of agonist
observed upon reconstitution of the membrane-bound 5-HT1 receptor with Giαβγ, was
inhibited by addition of the GPR peptide (Fig 4). This action of the GPR peptide was not
observed with the R23F peptide and was selective for Gi versus Go (Fig 4).4,5

249

The influence of the single amino acid substitutions on the bioactivity of the GPR
both within the context of a short peptide and a GST fusion protein containing an
additional 74 amino acids of AGS3 sequence strongly suggest a relatively discrete and
specific surface interaction with Giα (Fig 2) (1).1 Helical wheel projections and 3-D
models (Swiss PDB viewer) indicated that when the GPR consensus peptide is fixed in an
αhelical conformation, the F8, A12, Q15, M19 and R23 residues are on the same face of
the helix. On this face of the helix is a hydrophobic sector defined by F8, A12 and M19,
which is bounded by polar residues, which may be involved in charge pairing to residues
in Giα. As was the case for the R23F substitution, disruption of this hydrophobic sector
by substitution of R for F8 also resulted in a loss of activity for the GST-AGS3-GPR
fusion protein in GTPγS binding and protein interaction assays (1).1 Thus, either
extension (R23F substitution) or shortening (F8R) of the hydrophobic sector on this face
of the helix resulted in a loss of bioactivity for the GPR motif. In contrast, strengthening
of this hydrophobic sector by substitution of A for Q15 did not alter the activity of the
GPR peptide. These data indicate an important role for a spatially constrained
hydrophobic stretch of ~16.6 angstroms that is key for peptide interaction with Giα.
The inability of receptor to productively couple to GαGDP-GPR is of interest. The
GαGDP conformation stabilized by the GPR peptide may differ from that stabilized by
Gβγ in such a manner that the receptor cannot recognize Gα. Indeed, the orientations of
the amino and carboxyl domains of Giα1, which are important interactions sites with
receptor, are quite different in the GiαGDP and GiαGDPβγ structures (11-13). In addition
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to such differences in the structural orientation of Giα domains interacting with receptor,
it is likely that receptor contact points on Gβγ also play a role in receptor-mediated
activation of guanine nucleotide exchange (14-18). Alternatively, the receptor may
indeed interact with the GαGDP-GPR complex, but this interaction stabilizes a receptor
conformation with low affinity for agonist (19). Ultimately, one may think of the GαGDPGPR complex as a type of dimeric G-protein, and it is not clear what might provide
“signal input” to such a complex.
Although, the GPR motif is present in several proteins that interact with Gα
and/or regulate nucleotide binding/hydrolysis (1,2), these proteins have different and
often opposing effects on the activation state of G-protein (20,21).1,4

Pcp2, which

contains two GPR motifs based upon this consensus sequence, actually appears to
increase the dissociation of GDP from Goα (21). Thus, there are either subtle differences
in this motif or other residues outside of this motif that play a key role in the specific
functional output gendered by interaction of the GPR motif with Gα. Of note is the
selective effects of the AGS3 GPR peptide for Giα versus Goα in both nucleotide
binding assays and the analysis of receptor coupling to G-proteins. Further dissection of
the structural basis for this selectivity will provide clues as to the site of interaction of the
GPR peptide with Giα and the mechanism by which it stabilizes the GDP-bound
conformation.

One prominent area of sequence divergence between Goα and Giα

encompasses switch IV, a region implicated in the formation of Gi1αGDP multimers
observed by X-ray crystallography (11).
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The role of AGS3 as a GDI is an unexpected concept for heterotrimeric Gproteins although such proteins serve similar regulator roles for ras-related G-proteins.
Proteins containing the AGS3-GPR motif may promote dissociation of Gα and Gβγ in
the absence of nucleotide exchange and present an opportunity for selective control of
Giα-and Gβγ−regulated effector systems. GPR-containing proteins likely play a role in
regulating basal activity of G-protein signaling systems in the cell and provide alternative
modes of signal input to G-protein signaling systems which may either augment,
complement or antagonize G-protein activation by GPCRs.
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FOOTNOTES
1

Bernard, M., Peterson, Y.K., Chung, P. and Lanier, S.M. Submitted.

2

Pizzinat, N, Takesono, A. and Lanier SM. Submitted.

3
4

Peterson YK and Lanier SM. Unpublished observations.
Natochin M, Lester B, Peterson YK, Bernard ML, Lanier SM and Artemyev NO. A

GST-AGS3 fusion protein containing two or four GPR motifs inhibited Gtαβγ activation
by light-activated rhodopsin and this involved inhibition of GDP dissociation from Gα.
Submitted.
5

Ma H, Bernard ML, Lanier SM and Graber SG.

A GST-AGS3 fusion protein

containing four GPR motifs also blocked the high affinity binding of agonist observed
upon reconstitution of the membrane-bound 5-HT1 receptor with Giαβγ and exhibited a
higher potency than the GPR peptide. Unpublished observations.
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FIGURE LEGENDS

Figure 1. Alignment of the GPR motifs found in AGS3 and related proteins.

The

overall domain structure of AGS3 (650 amino acid protein) is indicated at the top of the
figure. The hashed boxes represent the TPR domain. The GPR domains of rat AGS3
(AAF08683), human AGS3 (CAB55951), the D. melanogaster PINS protein
(AAF36967), the C. elegans protein (CE) (AAA81387) and the Tetraodon nigroviridis
(puffer fish) protein (AL338846) were aligned by PILEUP (University of Wisconsin
GCG program) and visual adjustment. A consensus amino acid was defined by the
presence of an amino acid or closely related residue in all four GPR repeats.

Figure 2. Influence of GPR peptides on the interaction of GST-AGS3GPR with Giα
α
and GTPγγS binding to Giα
α.

A,B) The carboxyl region of AGS3

(P463-S650)

containing all four GPR repeats was generated as a HIS-tagged (A) or GST fusion (B)
protein for protein interaction assays as described in “Experimental Procedures”. All
interactions were done in the presence of 10 µM GDP and the input lanes represent one
tenth of the G-protein used in each interaction assay. A) Giα1 (75 nM) was incubated
with 300 nM HIS-tagged AGS3-GPR in the absence and presence of increasing amounts
of the GPR peptide after which bound Giα was isolated on a nickel affinity matrix and
samples processed for immunoblotting with Giα antisera. The blot in the upper panel of
A was stripped and reprobed with AGS3 antisera to provide internal controls for protein
loading. B) Giα2 (75 nM) was incubated with 300 nM AGS3-GPR or GST in the
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presence and absence of 100 µM GPR consensus peptide, GPR peptide Q15A or GPR
peptide R23F. The immunoblots presented in A and B are representative of three
experiments.

C,D) GTPγ35S binding to G-proteins (100 nM) was measured in the

absence and presence of peptides as described in “Experimental Procedures”. Data are
expressed as the percent of specific binding (~5 pmol) observed in the absence of peptide
and represent the means + SEM derived from three experiments. The concentration of
peptides in (D) is 10 µM.

Figure 3.

Stabilization of the GDP-bound conformation of Giα
α2 by the GPR

consensus peptide. A)

3

H GDP dissociation from Giα2 (100 nM). Giα2 was loaded

with 3H-GDP and dissociation initiated by addition of GTPγS (100 µM) as described in
“Experimental Procedures”. Data are expressed as the percent of specific binding
observed in control samples for each time point that did not receive 100 µM GTPγS. The
peptide concentration was 10 µM. B) Giα2 (100 nM) was loaded with 3H-GDP and
incubated with 300 nM GST or GST-AGS3-GPR in the presence and absence of 10 µM
GPR consensus peptide and processed for protein interactions as described in
“Experimental Procedures”. The proteins bound to the glutathione affinity matrix were
eluted and the amount of bound GDP measured by liquid scintillation spectroscopy. Data
in A and B are presented as the means + SEM derived from three experiments.

Figure 4. Influence of GPR peptides on receptor interaction with G-proteins. Sf9
cell membranes expressing 5-HT1A receptors were reconstituted with G-proteins in the
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presence and absence of GPR peptides as described in “Experimental Procedures”. The
final concentration of peptide was 114 µM. Radioligand binding assays used a
concentration of 3H-5HT near the Kd for the high affinity, Gpp(NH)p sensitive binding
site (8,10). The control bar indicates the amount of agonist binding observed in the
absence of added G-protein. Data are presented as the mean + SEM from 4 independent
experiments.
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Figure 1.
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